<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>(The Champion Batch Hyderabad) - 30-09-2025 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Champions Batch
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">200</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 29301,
    "choices": [
      {
        "id": 117110,
        "text": "<p><span style=\"font-size:14.0pt;\">Invasive ductal cancer</span></p>"
      },
      {
        "id": 117111,
        "text": "<p><span style=\"font-size:14.0pt;\">Invasive lobular cancer&nbsp;</span></p>"
      },
      {
        "id": 117112,
        "text": "<p><span style=\"font-size:14.0pt;\">Mucinous carcinoma&nbsp;</span></p>"
      },
      {
        "id": 117113,
        "text": "<p><span style=\"font-size:14.0pt;\">Medullary carcinoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A lady presents with a lump and has been diagnosed with breast cancer. Her biopsy report revealed the presence of tumor cells with signet ring appearance, mucin deposition and Indian file pattern. Which of the following is a likely diagnosis in her?&nbsp;</span></p>",
    "unique_key": "Q7883216",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634539,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Invasive lobular cancer&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical and histopathological features described in the question\u2014<strong>signet ring appearance</strong>, <strong>mucin deposition</strong>, and <strong>Indian file pattern</strong>\u2014are hallmarks of <strong>invasive lobular carcinoma (ILC)</strong> of the breast.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Indian file pattern</strong>: Tumor cells are arranged in a single file or linear pattern due to loss of cell adhesion, which is a key feature of ILC.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Signet ring appearance</strong>: Tumor cells with intracellular mucin push the nucleus to the periphery, giving a signet ring-like morphology.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mucin deposition</strong>: Reflects the production of mucin by the tumor cells, which is a common finding in ILC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Additional characteristics of invasive lobular carcinoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Frequently <strong>bilateral</strong> and multifocal.</span></li><li><span style=\"font-size:14.0pt;\">Associated with a mutation in the <strong>CDH1 gene</strong>, which encodes E-cadherin, a cell adhesion protein. Loss of E-cadherin function is a hallmark of ILC.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Signet ring cells</strong> can also be seen in <strong>familial gastric carcinoma</strong>, particularly the diffuse variant, which is also associated with CDH1 gene mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Invasive ductal cancer:&nbsp;</strong>While invasive ductal carcinoma (IDC) is the most common type of breast cancer, it does not exhibit the <strong>Indian file pattern</strong> or <strong>signet ring cells</strong>. IDC typically presents as a solid mass with a diverse histopathological appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Mucinous carcinoma:</strong> Mucinous carcinoma is characterized by abundant extracellular mucin but lacks the <strong>Indian file pattern</strong> and <strong>signet ring appearance</strong>. It is a less aggressive subtype of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Medullary carcinoma:</strong> Medullary carcinoma of the breast shows syncytial growth of tumor cells with prominent lymphoplasmacytic infiltration and does not exhibit features like <strong>signet ring cells</strong> or <strong>Indian file pattern</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Invasive lobular carcinoma (ILC)</strong> of the breast is characterized by <strong>signet ring cells</strong>, <strong>mucin deposition</strong>, and the <strong>Indian file pattern</strong>. It is often bilateral and associated with <strong>CDH1 gene mutations</strong>, which lead to loss of E-cadherin expression.</span></p>",
    "correct_choice_id": 117111,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74166,
    "choices": [
      {
        "id": 295593,
        "text": "<p><span style=\"font-size:14.0pt;\">Methyldopa</span></p>"
      },
      {
        "id": 295594,
        "text": "<p><span style=\"font-size:14.0pt;\">Labetalol</span></p>"
      },
      {
        "id": 295595,
        "text": "<p><span style=\"font-size:14.0pt;\">Enalapril</span></p>"
      },
      {
        "id": 295596,
        "text": "<p><span style=\"font-size:14.0pt;\">Nifedipine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;32-year-old pregnant woman at 26 weeks of gestation&nbsp;presents with&nbsp;chronic hypertension&nbsp;and requires antihypertensive therapy. She has a history of&nbsp;bronchial asthma&nbsp;and was recently diagnosed with&nbsp;autoimmune hemolytic anemia. Which of the following is the most appropriate choice?</span></p>",
    "unique_key": "Q9643733",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633409,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Nifedipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">All listed drugs are&nbsp;<strong>safe in pregnancy</strong>&nbsp;except&nbsp;<strong>Enalapril</strong>, which is&nbsp;<strong>contraindicated</strong>&nbsp;due to its risk of&nbsp;<strong>fetal renal damage, oligohydramnios, and congenital anomalies</strong>. Some other options are contraindicated due to the patient's comorbidities:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Methyldopa</strong>&nbsp;is avoided due to its association with&nbsp;<strong>hemolytic anemia</strong>&nbsp;(positive Coombs test).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Labetalol</strong>&nbsp;should be avoided in&nbsp;<strong>asthma</strong>&nbsp;due to its potential to cause&nbsp;<strong>bronchospasm</strong>.</span><br><span style=\"font-size:14.0pt;\">Thus,&nbsp;<strong>Nifedipine</strong>&nbsp;(a calcium channel blocker) is the safest choice in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Methyldopa:</strong>&nbsp;<strong>Safe in pregnancy</strong>, but contraindicated in&nbsp;<strong>hemolytic anemia</strong>&nbsp;due to risk of&nbsp;<strong>drug-induced hemolysis</strong>&nbsp;(Coombs-positive hemolytic anemia).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Labetalo:</strong>&nbsp;<strong>Safe in pregnancy</strong>, but contraindicated in&nbsp;<strong>asthma</strong>&nbsp;due to its&nbsp;<strong>beta-2 blocking effects</strong>, which can lead to&nbsp;<strong>bronchoconstriction</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Enalapril:</strong>&nbsp;<strong>Contraindicated in pregnancy</strong>&nbsp;as it is an&nbsp;<strong>ACE inhibitor</strong>, causing&nbsp;<strong>fetal renal damage and teratogenic effects</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">ACE inhibitors like Enalapril are strictly contraindicated in pregnancy. Methyldopa should be avoided in hemolytic anemia, and Labetalol should be avoided in asthma. Nifedipine is the preferred choice when these contraindications exist.</span></p>",
    "correct_choice_id": 295596,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 52116,
    "choices": [
      {
        "id": 207965,
        "text": "<p><span style=\"font-size:12.0pt;\">Thin smear with Giemsa</span></p>"
      },
      {
        "id": 207966,
        "text": "<p><span style=\"font-size:12.0pt;\">Thick smear with Giemsa</span></p>"
      },
      {
        "id": 207967,
        "text": "<p><span style=\"font-size:12.0pt;\">Thin smear with acridine orange</span></p>"
      },
      {
        "id": 207968,
        "text": "<p><span style=\"font-size:12.0pt;\">QBC (Quantitative Buffy Coat)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is best for the malaria species identification? (</span>INICET May 2024)</p>",
    "unique_key": "Q9150783",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633816,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Thin smear with Giemsa</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thin smear with Giemsa stain is the best method for identifying malaria species. This is because thin smears allow for detailed observation of the morphological characteristics of the malaria parasites within red blood cells. The Giemsa stain helps to highlight these features clearly, enabling the identification of the different Plasmodium species based on their unique structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Thin Smear Usage:</strong> Thin smears are used for speciation as they provide a detailed view of the parasites' morphology. This allows for differentiation among the four Plasmodium species (P. vivax, P. falciparum, P. malariae, and P. ovale) by examining the shapes and forms of the parasites within the red blood cells. Thin smears enable the visualization of specific features such as the ring form, amoeboid form, and schizonts in P. vivax, as well as multiple rings and banana-shaped gametocytes in P. falciparum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thick smear with Giemsa:</strong> Thick smears are primarily used for quantification of parasites and for genus identification but are not ideal for speciation because the density of the sample can obscure detailed morphological features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thin smear with acridine orange:</strong> Acridine orange is a fluorescent stain used for rapid screening but is less effective than Giemsa for detailed species identification. It is better suited for initial diagnosis rather than detailed speciation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. QBC (Quantitative Buffy Coat):</strong> QBC is a method used for detecting malaria parasites based on fluorescence microscopy. While it is rapid and sensitive, it does not provide detailed morphological information necessary for accurate species identification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thin smear with Giemsa stain is the best method for detailed malaria species identification due to its ability to highlight specific morphological features of the Plasmodium parasites.</span></p>",
    "correct_choice_id": 207965,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 35223,
    "choices": [
      {
        "id": 140703,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin and amikacin</span></span></span></span></p>"
      },
      {
        "id": 140704,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalexin and gentamicin</span></span></span></span></p>"
      },
      {
        "id": 140705,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampicillin and chloramphenicol</span></span></span></span></p>"
      },
      {
        "id": 140706,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ciprofloxacin and piperacillin</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A post-operative patient developed septicemia and was empirically started on combination chemotherapy by a new resident doctor. However, when the patient did not respond even after 10 days of antibiotics treatment, the review of the charts was done. It was found that that the resident doctor had started the combination of antibiotics which was mutually antagonistic in action. Which of the following is the most likely combination that was given?</span></span></p>",
    "unique_key": "Q2614951",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633806,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ampicillin and chloramphenicol</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation for each option:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ampicillin and chloramphenicol:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampicillin is a penicillin antibiotic effective against Gram-positive and some Gram-negative bacteria.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloramphenicol is a broad-spectrum antibiotic effective against a wide range of bacteria, both Gram-positive and Gram-negative.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of ampicillin and chloramphenicol is known to be antagonistic, as they interfere with each other&#39;s mechanism of action. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Vancomycin and amikacin:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vancomycin is a glycopeptide antibiotic used to treat Gram-positive bacterial infections.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amikacin is an aminoglycoside antibiotic effective against various Gram-negative bacteria.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These antibiotics target different types of bacteria, and there is no known antagonistic interaction between them.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cephalexin and gentamicin:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cephalexin is a cephalosporin antibiotic primarily used for Gram-positive bacterial infections.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gentamicin is an aminoglycoside antibiotic effective against various Gram-negative bacteria.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These antibiotics also target different types of bacteria, and there is no known antagonistic interaction between them.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ciprofloxacin and piperacillin:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ciprofloxacin is a fluoroquinolone antibiotic effective against a variety of Gram-negative and some Gram-positive bacteria.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piperacillin is a broad-spectrum penicillin antibiotic used for both Gram-positive and Gram-negative bacterial infections.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These antibiotics target different types of bacteria, and there is no known antagonistic interaction between them.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To highlight the importance of understanding the interactions between antibiotics when prescribing combination therapy. In this case, the combination of ampicillin and chloramphenicol was chosen, which is known to be antagonistic. It is crucial for healthcare professionals to be aware of potential drug interactions to ensure effective and safe treatment for patients.</span></span></span></span></p>",
    "correct_choice_id": 140705,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26661,
    "choices": [
      {
        "id": 106586,
        "text": "<p><span style=\"font-size:14.0pt;\">1-a, 2-b, 3-c, 4-d</span></p>"
      },
      {
        "id": 106587,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-c, 3-a, 4-d</span></p>"
      },
      {
        "id": 106588,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-a, 4-b</span></p>"
      },
      {
        "id": 106589,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is correctly matched about liver tumor?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/14/untitled-372.jpg\" alt=\"\" width=\"700\" height=\"216\"></span></p>",
    "unique_key": "Q3558446",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634574,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 1-d, 2-c, 3-a, 4-b</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Hepatoblastoma \u2192 (d) Malignant tumor in children with high AFP levels</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Hepatoblastoma is the <strong>most common malignant liver tumor in children</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with <strong>high levels of alpha-fetoprotein (AFP)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Not a benign tumor (common misconception).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Cavernous hemangioma \u2192 (c) Commonest benign tumor in which biopsy is contraindicated</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Most common benign liver tumor</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Biopsy is contraindicated</strong> due to <strong>high risk of hemorrhage</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Angiosarcoma \u2192 (a) Plastic pipe factory worker with vWF as marker</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Highly aggressive</strong> malignant tumor of the liver.</span></li><li><span style=\"font-size:14.0pt;\">Associated with exposure to <strong>vinyl chloride (plastic industry), arsenic, and thorotrast</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>vWF (von Willebrand factor) is a marker</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Fibrolamellar HCC \u2192 (b) Young adult with PRKACA-DNAJB1 oncogene (+)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Rare variant of hepatocellular carcinoma (HCC).</span></li><li><span style=\"font-size:14.0pt;\">Occurs in <strong>young adults without hepatitis B or cirrhosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Associated with <strong>PRKACA-DNAJB1 fusion oncogene</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hepatoblastoma is a malignant liver tumor in children with high AFP levels.</span></li><li><span style=\"font-size:14.0pt;\">Cavernous hemangioma is the most common benign liver tumor, and biopsy is contraindicated.</span></li><li><span style=\"font-size:14.0pt;\">Angiosarcoma is linked to vinyl chloride exposure and expresses vWF.</span></li><li><span style=\"font-size:14.0pt;\">Fibrolamellar HCC occurs in young adults and is associated with PRKACA-DNAJB1 oncogene.</span></li></ul>",
    "correct_choice_id": 106588,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29333,
    "choices": [
      {
        "id": 117238,
        "text": "<p><span style=\"font-size:14.0pt;\">Autoimmune hemolytic anemia&nbsp;</span></p>"
      },
      {
        "id": 117239,
        "text": "<p><span style=\"font-size:14.0pt;\">Hereditary spherocytosis&nbsp;</span></p>"
      },
      {
        "id": 117240,
        "text": "<p><span style=\"font-size:14.0pt;\">Microangiopathic haemolytic anemia&nbsp;</span></p>"
      },
      {
        "id": 117241,
        "text": "<p><span style=\"font-size:14.0pt;\">Thermal injury causing anemia&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is associated with an intrinsic defect in the RBC membrane?&nbsp;</span></p>",
    "unique_key": "Q9170860",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634555,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hereditary spherocytosis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hereditary spherocytosis</strong> is an <strong>intrinsic defect of the RBC membrane</strong> caused by mutations in genes encoding membrane proteins such as <strong>ankyrin</strong>, <strong>band 3</strong>, or <strong>spectrin</strong>. This leads to increased RBC fragility and premature destruction in the spleen. Key features include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Intrinsic membrane defect</strong>: Unlike autoimmune or external causes, the defect originates within the RBC membrane.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Clinical features</strong>: Patients may present with hemolytic anemia, jaundice, splenomegaly, and gallstones.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Diagnostic tests</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Osmotic fragility test</strong>: Increased due to the fragile nature of spherocytes in hypotonic solutions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Flow cytometry with eosin-5-maleimide (EMA)</strong>: A confirmatory test for hereditary spherocytosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Coombs test</strong>: Negative, differentiating it from autoimmune hemolytic anemia.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Autoimmune hemolytic anemia:&nbsp;</strong>Autoimmune hemolytic anemia (AIHA) is caused by <strong>extrinsic factors</strong>, specifically autoantibodies targeting RBCs. It is diagnosed with a <strong>positive Coombs test</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Microangiopathic hemolytic anemia:&nbsp;</strong>Microangiopathic hemolytic anemia (MAHA) is caused by mechanical damage to RBCs in conditions like <strong>disseminated intravascular coagulation (DIC)</strong> or <strong>thrombotic thrombocytopenic purpura (TTP)</strong>. The defect is extrinsic, and schistocytes are seen on peripheral smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Thermal injury causing anemia:&nbsp;</strong>Thermal injury anemia is due to <strong>burn-related damage</strong> to RBCs, causing extrinsic hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hereditary spherocytosis</strong> involves an intrinsic defect in the RBC membrane caused by mutations in ankyrin, spectrin, or band 3.</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is confirmed via the <strong>osmotic fragility test</strong> and <strong>flow cytometry with EMA</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is differentiated from autoimmune hemolytic anemia by a <strong>negative Coombs test</strong> and from MAHA by the absence of schistocytes.</span></li></ul>",
    "correct_choice_id": 117239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74160,
    "choices": [
      {
        "id": 295569,
        "text": "<p><span style=\"font-size:14.0pt;\">Clopidogrel</span></p>"
      },
      {
        "id": 295570,
        "text": "<p><span style=\"font-size:14.0pt;\">Atorvastatin</span></p>"
      },
      {
        "id": 295571,
        "text": "<p><span style=\"font-size:14.0pt;\">Isosorbide dinitrate</span></p>"
      },
      {
        "id": 295572,
        "text": "<p><span style=\"font-size:14.0pt;\">Metoprolol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male with a history of coronary artery disease and chronic stable angina is brought to the emergency department after collapsing at home. His wife reports that he took a medication for erectile dysfunction earlier that evening. His blood pressure is&nbsp;70/40 mmHg, and he appears confused. Which of the following medications is most likely to have interacted with his erectile dysfunction drug, causing this severe hypotension?</span></p>",
    "unique_key": "Q7754000",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633406,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Isosorbide dinitrate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient\u2019s collapse and severe hypotension (<strong>BP 70/40 mmHg</strong>) after taking an&nbsp;<strong>erectile dysfunction (ED) medication </strong>(likely&nbsp;<strong>sildenafil</strong>) suggests a&nbsp;<strong>dangerous drug interaction with nitrates</strong>.&nbsp;<strong>Isosorbide dinitrate</strong>, a nitrate, is commonly used for&nbsp;<strong>angina</strong>&nbsp;and works by causing&nbsp;<strong>vasodilation</strong>. Sildenafil (<strong>PDE-5 inhibitor</strong>) also causes vasodilation by increasing&nbsp;<strong>cGMP levels</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When&nbsp;<strong>nitrates and sildenafil</strong>&nbsp;are taken together, they cause&nbsp;<strong>severe systemic vasodilation</strong>, leading to a&nbsp;<strong>profound drop in blood pressure</strong>, syncope, and even life-threatening shock.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Clopidogrel:</strong> An antiplatelet drug used to prevent clot formation. It does not cause hypotension or interact with sildenafil.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Atorvastatin:</strong> A statin used for lipid control; does not cause hypotension or interact with sildenafil.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metoprolol</strong>: A&nbsp;<strong>beta-blocker</strong>&nbsp;that can cause mild bradycardia and hypotension but does not have a severe interaction with sildenafil.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sildenafil is absolutely contraindicated in patients on nitrates due to the risk of life-threatening hypotension.</span></p>",
    "correct_choice_id": 295571,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74189,
    "choices": [
      {
        "id": 295685,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of TNF-alpha</span></p>"
      },
      {
        "id": 295686,
        "text": "<p><span style=\"font-size:14.0pt;\">IL-1 receptor antagonist</span></p>"
      },
      {
        "id": 295687,
        "text": "<p><span style=\"font-size:14.0pt;\">Monoclonal antibody against IL-6</span></p>"
      },
      {
        "id": 295688,
        "text": "<p><span style=\"font-size:14.0pt;\">Extracellular increase in adenosine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female with rheumatoid arthritis has persistent joint pain and swelling despite being on methotrexate. Her rheumatologist is considering adding anakinra to her treatment regimen. What is the mechanism of action of anakinra?</span></p>",
    "unique_key": "Q7498935",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633422,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) IL-1 receptor antagonist</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anakinra is a&nbsp;<strong>recombinant IL-1 receptor antagonist (IL-1Ra)</strong>&nbsp;that&nbsp;<strong>blocks the action of interleukin-1 (IL-1) by competitively binding to the IL-1 receptor</strong>, preventing IL-1\u03b1 and IL-1\u03b2 from exerting their pro-inflammatory effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">IL-1 plays a key role in the&nbsp;<strong>pathogenesis of rheumatoid arthritis (RA)</strong>&nbsp;by promoting:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Synovial inflammation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Cartilage degradation</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Bone resorption</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">By&nbsp;<strong>blocking IL-1 signaling</strong>, anakinra&nbsp;<strong>reduces inflammation and joint damage</strong>&nbsp;in RA and is also used in&nbsp;<strong>auto-inflammatory syndromes&nbsp;</strong>like<strong> systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still\u2019s disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Inhibition of TNF-alpha:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>TNF-alpha inhibitors</strong>&nbsp;(e.g., infliximab, etanercept, adalimumab) block TNF signaling.</span></li><li><span style=\"font-size:14.0pt;\">Anakinra&nbsp;<strong>does not target TNF-alpha</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Monoclonal antibody against IL-6:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tocilizumab</strong>&nbsp;is a monoclonal antibody that targets&nbsp;<strong>IL-6 receptors</strong>, not anakinra.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Extracellular increase in adenosine:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Methotrexate</strong>&nbsp;increases extracellular adenosine, leading to anti-inflammatory effects.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Anakinra works via IL-1 receptor antagonism, not adenosine modulation.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anakinra is an IL-1 receptor antagonist, blocking IL-1 effects in inflammatory diseases.</span></li><li><span style=\"font-size:14.0pt;\">Used in RA, Still\u2019s disease, and auto-inflammatory syndromes.</span></li><li><span style=\"font-size:14.0pt;\">Does not inhibit TNF-alpha, IL-6, or increase extracellular adenosine.</span></li><li><span style=\"font-size:14.0pt;\">Less commonly used than TNF inhibitors but helpful in certain cases.</span></li></ul>",
    "correct_choice_id": 295686,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35227,
    "choices": [
      {
        "id": 140719,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anthracyclines </span></span></span></span></p>"
      },
      {
        "id": 140720,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkylating agents </span></span></span></span></p>"
      },
      {
        "id": 140721,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platinum compounds </span></span></span></span></p>"
      },
      {
        "id": 140722,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisphosphonates</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old woman named Hema has locally advanced breast cancer and has been recommended for chemotherapy. She has a history of myocardial infarction and congestive heart failure. Which antineoplastic drug should be avoided in her treatment?</span></span></span></span></p>",
    "unique_key": "Q5347477",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633808,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Anthracyclines</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation for each option:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Anthracyclines:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anthracyclines, such as doxorubicin and daunorubicin, are commonly used antineoplastic drugs for various cancers, including breast cancer.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">However, they are known for their potential cardiotoxicity, which can lead to congestive heart failure and exacerbate cardiac issues.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the patient&#39;s history of myocardial infarction and congestive heart failure, anthracyclines should be avoided to minimize the risk of further cardiac damage.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alkylating agents:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkylating agents, like cyclophosphamide, work by damaging the DNA of cancer cells, preventing their growth.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While they can have various side effects, they are not typically associated with significant cardiotoxicity.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkylating agents are not a direct concern in this patient&#39;s case due to her cardiac history.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Platinum compounds:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platinum-based drugs such as cisplatin and carboplatin are used in chemotherapy for various cancers.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are not typically associated with cardiotoxicity.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Platinum compounds are not a direct concern for this patient&#39;s cardiac condition.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Bisphosphonates:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisphosphonates are not antineoplastic drugs; they are used to treat bone-related issues, such as osteoporosis or hypercalcemia.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They are not directly related to breast cancer treatment and are not a concern in this context.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational objective here is to emphasize the importance of tailoring chemotherapy regimens to the individual patient&#39;s medical history and comorbidities. It is crucial to avoid drugs with known cardiotoxic effects in patients with a history of heart conditions to ensure their safety during cancer treatment.</span></span></span></span></p>",
    "correct_choice_id": 140719,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35937,
    "choices": [
      {
        "id": 143543,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotaxime has more oral bioavailability</span></span></span></p>"
      },
      {
        "id": 143544,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotaxime is more active against H. influenza having altered penicillin binding proteins</span></span></span></p>"
      },
      {
        "id": 143545,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotaxime is a cidal drug whereas ampicillin is bacteriostatic</span></span></span></p>"
      },
      {
        "id": 143546,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotaxime is more active against beta-lactamase producing strains</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A child was admitted to the hospital with H. Influenzae meningitis. Cefotaxime is preferred over ampicillin because: </span></span></span></p>",
    "unique_key": "Q7375771",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633802,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Cefotaxime is more active against beta-lactamase producing strains</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotaxime is an injectable 3<sup>rd</sup> generation cephalosporin whereas ampicillin is an oral penicillin. This can be used to find out that ampicillin has higher oral bioavailability as compared to cefotaxime. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All beta lactams (including cefotaxime and ampicillin) are bactericidal drugs. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistance to most strains of H. influenza occurs due to production of beta lactamases. Therefore, ampicillin (which was the drug of choice earlier) is not effective in many patients. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Now, a third-generation cephalosporin like cefotaxime is preferred among beta lactams. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Another highly effective drug for H. influenza is azithromycin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If there is alteration of penicillin binding proteins, usually most beta lactams become ineffective.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 143546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73314,
    "choices": [
      {
        "id": 292209,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 4&nbsp;</span></p>"
      },
      {
        "id": 292210,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 292211,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3&nbsp;</span></p>"
      },
      {
        "id": 292212,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A sputum sample shows gram-positive cocci on microscopy. The organism is catalase-negative and shows partial hemolysis on blood agar. Which of the following tests can be performed to differentiate the organisms?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Optochin sensitivity</span></li><li><span style=\"font-size:14.0pt;\">Bacitracin sensitivity</span></li><li><span style=\"font-size:14.0pt;\">Growth in 6.5% NaCl</span></li><li><span style=\"font-size:14.0pt;\">Bile solubility</span></li><li><span style=\"font-size:14.0pt;\">Novobiocin sensitivity</span></li></ol>",
    "unique_key": "Q5917176",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634466,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 4</strong></span></p>",
    "correct_choice_id": 292209,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73283,
    "choices": [
      {
        "id": 292085,
        "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcus aureus</span></p>"
      },
      {
        "id": 292086,
        "text": "<p><span style=\"font-size:14.0pt;\">Escherichia coli&nbsp;</span></p>"
      },
      {
        "id": 292087,
        "text": "<p><span style=\"font-size:14.0pt;\">Neisseria gonorrhea</span></p>"
      },
      {
        "id": 292088,
        "text": "<p><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the organism based on the provided image:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Gbmr9tu.png\" width=\"735\" height=\"683\"></span></p>",
    "unique_key": "Q4864764",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634409,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Neisseria gonorrhea</strong></span></p>",
    "correct_choice_id": 292087,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 52122,
    "choices": [
      {
        "id": 207989,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryptosporidium</span></p>"
      },
      {
        "id": 207990,
        "text": "<p><span style=\"font-size:12.0pt;\">Isospora</span></p>"
      },
      {
        "id": 207991,
        "text": "<p><span style=\"font-size:12.0pt;\">Cyclospora</span></p>"
      },
      {
        "id": 207992,
        "text": "<p><span style=\"font-size:12.0pt;\">Microsporidia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old renal transplant patient presented with watery diarrhea. Stool examination revealed oval cysts 30 x 15 microns as shown in the image below. Which among the following is the causative organism:&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-161435.png\" alt=\"\" width=\"300\" height=\"193\"></span></p>",
    "unique_key": "Q1452034",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633819,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Isospora</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient is a renal transplant recipient, indicating an immunocompromised state due to immunosuppressive drugs. Immunocompromised patients are more susceptible to infections, including parasitic infections causing diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The stool examination revealed oval cysts measuring 30 x 15 microns, which were acid-fast positive. These characteristics are crucial in identifying the parasite:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Immunocompromised State:</strong> This condition makes the patient more prone to infections by opportunistic parasites.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Acid-Fast Positive Cysts:</strong> This staining characteristic is seen in certain parasitic cysts.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Size and Shape of Cysts:</strong> The cysts are oval and measure 30 x 15 microns.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Based on the provided images and reference notes, Isospora belli (now known as Cystoisospora belli) is the parasite that fits these criteria. Isospora cysts are known to be oval in shape and measure approximately 20 to 30 microns in length, consistent with the 30 x 15 microns cysts described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryptosporidium</strong>: Cryptosporidium cysts are round, not oval, and are much smaller (4 to 6 microns). They do not fit the size and shape described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cyclospora</strong>: Cyclospora cysts are also round and measure approximately 8 to 10 microns, which do not match the size and shape given in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Microsporidia</strong>: Microsporidia produce very small spores (1 to 2 microns) and are not typically described as having 30 x 15 microns cysts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Isospora belli (Cystoisospora belli) causes watery diarrhea in immunocompromised patients and is identified by its oval cysts measuring approximately 20 to 30 microns, which are acid-fast positive.</span></p>",
    "correct_choice_id": 207990,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 29309,
    "choices": [
      {
        "id": 117142,
        "text": "<p><span style=\"font-size:14.0pt;\">Minimal change disease</span></p>"
      },
      {
        "id": 117143,
        "text": "<p><span style=\"font-size:14.0pt;\">Post streptococcal glomerulonephritis&nbsp;</span></p>"
      },
      {
        "id": 117144,
        "text": "<p><span style=\"font-size:14.0pt;\">(FSGS)&nbsp;Focal segmental glomerulosclerosis&nbsp;</span></p>"
      },
      {
        "id": 117145,
        "text": "<p><span style=\"font-size:14.0pt;\">IgA nephropathy</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A child develops sore throat. After 2 weeks he develops edema and cola coloured urine. This is suggestive of:</span></p>",
    "unique_key": "Q6377493",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634543,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Post streptococcal glomerulonephritis&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The clinical presentation of a <strong>sore throat</strong>, followed by <strong>edema</strong> and <strong>cola-colored urine</strong> after 2 weeks, is characteristic of <strong>post-streptococcal glomerulonephritis (PSGN)</strong>. PSGN is a classic example of a <strong>type III hypersensitivity reaction</strong> triggered by immune complex deposition in the kidneys following a group A beta-hemolytic streptococcal (GABHS) infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key diagnostic features:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Latency period:</strong> The onset of symptoms occurs 1\u20132 weeks after a streptococcal infection (e.g., sore throat or skin infection).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Edema and cola-colored urine:</strong> Due to nephritic syndrome, characterized by hematuria, mild proteinuria, and hypertension.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Kidney biopsy findings:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Electron microscopy:</strong> Subepithelial \"humps\" formed by immune complex deposits.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immunofluorescence:</strong> \"Starry sky\" appearance due to scattered immune deposits.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Minimal change disease (MCD):&nbsp;</strong>MCD typically causes nephrotic syndrome (severe proteinuria, hypoalbuminemia, edema) and is most common in young children. It does not follow a streptococcal infection or present with hematuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. FSGS (Focal Segmental Glomerulosclerosis):&nbsp;</strong>FSGS causes nephrotic syndrome and is commonly associated with conditions like obesity, HIV, or heroin use. It is not linked to a prior infection or cola-colored urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IgA nephropathy:&nbsp;</strong>IgA nephropathy (Berger's disease) can present with hematuria following an upper respiratory tract infection, but symptoms usually occur within <strong>1\u20132 days (synpharyngitic hematuria)</strong> rather than 1\u20132 weeks, as seen in PSGN.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Post-streptococcal glomerulonephritis (PSGN)</strong> occurs 1\u20132 weeks after a streptococcal infection and is characterized by <strong>immune complex-mediated glomerular injury</strong>. Key findings include <strong>subepithelial humps</strong> on electron microscopy and a <strong>starry sky appearance</strong> on immunofluorescence.</span></p>",
    "correct_choice_id": 117143,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26702,
    "choices": [
      {
        "id": 106746,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemolytic anemia</span></p>"
      },
      {
        "id": 106747,
        "text": "<p><span style=\"font-size:14.0pt;\">Alcoholic liver disease</span></p>"
      },
      {
        "id": 106748,
        "text": "<p><span style=\"font-size:14.0pt;\">Biliary obstruction</span></p>"
      },
      {
        "id": 106749,
        "text": "<p><span style=\"font-size:14.0pt;\">Gilbert's syndrome</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 25-year-old male Kabir presents with complaints of yellowish discoloration of the skin and sclerae for the past few days. He denies any recent fever, abdominal pain, or dark urine. On examination, there is jaundice noted. Laboratory tests reveal elevated levels of unconjugated bilirubin in the serum with normal hemoglobin. Which of the following is the most likely cause of his unconjugated hyperbilirubinemia?</span></p>",
    "unique_key": "Q2594778",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634580,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Gilbert's syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The key findings in this patient include <strong>isolated unconjugated hyperbilirubinemia</strong> with <strong>normal hemoglobin levels</strong> and <strong>no signs of hemolysis or liver dysfunction</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Gilbert's syndrome</strong> is a <strong>benign inherited disorder</strong> caused by <strong>reduced activity of the enzyme UDP-glucuronosyltransferase (UGT1A1)</strong>, which leads to <strong>impaired bilirubin conjugation in the liver</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Typical triggers for jaundice in Gilbert's syndrome include</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Fasting or stress</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Infections</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Exertion or dehydration</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Menstruation</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Patients are otherwise healthy</strong>, and the condition is diagnosed <strong>incidentally</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hemolytic Anemia&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hemolysis leads to <strong>increased RBC breakdown</strong>, resulting in <strong>unconjugated hyperbilirubinemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>However, this patient has normal hemoglobin</strong>, ruling out hemolysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Alcoholic Liver Disease&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Alcoholic liver disease causes <strong>both conjugated and unconjugated hyperbilirubinemia</strong> due to liver dysfunction.</span></li><li><span style=\"font-size:14.0pt;\">This patient has <strong>isolated unconjugated bilirubin elevation</strong>, and <strong>no history of alcohol use</strong> is given.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Biliary Obstruction&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Biliary obstruction leads to <strong>conjugated hyperbilirubinemia</strong>, not unconjugated.</span></li><li><span style=\"font-size:14.0pt;\">It is usually associated with <strong>pale stools, dark urine, and itching</strong>, which are absent in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Gilbert\u2019s syndrome is a common, benign cause of unconjugated hyperbilirubinemia</strong> due to <strong>reduced UGT1A1 enzyme activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It is often triggered by stress, fasting, infections, or exertion</strong> and presents without liver dysfunction or hemolysis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It does not require treatment and is managed with reassurance.</strong></span></li></ul>",
    "correct_choice_id": 106749,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74186,
    "choices": [
      {
        "id": 295673,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of cyclooxygenase by aspirin&nbsp;</span></p>"
      },
      {
        "id": 295674,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of thromboxane A2 synthase by aspirin&nbsp;</span></p>"
      },
      {
        "id": 295675,
        "text": "<p><span style=\"font-size:14.0pt;\">Gastric bleeding caused by aspirin to peptic ulcer&nbsp;</span></p>"
      },
      {
        "id": 295676,
        "text": "<p><span style=\"font-size:14.0pt;\">All of these. give answer and explanation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient on low dose aspirin therapy presented with occult blood in the stool. Which of the following best describes the mechanism of this adverse effect?&nbsp;</span></p>",
    "unique_key": "Q4628520",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633420,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Inhibition of Cyclooxygenase by Aspirin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Aspirin, even at&nbsp;<strong>low doses (75\u2013150 mg/day)</strong>, is associated with&nbsp;<strong>occult GI bleeding</strong>, but it does&nbsp;<strong>not directly cause peptic ulcers</strong>. Instead, its&nbsp;<strong>primary mechanism</strong>&nbsp;for GI bleeding is through&nbsp;<strong>inhibition of cyclooxygenase (COX), particularly COX-1</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. Low-dose aspirin does not cause peptic ulcers</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Peptic ulcers are primarily caused by H. pylori infection and NSAIDs that significantly inhibit COX-1.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low-dose aspirin is a weak acid and can cause mucosal injury,</strong>&nbsp;but it is less likely to induce&nbsp;<strong>deep ulcer formation</strong>&nbsp;compared to non-selective NSAIDs (e.g., ibuprofen, naproxen).</span></li><li><span style=\"font-size:14.0pt;\">However, low-dose aspirin can&nbsp;<strong>increase the risk of bleeding</strong>&nbsp;from&nbsp;<strong>pre-existing ulcers</strong>&nbsp;due to its&nbsp;<strong>antiplatelet effects</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. Inhibition of Thromboxane A\u2082 Synthesis via COX Inhibition (Not TXA\u2082 Synthase Inhibition)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aspirin&nbsp;<strong>does NOT inhibit thromboxane A\u2082 (TXA\u2082) synthase directly</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Instead, it irreversibly&nbsp;<strong>inhibits COX-1</strong>, which prevents the conversion of&nbsp;<strong>arachidonic acid into prostaglandin H\u2082 (PGH\u2082),</strong>&nbsp;the precursor for thromboxane A\u2082.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TXA\u2082 synthase remains functional,</strong>&nbsp;but since its substrate (PGH\u2082) is depleted, TXA\u2082 production decreases, leading to&nbsp;<strong>impaired platelet aggregation and increased bleeding risk</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. COX-1 Inhibition as the Main Cause of GI Bleeding</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>COX-1 inhibition reduces protective prostaglandins (PGE2, PGI2) in the gastric mucosa</strong>, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Decreased mucus and bicarbonate secretion</span></li><li><span style=\"font-size:14.0pt;\">Increased gastric acid secretion</span></li><li><span style=\"font-size:14.0pt;\">Mucosal injury and increased susceptibility to microbleeds</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This explains why&nbsp;<strong>occult GI bleeding occurs even without ulcer formation</strong>&nbsp;in patients on low-dose aspirin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Inhibition of thromboxane A\u2082 synthase by aspirin:</strong> Aspirin<strong> does not directly inhibit TXA\u2082 synthase</strong>; it only&nbsp;<strong>reduces the availability of its precursor (PGH\u2082)</strong>by inhibiting COX.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gastric bleeding caused by aspirin due to peptic ulcer: Low-dose aspirin does not directly cause peptic ulcers</strong>&nbsp;but can&nbsp;<strong>exacerbate bleeding from pre-existing ulcers.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. All of these:&nbsp;</strong>Since&nbsp;<strong>Option B and C are not entirely correct</strong>, the&nbsp;<strong>best answer remains A (COX inhibition).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Low-dose aspirin does not cause peptic ulcers but increases the risk of GI bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Aspirin inhibits COX, not thromboxane A\u2082 synthase.</span></li><li><span style=\"font-size:14.0pt;\">COX-1 inhibition leads to decreased gastric protection and increased risk of occult bleeding.</span></li><li><span style=\"font-size:14.0pt;\">Aspirin-induced GI bleeding can be reduced with PPIs (e.g., omeprazole) or enteric-coated formulations.</span></li></ul>",
    "correct_choice_id": 295673,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29341,
    "choices": [
      {
        "id": 117270,
        "text": "<p><span style=\"font-size:14.0pt;\">2 only</span></p>"
      },
      {
        "id": 117271,
        "text": "<p><span style=\"font-size:14.0pt;\">3 only&nbsp;</span></p>"
      },
      {
        "id": 117272,
        "text": "<p><span style=\"font-size:14.0pt;\">1 and 4</span></p>"
      },
      {
        "id": 117273,
        "text": "<p><span style=\"font-size:14.0pt;\">2 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true about proto-oncogenes?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">KIT has decreased expression in GIST.</span></li><li><span style=\"font-size:14.0pt;\">KRAS mutation is more commonly associated with small-cell lung carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">ERBB2 over-expression is associated with breast carcinomas.</span></li><li><span style=\"font-size:14.0pt;\">PDGFR-\u03b2 has suppressed expression in colorectal cancers.</span></li></ol>",
    "unique_key": "Q7124184",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634559,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 3 Only&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">ERBB2 encodes for HER2, which is involved in Breast carcinoma. ERBB1 encodes for EGRF, which is involved in Adenocarcinoma of lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. ERBB2 over-expression is associated with breast carcinomas</strong>: Correct. <strong>ERBB2 (HER2)</strong> over-expression/amplification is a well-known driver in <strong>breast carcinomas</strong> and is targeted by therapies such as trastuzumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. KIT has decreased expression in GIST:&nbsp;</strong>Incorrect. <strong>KIT (CD117)</strong> is <strong>over-expressed</strong> or activated in gastrointestinal stromal tumors (GISTs). Most GISTs are associated with activating mutations in the KIT gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. KRAS mutation is more commonly associated with small-cell lung carcinoma:&nbsp;</strong>Incorrect. <strong>KRAS mutations</strong> are associated with <strong>non-small cell lung carcinoma (NSCLC)</strong>, particularly adenocarcinomas, but not small-cell lung carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>4. PDGFR-\u03b2 has suppressed expression in colorectal cancers:&nbsp;</strong>Incorrect. <strong>PDGFR-\u03b2</strong> is often over-activated in various cancers, including colorectal cancers. Suppressed expression is not typically observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>ERBB2 (HER2)</strong> over-expression is a hallmark of <strong>breast cancer</strong> and is a critical target for treatment.</span></li></ul>",
    "correct_choice_id": 117271,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73432,
    "choices": [
      {
        "id": 292677,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      },
      {
        "id": 292678,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 292679,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 292680,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">IgG2 deficiency causes recurrent sinopulmonary infections specifically caused by encapsulated bacteria.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Positive hair perforation test is seen in Trichophyton mentagrophytes.</span></li><li><span style=\"font-size:14.0pt;\">Antibody detection in stool samples is the best diagnostic approach for confirming rotavirus infection</span></li><li><span style=\"font-size:14.0pt;\">Thayer Martin agar is the selective medium of choice for isolating Neisseria gonorrhoeae</span></li></ol>",
    "unique_key": "Q8451226",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634399,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span>&nbsp;<span style=\"font-size:14.0pt;\"><strong>D) 1, 2, 4</strong></span></p>",
    "correct_choice_id": 292680,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54520,
    "choices": [
      {
        "id": 217549,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Post streptococcal glomerulonephritis</span></span></span></p>"
      },
      {
        "id": 217550,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis</span></span></span></p>"
      },
      {
        "id": 217551,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
      },
      {
        "id": 217552,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rhabdomyolysis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient had fever and sore throat for which he was started on antibiotic treatment. He develops abdominal pain. He has eosinophiluria and also has WBC casts in his urine. What is the likely diagnosis of the patient? (</span></span></span>INICET May 2024)</p>",
    "unique_key": "Q4007245",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634530,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) Tubulointerstitial nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis, also known as acute allergic interstitial nephritis, is often caused by an allergic reaction to medications such as antibiotics. In this scenario, the patient had a fever and sore throat and was subsequently treated with antibiotics, likely from the penicillin group. Penicillin and other beta-lactam antibiotics are common culprits in causing type 1 hypersensitivity reactions, leading to the presence of eosinophils in the urine (eosinophiluria). This condition is also associated with the presence of WBC casts in the urine, indicating inflammation of the renal interstitium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Post streptococcal glomerulonephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This condition typically presents with RBC casts rather than WBC casts and does not involve eosinophiluria. It follows a streptococcal infection and involves immune complex deposition in the glomeruli.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Lupus nephritis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Lupus nephritis is characterized by immune complex deposition in the glomeruli, leading to glomerulonephritis. It is not typically associated with eosinophiluria and primarily presents with RBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Rhabdomyolysis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rhabdomyolysis involves the breakdown of muscle tissue, leading to the release of muscle contents into the bloodstream, including myoglobin, which can cause renal damage. It is characterized by elevated creatine kinase levels and does not present with eosinophiluria or WBC casts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubulointerstitial nephritis can present with eosinophiluria and WBC casts in the urine, often following antibiotic treatment, particularly with beta-lactam antibiotics. This condition results from an allergic reaction causing inflammation in the renal interstitium.</span></span></span></p>",
    "correct_choice_id": 217550,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 74162,
    "choices": [
      {
        "id": 295577,
        "text": "<p><span style=\"font-size:14.0pt;\">Abacavir</span></p>"
      },
      {
        "id": 295578,
        "text": "<p><span style=\"font-size:14.0pt;\">Efavirenz</span></p>"
      },
      {
        "id": 295579,
        "text": "<p><span style=\"font-size:14.0pt;\">Emtricitabine</span></p>"
      },
      {
        "id": 295580,
        "text": "<p><span style=\"font-size:14.0pt;\">Ritonavir</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old HIV-positive male with a&nbsp;CD4 count of 180 cells/mm\u00b3&nbsp;is started on&nbsp;antiretroviral therapy (ART). Two weeks later, he presents with complaints of&nbsp;vivid dreams, nightmares, dizziness, and difficulty concentrating, especially at night. Which of the following drugs is most likely responsible for these symptoms?</span></p>",
    "unique_key": "Q3943984",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633407,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Efavirenz</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">One of the&nbsp;<strong>non-nucleoside reverse transcriptase inhibitors (NNRTIs)</strong>&nbsp;is known to cause&nbsp;<strong>CNS side effects</strong>, including&nbsp;<strong>vivid dreams, nightmares, dizziness, and difficulty concentrating</strong>, particularly during the first few weeks of therapy. These symptoms often improve with time.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Abacavir:</strong> Can cause&nbsp;<strong>hypersensitivity reactions (HLA-B*5701 testing required)</strong>&nbsp;but not CNS toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Emtricitabine:</strong> Well-tolerated, with&nbsp;<strong>hyperpigmentation of palms/soles</strong>&nbsp;as a possible side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ritonavir:</strong> Used as a&nbsp;<strong>pharmacokinetic booster</strong>&nbsp;(CYP3A4 inhibitor), but does not cause CNS effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Efavirenz is known for its CNS side effects, which typically improve over time and are more pronounced when taken close to bedtime.</span></p>",
    "correct_choice_id": 295578,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74148,
    "choices": [
      {
        "id": 295521,
        "text": "<p><span style=\"font-size:14.0pt;\">Continue LMWH until delivery</span></p>"
      },
      {
        "id": 295522,
        "text": "<p><span style=\"font-size:14.0pt;\">Switch to intravenous unfractionated heparin</span></p>"
      },
      {
        "id": 295523,
        "text": "<p><span style=\"font-size:14.0pt;\">Stop LMWH and induce labor</span></p>"
      },
      {
        "id": 295524,
        "text": "<p><span style=\"font-size:14.0pt;\">Switch to warfarin immediately</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman at&nbsp;35 weeks of gestation&nbsp;is receiving&nbsp;LMWH&nbsp;for a&nbsp;history of deep vein thrombosis (DVT) earlier in pregnancy. She presents to the hospital in&nbsp;early labor. What is the most appropriate next step in management?</span></p>",
    "unique_key": "Q6943216",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633400,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Switch to intravenous unfractionated heparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Why?</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>LMWH has a long half-life (~12 hours)</strong>&nbsp;and is&nbsp;<strong>not easily reversible</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In late pregnancy (<strong>\u226536 weeks</strong>), patients at&nbsp;<strong>high risk of thrombosis</strong>&nbsp;are typically&nbsp;<strong>switched from LMWH to unfractionated heparin (UFH)</strong>&nbsp;because:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">UFH has a&nbsp;<strong>shorter half-life (~1-2 hours)</strong>, allowing&nbsp;<strong>easier discontinuation before delivery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It can be&nbsp;<strong>rapidly reversed with protamine sulfate</strong>, reducing the risk of&nbsp;<strong>excessive bleeding at delivery</strong>.</span></li><li><span style=\"font-size:14.0pt;\">UFH is&nbsp;<strong>stopped 4-6 hours before delivery</strong>&nbsp;and restarted postpartum.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">UFH provides&nbsp;<strong>better control before delivery</strong>, and can be stopped quickly if labor progresses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Continue LMWH until delivery</strong>: Incorrect. LMWH has&nbsp;<strong>a long half-life</strong>, increasing the risk of&nbsp;<strong>bleeding complications</strong>&nbsp;during delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Stop LMWH and induce labor:&nbsp;</strong>Incorrect. Stopping LMWH without a bridge increases&nbsp;<strong>thrombosis risk</strong>. Induction is&nbsp;<strong>not routinely needed</strong>&nbsp;unless obstetrically indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Switch to warfarin immediately:</strong> Incorrect. Warfarin is <strong>teratogenic and contraindicated in pregnancy</strong>, and should be <strong>started</strong> <strong>postpartum</strong> if long-term anticoagulation is needed.</span></p>",
    "correct_choice_id": 295522,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 69405,
    "choices": [
      {
        "id": 276705,
        "text": "<p><span style=\"font-size:14.0pt;\">Moraxella catarrhalis</span></p>"
      },
      {
        "id": 276706,
        "text": "<p><span style=\"font-size:14.0pt;\">Proteus mirabilis</span></p>"
      },
      {
        "id": 276707,
        "text": "<p><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa&nbsp;</span></p>"
      },
      {
        "id": 276708,
        "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus pneumoniae</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 3-year-old boy is brought to the clinic due to left ear pain over the past 3 days. Last week, the patient developed a runny nose and cough, which resolved 2 days prior to the development of ear pain. There is purulent drainage from the left ear. Otoscopic examination of the left ear reveals a normal-appearing external canal and an erythematous tympanic membrane with purulent fluid pooling within the distal external canal. Which of the following organisms is the most likely cause of this patient's diagnosis?</span></p>",
    "unique_key": "Q5299489",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634407,
    "difficulty_level": "beginner",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Streptococcus pneumoniae</strong></span></p>",
    "correct_choice_id": 276708,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73358,
    "choices": [
      {
        "id": 292381,
        "text": "<p><span style=\"font-size:14.0pt;\">H. nana&nbsp;</span></p>"
      },
      {
        "id": 292382,
        "text": "<p><span style=\"font-size:14.0pt;\">T. solium</span></p>"
      },
      {
        "id": 292383,
        "text": "<p><span style=\"font-size:14.0pt;\">E. granulosus</span></p>"
      },
      {
        "id": 292384,
        "text": "<p><span style=\"font-size:14.0pt;\">D. latum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the organism from the head end as shown below:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Bvkuye9.png\" width=\"448\" height=\"259\"></span></p>",
    "unique_key": "Q2246963",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634474,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) D. latum</strong></span></p>",
    "correct_choice_id": 292384,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73308,
    "choices": [
      {
        "id": 292185,
        "text": "<p><span style=\"font-size:14.0pt;\">Aspergillus&nbsp;</span></p>"
      },
      {
        "id": 292186,
        "text": "<p><span style=\"font-size:14.0pt;\">Mucor&nbsp;</span></p>"
      },
      {
        "id": 292187,
        "text": "<p><span style=\"font-size:14.0pt;\">Rhizopus&nbsp;</span></p>"
      },
      {
        "id": 292188,
        "text": "<p><span style=\"font-size:14.0pt;\">Blastomyces</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the organism in the given image showing KOH and LPCB culture morphology:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_A1mymnD.png\" width=\"493\" height=\"203\"></p>",
    "unique_key": "Q3288938",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634415,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Rhizopus</strong></span></p>",
    "correct_choice_id": 292187,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 26615,
    "choices": [
      {
        "id": 106402,
        "text": "<p><span style=\"font-size:14.0pt;\">Fresh frozen plasma&nbsp;</span></p>"
      },
      {
        "id": 106403,
        "text": "<p><span style=\"font-size:14.0pt;\">Platelet rich plasma&nbsp;</span></p>"
      },
      {
        "id": 106404,
        "text": "<p><span style=\"font-size:14.0pt;\">Single donor platelets&nbsp;</span></p>"
      },
      {
        "id": 106405,
        "text": "<p><span style=\"font-size:14.0pt;\">Cryoprecipitate&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">You are working in a hospital where you are training blood bank technicians about blood components. Which of the following blood component does not show ABO incompatibility?&nbsp;</span></p>",
    "unique_key": "Q9283608",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634568,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Cryoprecipitate&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When transfusing <strong>blood components</strong>, <strong>ABO compatibility is crucial</strong> for most products, particularly those containing <strong>plasma and red blood cell antigens</strong>. However, <strong>cryoprecipitate does not show ABO incompatibility</strong> and can be transfused without strict ABO matching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Concepts:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fresh frozen plasma (FFP)</strong> and <strong>platelet-rich plasma (PRP)</strong> contain <strong>plasma proteins and antibodies</strong>, requiring <strong>ABO compatibility</strong> to prevent hemolysis or immune reactions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Single donor platelets</strong> also express <strong>minor ABO antigens</strong>, and <strong>ABO matching is preferred</strong> for optimal transfusion efficacy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cryoprecipitate is primarily composed of clotting factors (Factor VIII, fibrinogen, von Willebrand factor, Factor XIII, and fibronectin)</strong> and contains <strong>minimal plasma</strong>, making ABO incompatibility <strong>insignificant</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Even though it is <strong>ideal</strong> to transfuse <strong>ABO-matched cryoprecipitate</strong>, it <strong>does not cause major reactions</strong> if mismatched.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Uses of Cryoprecipitate:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hemophilia A (Factor VIII deficiency)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Von Willebrand disease (vWF deficiency)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypofibrinogenemia (low fibrinogen levels in bleeding patients)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>other coagulation factor deficiencies</strong> (e.g., <strong>Hemophilia B or Factor IX deficiency</strong>), <strong>fresh frozen plasma (FFP)</strong> is used instead of cryoprecipitate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fresh frozen plasma: Contains plasma proteins and antibodies</strong>, requiring <strong>ABO compatibility</strong> to prevent hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Platelet-rich plasma</strong>: <strong>Platelets express ABO antigens</strong>, and plasma contains <strong>antibodies</strong>, necessitating <strong>ABO matching for better efficacy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Single donor platelets</strong>: <strong>ABO matching is preferred</strong>, as platelets contain some <strong>ABO antigens</strong>, and transfusion from a mismatched donor can reduce platelet survival and function.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cryoprecipitate does not show significant ABO incompatibility</strong> and can be transfused <strong>regardless of blood group</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fresh frozen plasma, platelet-rich plasma, and single donor platelets require ABO compatibility</strong> due to the presence of <strong>antigens and antibodies</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cryoprecipitate is used primarily for Hemophilia A, von Willebrand disease, and hypofibrinogenemia.</strong></span></li></ul>",
    "correct_choice_id": 106405,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 43914,
    "choices": [
      {
        "id": 175319,
        "text": "<p><span style=\"font-size:12.0pt;\">Dilated cardiomyopathy</span></p>"
      },
      {
        "id": 175320,
        "text": "<p><span style=\"font-size:12.0pt;\">HOCM</span></p>"
      },
      {
        "id": 175321,
        "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
      },
      {
        "id": 175322,
        "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 73-year-old diabetic, hypertensive woman underwent a cardiac biopsy. Her histology image with special stain is as shown below. What is the diagnosis?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151313.JPG\" alt=\"\" width=\"300\" height=\"236\"></span></p>",
    "unique_key": "Q5322423",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634478,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Restrictive cardiomyopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy is characterized by abnormal diastolic filling with relatively preserved systolic function. The histology often shows increased myocardial stiffness due to fibrosis, which is evident as diffuse fibrotic deposition within the myocardium. The cardiac muscle appears normal in size or slightly hypertrophic without significant dilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dilated cardiomyopathy:&nbsp;</strong>Typically shows dilated heart chambers and significant myocardial thinning with fibrosis, which is not evident in the provided histology image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypertrophic obstructive cardiomyopathy (HOCM):&nbsp;</strong>Characterized by marked hypertrophy of the myocardium, especially the septum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atrial fibrillation:&nbsp;</strong>This is primarily an electrical disorder of the heart, typically not diagnosed via myocardial biopsy and does not have a distinctive histopathological appearance related to the rhythm disorder itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In restrictive cardiomyopathy, the key histological feature is myocardial fibrosis leading to stiffening of the heart muscle, which impacts its ability to fill properly during diastole, though systolic function might be preserved.</span></p>",
    "correct_choice_id": 175321,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 73445,
    "choices": [
      {
        "id": 292729,
        "text": "<p><span style=\"font-size:14.0pt;\">Borrelia quinatana&nbsp;</span></p>"
      },
      {
        "id": 292730,
        "text": "<p><span style=\"font-size:14.0pt;\">Borrelia vincentii&nbsp;</span></p>"
      },
      {
        "id": 292731,
        "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcus aureus&nbsp;</span></p>"
      },
      {
        "id": 292732,
        "text": "<p><span style=\"font-size:14.0pt;\">Streptococcus agalactiae&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old girl complains of low-grade fever and mild discomfort in her throat. On examination, a membrane is seen over the tonsil that can be removed easily. After removal of the membrane, an irregular ulcer is seen on the surface of the tonsil. What is the likely cause of Trench mouth?&nbsp;</span></p>",
    "unique_key": "Q8123956",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634401,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Borrelia vincentii</strong></span></p>",
    "correct_choice_id": 292730,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73398,
    "choices": [
      {
        "id": 292541,
        "text": "<p><span style=\"font-size:14.0pt;\">Transmitted by chiggers</span></p>"
      },
      {
        "id": 292542,
        "text": "<p><span style=\"font-size:14.0pt;\">Caused by obligate intracellular Gram-negative bacterium&nbsp;</span></p>"
      },
      {
        "id": 292543,
        "text": "<p><span style=\"font-size:14.0pt;\">Produces NLF producing colonies in MacConkey agar</span></p>"
      },
      {
        "id": 292544,
        "text": "<p><span style=\"font-size:14.0pt;\">Man is an accidental host</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All of the following is true regarding scrub typhus except:&nbsp;</span></p>",
    "unique_key": "Q2665722",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634389,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Produces NLF producing colonies in MacConkey agar&nbsp;</strong></span></p>",
    "correct_choice_id": 292543,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 33854,
    "choices": [
      {
        "id": 135254,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Chloroquine plus primaquine</span></p>"
      },
      {
        "id": 135255,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Quinine</span></p>"
      },
      {
        "id": 135256,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Artemisinin based combination therapy</span></p>"
      },
      {
        "id": 135257,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Doxycycline</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
    "unique_key": "Q7962807",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633424,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) Quinine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">For a pregnant woman with Plasmodium vivax malaria, Chloroquine alone is the appropriate choice. Primaquine is contraindicated during pregnancy due to potential risks to the fetus. Quinine is normally used for Plasmodium falciparum malaria but can be used in P. vivax malaria also if other options are not available. It is safe in pregnancy. ACTs are generally avoided in the first trimester, and Doxycycline is contraindicated in pregnancy. Therefore, Chloroquine, without Primaquine, is the safest and most effective option in this case. However, as it is not in the options, so the next best option i.e. quinine will be the answer.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Chloroquine plus Primaquine:</strong> Chloroquine is considered safe and effective for the treatment of Plasmodium vivax malaria during pregnancy. However, primaquine is contraindicated in pregnancy due to the risk of hemolytic anemia in the fetus, especially if there is G6PD deficiency, which cannot be tested for in the fetus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Artemisinin-Based Combination Therapy (ACT):</strong> While ACTs are very effective in treating Plasmodium falciparum malaria, their safety profile in the first trimester of pregnancy is not well-established. Generally, they are avoided in the first trimester unless no other options are available.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Doxycycline:</strong> Doxycycline is contraindicated in pregnancy due to the risk of interfering with bone and teeth development in the fetus.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Quinine is often used as a treatment for malaria during pregnancy, especially if other options are not available or suitable. However, it is usually more associated with the treatment of Plasmodium falciparum rather than Plasmodium vivax.</span></p>",
    "correct_choice_id": 135255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 29323,
    "choices": [
      {
        "id": 117198,
        "text": "<p><span style=\"font-size:14.0pt;\">Biopsy shall have unaltered mucosal thickness&nbsp;</span></p>"
      },
      {
        "id": 117199,
        "text": "<p><span style=\"font-size:14.0pt;\">Dietary substitution is helpful for this patient&nbsp;</span></p>"
      },
      {
        "id": 117200,
        "text": "<p><span style=\"font-size:14.0pt;\">There is reduced risk of small bowel lymphoma&nbsp;</span></p>"
      },
      {
        "id": 117201,
        "text": "<p><span style=\"font-size:14.0pt;\">Chronic, intensely itchy blistering skin rash may develop in 10% patients.&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A middle-aged lady has diarrhea and abdominal flatulence.&nbsp; Her intestinal biopsy demonstrated villous atrophy and serum had the Anti - TTG antibodies present in it. Which of the following is not true about this condition?</span></p>",
    "unique_key": "Q8965427",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634550,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) There is reduced risk of small bowel lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">False. Celiac disease is associated with an <strong>increased risk of small bowel lymphoma</strong>, particularly <strong>Enteropathy-Associated T-cell Lymphoma (EATL)</strong>. This is one of the serious long-term complications of untreated or refractory celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Biopsy shall have unaltered mucosal thickness:&nbsp;</strong>True. Despite villous atrophy and crypt hyperplasia, the overall mucosal thickness remains unaltered in celiac disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dietary substitution is helpful for this patient:&nbsp;</strong>True. A gluten-free diet is the mainstay of treatment and can help reverse the histological changes, alleviate symptoms, and reduce long-term risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chronic, intensely itchy blistering skin rash may develop in 10% of patients: </strong>True. <strong>Dermatitis herpetiformis</strong>, a chronic blistering rash, is seen in about 10% of celiac patients. It is highly pruritic and responds well to <strong>dapsone</strong> in addition to a gluten-free diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Celiac disease</strong> is characterized by <strong>villous atrophy</strong>, <strong>crypt hyperplasia</strong>, and <strong>anti-TTG antibodies</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Long-term risks include <strong>iron deficiency anemia</strong> and <strong>small bowel lymphoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A gluten-free diet is both diagnostic and therapeutic.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dermatitis herpetiformis</strong> is a common extraintestinal manifestation treated with <strong>dapsone</strong> alongside dietary management.</span></li></ul>",
    "correct_choice_id": 117200,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 43911,
    "choices": [
      {
        "id": 175307,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATM</span></span></span></span></p>"
      },
      {
        "id": 175308,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 1</span></span></span></span></p>"
      },
      {
        "id": 175309,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MSH 2</span></span></span></span></p>"
      },
      {
        "id": 175310,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ku 70</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one is not helpful in DNA Double stand break repair?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2023)</span></span></p>",
    "unique_key": "Q9025800",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634523,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) MSH 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MSH 2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is part of the mismatch repair (MMR) system and does not play a direct role in repairing double-strand breaks (DSBs) in DNA. Its main function is to correct base-pair mismatches and insertion-deletion loops during DNA replication and recombination.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. ATM:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ataxia telangiectasia mutated (ATM) protein is crucial for recognizing DNA double-strand breaks and initiating repair via the homologous recombination pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. BRCA 1:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breast cancer type 1 susceptibility protein is involved in the repair of DNA double-strand breaks predominantly through the homologous recombination pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Ku 70:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ku 70, along with Ku 80, forms the Ku heterodimer, which binds to DNA double-strand breaks and plays a critical role in the non-homologous end joining (NHEJ) repair pathway.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MSH 2 is associated with mismatch repair and not directly involved in the repair mechanisms of double-strand breaks, which are crucial processes for maintaining genomic stability and preventing malignant transformations</span></span></span></p>",
    "correct_choice_id": 175309,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73292,
    "choices": [
      {
        "id": 292121,
        "text": "<p><span style=\"font-size:14.0pt;\">A-3, B-2, C-4, D-1</span></p>"
      },
      {
        "id": 292122,
        "text": "<p><span style=\"font-size:14.0pt;\">A-2, B-1, C-4 ,D-3</span></p>"
      },
      {
        "id": 292123,
        "text": "<p><span style=\"font-size:14.0pt;\">A-1, B-2, C-3, D-4</span></p>"
      },
      {
        "id": 292124,
        "text": "<p><span style=\"font-size:14.0pt;\">A-4, B-3, C-1, D-2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following parasites with their respective hosts:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DuTpOnY.png\" width=\"822\" height=\"299\"></span></p>",
    "unique_key": "Q8300035",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634411,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;A-3, B-2, C-4, D-1</strong></span></p>",
    "correct_choice_id": 292121,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74144,
    "choices": [
      {
        "id": 295505,
        "text": "<p><span style=\"font-size:14.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 295506,
        "text": "<p><span style=\"font-size:14.0pt;\">Bisoprolol</span></p>"
      },
      {
        "id": 295507,
        "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
      },
      {
        "id": 295508,
        "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old male with a history of chronic heart failure (EF = 35%) and hypertension presents to the emergency department with complaints of worsening shortness of breath and dizziness. He was recently started on a new medication for heart failure. On examination, his heart rate is 48 bpm, and his blood pressure is 95/60 mmHg. ECG shows sinus bradycardia without AV block. Which of the following medications is most likely responsible for his symptoms?</span></p>",
    "unique_key": "Q1822419",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633398,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Bisoprolol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Beta-blockers like&nbsp;<strong>Bisoprolol, Carvedilol, and Metoprolol succinate</strong>&nbsp;are recommended for&nbsp;<strong>heart failure with reduced ejection fraction (HFrEF)</strong>&nbsp;because they&nbsp;<strong>reduce mortality</strong>. However, they can cause&nbsp;<strong>bradycardia and hypotension</strong>, especially when started at a high dose or in patients with a low baseline heart rate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Digoxin:</strong> Can cause&nbsp;<strong>bradycardia</strong>, but it is more commonly associated with&nbsp;<strong>AV block and arrhythmias</strong>&nbsp;rather than just sinus bradycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Furosemide:</strong> A loop diuretic used for volume overload in CHF. It does not typically cause&nbsp;<strong>bradycardia</strong>, but it can lead to&nbsp;<strong>hypotension</strong>&nbsp;if overused.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Spironolactone:</strong> A <strong>potassium-sparing diuretic</strong> that reduces mortality in CHF. It does not directly cause <strong>bradycardia</strong>, though <strong>hyperkalemia-induced conduction abnormalities</strong> can occur.</span></p>",
    "correct_choice_id": 295506,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26623,
    "choices": [
      {
        "id": 106434,
        "text": "<p><span style=\"font-size:14.0pt;\">Mucoprotein&nbsp;</span></p>"
      },
      {
        "id": 106435,
        "text": "<p><span style=\"font-size:14.0pt;\">Uric acid</span></p>"
      },
      {
        "id": 106436,
        "text": "<p><span style=\"font-size:14.0pt;\">Magnesium ammonium phosphate</span></p>"
      },
      {
        "id": 106437,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium oxalate</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 24-year-old man has severe lower abdominal pain that radiates to the groin. He then notes blood in his urine. Which of the following substances is most likely to be increased in his urine?</span></p>",
    "unique_key": "Q1638871",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634572,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Calcium oxalate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient\u2019s <strong>sudden onset of severe lower abdominal pain radiating to the groin</strong>, along with <strong>hematuria (blood in urine)</strong>, suggests <strong>nephrolithiasis (kidney stone disease)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Most Common Type of Kidney Stones:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Calcium oxalate stones</strong> are the <strong>most common type</strong> (80% of kidney stones).</span></li><li><span style=\"font-size:14.0pt;\">They form in <strong>acidic urine</strong> and appear as <strong>envelope-shaped (dihydrate) or dumbbell-shaped (monohydrate) crystals</strong> on urine microscopy.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hypercalciuria (increased calcium in urine)</strong> and <strong>hyperoxaluria (increased oxalate in urine)</strong> are major risk factors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Causes of Calcium Oxalate Stones:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Idiopathic hypercalciuria</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Diet high in oxalate-rich foods (spinach, nuts, chocolate)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Low fluid intake (dehydration)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperparathyroidism (increased calcium excretion)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mucoprotein:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mucoprotein forms the <strong>organic matrix of kidney stones</strong>, serving as a <strong>nidus (core) for crystal deposition</strong>.</span></li><li><span style=\"font-size:14.0pt;\">However, it <strong>does not directly contribute to stone formation or appear in large amounts in urine.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Uric acid:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uric acid stones form in <strong>acidic urine</strong> and are associated with <strong>gout, chronic diarrhea, or high-purine diets</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Microscopically appear as rhomboid or rosette-shaped crystals.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Magnesium ammonium phosphate (Struvite stones):</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Struvite stones are associated with <strong>urinary tract infections (UTIs)</strong> caused by <strong>urease-producing bacteria (Proteus, Klebsiella, Ureaplasma urealyticum)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Microscopically appear as \"coffin-lid\" crystals.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Calcium oxalate stones are the most common type of kidney stones and appear as envelope- or dumbbell-shaped crystals in urine.</span></li><li><span style=\"font-size:14.0pt;\">Risk factors include hypercalciuria, hyperoxaluria, and low fluid intake.</span></li><li><span style=\"font-size:14.0pt;\">Other types of stones include uric acid (rhomboid), struvite (coffin-lid), and cystine (hexagonal) stones.</span></li></ul>",
    "correct_choice_id": 106437,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29337,
    "choices": [
      {
        "id": 117254,
        "text": "<p><span style=\"font-size:14.0pt;\">Febrile non-hemolytic transfusion reaction&nbsp;</span></p>"
      },
      {
        "id": 117255,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemolysis</span></p>"
      },
      {
        "id": 117256,
        "text": "<p><span style=\"font-size:14.0pt;\">Transmission of infections&nbsp;</span></p>"
      },
      {
        "id": 117257,
        "text": "<p><span style=\"font-size:14.0pt;\">Electrolyte imbalance&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Most common blood transfusion reaction is:</span></p>",
    "unique_key": "Q2999901",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634557,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Febrile non-hemolytic transfusion reaction&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>most common blood transfusion reaction</strong> is a <strong>Febrile Non-Hemolytic Transfusion Reaction (FNHTR)</strong>, occurring in up to 1% of transfusions. It is a mild, non-life-threatening reaction characterized by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Fever</strong> (increase of \u22651\u00b0C above baseline).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chills or rigors</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Occurs without evidence of <strong>hemolysis</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cause:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">FNHTR is typically caused by <strong>cytokines</strong> released by donor leukocytes or by the recipient's immune response to donor leukocyte antigens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Stop the transfusion</strong> to rule out hemolytic reactions.</span></li><li><span style=\"font-size:14.0pt;\">Administer <strong>antipyretics (e.g., paracetamol)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Use leukoreduced blood products in future transfusions to prevent recurrence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hemolysis:&nbsp;</strong>Incorrect. <strong>Hemolytic transfusion reactions</strong> are less common but more severe, caused by ABO incompatibility or other alloantibodies. They can present with fever, pain at the infusion site, hemoglobinuria, or disseminated intravascular coagulation (DIC).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Transmission of infections:</strong> Incorrect. While the risk of infection transmission (e.g., HIV, Hepatitis B/C) exists, it is very low with current screening protocols.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">O<strong>ption D. Electrolyte imbalance:</strong> Incorrect. Electrolyte imbalances like hyperkalemia or hypocalcemia can occur with massive transfusions but are much less common than FNHTR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Febrile Non-Hemolytic Transfusion Reaction (FNHTR)</strong> is the <strong>most common</strong> reaction, usually mild, and associated with donor leukocyte antigens or cytokines.</span></li></ul>",
    "correct_choice_id": 117254,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 43955,
    "choices": [
      {
        "id": 175483,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 175484,
        "text": "<p><span style=\"font-size:12.0pt;\">Aplastic Anaemia</span></p>"
      },
      {
        "id": 175485,
        "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anaemia</span></p>"
      },
      {
        "id": 175486,
        "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old vegetarian patient presented with weakness and reduced work capacity. He had a Hb of 10gm/dl and MCV-110. What is the most likely diagnosis?&nbsp;(INICET NOV 2023)</span></p>",
    "unique_key": "Q6778398",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634476,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Megaloblastic anemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Megaloblastic anemia&nbsp;</strong>is characterized by the presence of large, abnormal red blood cells (megaloblasts) in the bone marrow. It is often caused by deficiencies in vitamin B12 or folic acid, both crucial for DNA synthesis in the production of red blood cells. The high mean corpuscular volume (MCV-110) indicates that the red blood cells are larger than normal, which is typical in megaloblastic anemia. Being vegetarian, the patient is at a higher risk of vitamin B12 deficiency, commonly seen in diets lacking in animal products.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iron deficiency anemia</strong>: Typically presents with a low MCV (microcytic anemia), not high, as it indicates smaller than normal red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Aplastic anemia</strong>: Involves pancytopenia (reduction of all blood cell types) and does not typically present with high MCV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thalassemia</strong>: Generally presents with a low MCV and affects the production of hemoglobin. It is a genetic disorder rather than related to dietary habits.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of anemia with high MCV, especially in vegetarians or those with dietary restrictions, megaloblastic anemia should be considered. Vitamin B12 and folate levels should be assessed to confirm the diagnosis, and dietary intake of these vitamins should be evaluated and corrected if deficient.</span></p>",
    "correct_choice_id": 175485,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 54536,
    "choices": [
      {
        "id": 217613,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma</span></span></span></p>"
      },
      {
        "id": 217614,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma</span></span></span></p>"
      },
      {
        "id": 217615,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
      },
      {
        "id": 217616,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcoma</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the most likely tumor arising from the slide shown in the image?&nbsp;</span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/whatsapp-image-2024-08-23-at-10620-pm-2.jpeg\" style=\"height:269px; width:300px\" /></p>",
    "unique_key": "Q3300240",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634533,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Adenocarcinoma</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The provided histopathological image shows multiple gland formations, which is characteristic of adenocarcinoma. Adenocarcinomas are malignant tumors that arise from glandular epithelial cells. The presence of glandular structures in the histological slide is a key indicator of this type of cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Squamous cell carcinoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This type of carcinoma is characterized by the presence of keratin pearls and intercellular bridges, which are not seen in the provided image.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Lymphoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Lymphomas are malignancies of the lymphoid tissue and do not typically show glandular patterns in histology.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Sarcoma:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sarcomas arise from mesenchymal cells and are characterized by spindle-shaped cells. They do not exhibit glandular formations.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenocarcinoma is identified by the presence of glandular formations in histopathological slides.</span></span></span></p>",
    "correct_choice_id": 217614,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 44830,
    "choices": [
      {
        "id": 178967,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is un-competitive inhibitor</span></p>"
      },
      {
        "id": 178968,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is competitive inhibitor and drug B is non-competitive inhibitor</span></p>"
      },
      {
        "id": 178969,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is non-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      },
      {
        "id": 178970,
        "text": "<p><span style=\"font-size:12pt;\">Drug A is un-competitive inhibitor and drug B is competitive inhibitor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following statements regarding the drugs shown in graph A and graph B is correct. (</span>INICET May 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/22/screenshot-2024-05-22-155759.png\" alt=\"\" width=\"400\" height=\"160\"></p>",
    "unique_key": "Q9825503",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633392,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans&nbsp;B) Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To determine the correct answer, let's analyze the Lineweaver-Burk plots and the types of enzyme inhibition they represent:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For non-competitive inhibitors, the lines intersect at the x-axis. This type of inhibitor decreases VmaxVmax\u200b without affecting KmKm\u200b.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Competitive Inhibition</strong>: On a Lineweaver-Burk plot, competitive inhibitors intersect with the no-inhibitor line at the y-axis. This is because competitive inhibitors increase the apparent KmKm\u200b (Michaelis constant) without affecting VmaxVmax\u200b (maximum velocity).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Uncompetitive Inhibition</strong>: Uncompetitive inhibitors result in parallel lines on the Lineweaver-Burk plot. They decrease both VmaxVmax\u200b and KmKm\u200b proportionally.</span>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Given the descriptions of the graphs:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Graph A</strong>: The lines meet at the y-axis, indicating competitive inhibition.</span></li><li><span style=\"font-size:12pt;\"><strong>Graph B</strong>: The lines start from the same point on the x-axis, indicating non-competitive inhibition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B. Drug A is competitive inhibitor and drug B is non-competitive inhibitor</strong></span></p>",
    "correct_choice_id": 178968,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 73264,
    "choices": [
      {
        "id": 292013,
        "text": "<p><span style=\"font-size:14.0pt;\">Bradyzoites</span></p>"
      },
      {
        "id": 292014,
        "text": "<p><span style=\"font-size:14.0pt;\">Tissue cysts</span></p>"
      },
      {
        "id": 292015,
        "text": "<p><span style=\"font-size:14.0pt;\">Tachyzoites</span></p>"
      },
      {
        "id": 292016,
        "text": "<p><span style=\"font-size:14.0pt;\">Oocysts</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">During her pregnancy, the lady regularly cleans her cat's litter. What is the specific infective stage of this organism found that the patient may be exposed to?&nbsp;</span></p>",
    "unique_key": "Q4187256",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634406,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Oocysts</strong></span></p>",
    "correct_choice_id": 292016,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73303,
    "choices": [
      {
        "id": 292165,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rWeJi78.png\" width=\"390\" height=\"301\"></p>"
      },
      {
        "id": 292166,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_gg85BfD.png\" width=\"318\" height=\"315\"></p>"
      },
      {
        "id": 292167,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JjHhWOF.png\" width=\"1025\" height=\"634\"></p>"
      },
      {
        "id": 292168,
        "text": "<p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_B328kya.png\" width=\"1875\" height=\"1250\"></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following viruses exhibits genetic re-assortment similar to that of influenza virus?&nbsp;</span></p>",
    "unique_key": "Q7873333",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634413,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_mEZyfIM.png\" width=\"390\" height=\"301\"></strong></span></p>",
    "correct_choice_id": 292165,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73387,
    "choices": [
      {
        "id": 292497,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 292498,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 292499,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
      },
      {
        "id": 292500,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct pair of gene&nbsp; with drug resistance&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">rpoB-Rifampicin</span></li><li><span style=\"font-size:14.0pt;\">katG-Ethambutol</span></li><li><span style=\"font-size:14.0pt;\">oxyR-Isoniazid</span></li><li><span style=\"font-size:14.0pt;\">pncA-Pyrazinamid</span></li></ol>",
    "unique_key": "Q4909626",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634385,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>D) 1, 3, 4</strong></span></p>",
    "correct_choice_id": 292500,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44826,
    "choices": [
      {
        "id": 178951,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></span></p>"
      },
      {
        "id": 178952,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></span></p>"
      },
      {
        "id": 178953,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></p>"
      },
      {
        "id": 178954,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old patient presents with progressive dyspnoea at rest and on exertion (e.g., climbing stairs). The patient also has a history of heart failure. Laboratory tests show a fasting plasma glucose of 136 mg/dL, haemoglobin (Hb) of 13 g%, and HbA1c of 7.8%, indicating poorly controlled type 2 diabetes mellitus. The physician needs to select an appropriate antidiabetic medication considering the patient&#39;s symptoms and medical condition. Which is the preferred antidiabetic drug in this patient?</span></span></span>(INICET MAY 2024)</p>",
    "unique_key": "Q7453314",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633390,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin is an SGLT2 inhibitor that promotes glucose excretion through the urine. It has been shown to provide significant benefits in patients with type 2 diabetes and heart failure, including reducing the risk of hospitalization for heart failure and cardiovascular death. Given the patient&#39;s history of heart failure, dapagliflozin is a preferred choice due to its cardiovascular benefits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glimepiride</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride is a sulfonylurea that increases insulin secretion. It is associated with a risk of hypoglycemia and weight gain, which might not be ideal for this patient considering the need to manage cardiovascular risk factors and avoid potential hypoglycemic episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin is a first-line treatment for type 2 diabetes due to its efficacy and safety profile. However, in this case, given the patient&#39;s history of heart failure, dapagliflozin may provide additional cardiovascular benefits that make it a more suitable choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sitagliptin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin is a DPP-4 inhibitor that helps improve blood glucose control with a low risk of hypoglycemia and is weight neutral. While it is effective, it does not have the same cardiovascular benefits as dapagliflozin in patients with heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In summary, dapagliflozin is the preferred antidiabetic drug for this patient due to its proven benefits in reducing heart failure-related outcomes, making it particularly suitable for a patient with a history of heart failure and poorly controlled diabetes.</span></span></p>",
    "correct_choice_id": 178951,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 73352,
    "choices": [
      {
        "id": 292357,
        "text": "<p><span style=\"font-size:14.0pt;\">Zika virus</span></p>"
      },
      {
        "id": 292358,
        "text": "<p><span style=\"font-size:14.0pt;\">Exanthem subitum</span></p>"
      },
      {
        "id": 292359,
        "text": "<p><span style=\"font-size:14.0pt;\">Kyasanur forest disease</span></p>"
      },
      {
        "id": 292360,
        "text": "<p><span style=\"font-size:14.0pt;\">West Nile fever</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A petechial rash is associated with all the following except?</span></p>",
    "unique_key": "Q8808511",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634383,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Exanthem subitum</strong></span></p>",
    "correct_choice_id": 292358,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44819,
    "choices": [
      {
        "id": 178923,
        "text": "<p><span style=\"font-size:12pt;\">Conjugated estrogen</span></p>"
      },
      {
        "id": 178924,
        "text": "<p><span style=\"font-size:12pt;\">Estrone</span></p>"
      },
      {
        "id": 178925,
        "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
      },
      {
        "id": 178926,
        "text": "<p><span style=\"font-size:12pt;\">Estriol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Most potent natural estrogen is (INICET MAY 2024)</span></p>",
    "unique_key": "Q6840690",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633389,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol (E2) is the most potent natural estrogen. It is the primary estrogen produced by the ovaries during the reproductive years and plays a crucial role in regulating the menstrual cycle and reproductive system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Conjugated estrogen</strong>: Conjugated estrogen like Ethinyl estradiol is a synthetic estrogen commonly used in oral contraceptives. It is not a natural estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Estrone</strong>: Estrone (E1) is one of the three naturally occurring estrogens. It is less potent than estradiol. Estrone is primarily produced in adipose tissue and is the predominant estrogen after menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Estriol</strong>: Estriol (E3) is the weakest of the three natural estrogens. It is primarily produced during pregnancy by the placenta. Estriol has much lower estrogenic activity compared to estradiol and estrone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, estradiol is the most potent natural estrogen and plays a significant role in the female reproductive system during the reproductive years.</span></p>",
    "correct_choice_id": 178925,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 32019,
    "choices": [
      {
        "id": 127946,
        "text": "<p><span style=\"font-size:18px;\">Herpes simplex virus</span></p>"
      },
      {
        "id": 127947,
        "text": "<p><span style=\"font-size:18px;\">Human herpesvirus 8</span></p>"
      },
      {
        "id": 127948,
        "text": "<p><span style=\"font-size:18px;\">Human papillomavirus</span></p>"
      },
      {
        "id": 127949,
        "text": "<p><span style=\"font-size:18px;\">Poxvirus</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">A 43-year-old, HIV-positive woman comes to the OPD due to lesions on her vulvar and perineal areas for the past 4 weeks. On examination, there are clusters of firm, shiny, round papules that are each 2-6 mm in diameter with central indentation. Microscopic examination of a lesion is shown in the image below:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/02/picture27_PXZsYgM.jpg\" alt=\"\" width=\"300\" height=\"226\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following is the most likely cause of this patient's presenting condition?</span></p>",
    "unique_key": "Q8573522",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634400,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Poxvirus</strong></span></p>",
    "correct_choice_id": 127949,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 74184,
    "choices": [
      {
        "id": 295665,
        "text": "<p><span style=\"font-size:14.0pt;\">Acetazolamide oral tablet 250 mg twice daily</span></p>"
      },
      {
        "id": 295666,
        "text": "<p><span style=\"font-size:14.0pt;\">Scopolamine transdermal patch (apply 30 minutes before travel)</span></p>"
      },
      {
        "id": 295667,
        "text": "<p><span style=\"font-size:14.0pt;\">Promethazine oral tablet (take 30 minutes before travel)</span></p>"
      },
      {
        "id": 295668,
        "text": "<p><span style=\"font-size:14.0pt;\">Ondansetron oral tablet (take 30 minutes before travel)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old male is planning a trip to the&nbsp;mountainous region of Shimla. He has a history of&nbsp;motion sickness&nbsp;and is concerned about developing symptoms such as&nbsp;nausea, dizziness, and vomiting&nbsp;during the winding road journey. He visits his physician for advice on prophylactic medication. Which of the following drugs would be most appropriate for the&nbsp;prevention of motion sickness?</span></p>",
    "unique_key": "Q4211906",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633419,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Promethazine oral tablet (take 30 minutes before travel)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Promethazine</strong>&nbsp;is a&nbsp;<strong>first-generation antihistamine (H1-blocker)</strong>&nbsp;that is effective in&nbsp;<strong>preventing motion sickness</strong>&nbsp;by blocking histamine receptors in the vestibular system. It should be taken&nbsp;<strong>30 minutes before travel</strong>&nbsp;for best results.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong>&nbsp;<strong>Acetazolamide</strong>&nbsp;is used for&nbsp;<strong>high-altitude sickness prevention</strong>, not motion sickness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Scopolamine transdermal patch should actually be applied 12 hours before travel</strong>, not 30 minutes before. Applying it too late may reduce its effectiveness, leading to students choosing this incorrectly.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong>&nbsp;<strong>Ondansetron</strong>&nbsp;is a&nbsp;<strong>5-HT\u2083 antagonist</strong>, mainly used for chemotherapy-induced nausea and&nbsp;<strong>not effective for motion sickness</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Many students may wrongly choose option B (Scopolamine patch 30 min before), but the correct answer is C (Promethazine 30 min before travel)</span></p>",
    "correct_choice_id": 295667,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74179,
    "choices": [
      {
        "id": 295645,
        "text": "<p><span style=\"font-size:14.0pt;\">Duration of action is longer than filgrastim</span></p>"
      },
      {
        "id": 295646,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a GM-CSF analog</span></p>"
      },
      {
        "id": 295647,
        "text": "<p><span style=\"font-size:14.0pt;\">It increases the risk of febrile neutropenia</span></p>"
      },
      {
        "id": 295648,
        "text": "<p><span style=\"font-size:14.0pt;\">All of these are correct</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female with&nbsp;breast cancer&nbsp;is undergoing&nbsp;chemotherapy&nbsp;and develops&nbsp;severe neutropenia. To stimulate neutrophil production, her oncologist prescribes&nbsp;pegylated-filgrastim&nbsp;instead of filgrastim. Which of the following is true about pegylated-filgrastim?</span></p>",
    "unique_key": "Q8520320",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633416,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Duration of action is longer than filgrastim</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pegylated-filgrastim</strong>&nbsp;is a&nbsp;<strong>pegylated (polyethylene glycol-modified) form of filgrastim</strong>, a&nbsp;<strong>granulocyte colony-stimulating factor (G-CSF)</strong>&nbsp;used to prevent neutropenia in chemotherapy patients.</span></li><li><span style=\"font-size:14.0pt;\"><strong>PEGylation increases its half-life</strong>, reducing the need for&nbsp;<strong>daily dosing</strong>&nbsp;as seen with filgrastim.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong>&nbsp;<strong>B. \"It is a GM-CSF analog\":</strong> Pegylated-filgrastim is a&nbsp;<strong>G-CSF (granulocyte colony-stimulating factor), not a GM-CSF (granulocyte-macrophage colony-stimulating factor) analog</strong>. GM-CSF (e.g., sargramostim) stimulates&nbsp;<strong>both granulocytes and macrophages</strong>, while G-CSF mainly stimulates&nbsp;<strong>neutrophil production</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. \"It increases the risk of febrile neutropenia\"</strong>: Pegylated-filgrastim&nbsp;<strong>reduces the risk</strong>&nbsp;of febrile neutropenia and infections by promoting neutrophil recovery after chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong>&nbsp;<strong>D. \"All of these are correct\"</strong>: Since&nbsp;<strong>B and C are incorrect</strong>, this option is also wrong.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pegylated-filgrastim has a longer duration of action than filgrastim, reducing the frequency of administration.</span></p>",
    "correct_choice_id": 295645,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 43953,
    "choices": [
      {
        "id": 175475,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Fluoroscein isothiocyanate</span></span></span></p>"
      },
      {
        "id": 175476,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Alkaline phosphatase</span></span></span></p>"
      },
      {
        "id": 175477,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Diamino benzidene</span></span></span></p>"
      },
      {
        "id": 175478,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Benzene</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following stains cause brown color to Her 2 neu cells of breast carcinoma as shown in the image?&nbsp;(INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-172631.JPG\" style=\"height:223px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q3263246",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634480,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\">Ans. C) Diamino benzidene</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diaminobenzidine (DAB) is commonly used as a chromogen in immunohistochemistry. It reacts with the peroxidase enzyme in a substrate solution, producing a brown precipitate that is visible under a microscope, marking the antigen-antibody binding site.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Fluorescein Isothiocyanate:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is a fluorochrome and not used for color development in traditional histopathological stains, but rather for fluorescence microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Alkaline Phosphatase:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This enzyme can be used in immunohistochemistry, typically resulting in red or blue stains, depending on the substrate used, not brown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Benzene:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is an organic solvent and not used as a chromogen in histopathology or immunohistochemistry.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For staining specific proteins like Her2 in breast carcinoma tissues, diaminobenzidine (DAB) is a preferred chromogen for peroxidase-mediated reactions in immunohistochemistry, yielding a distinct brown coloration which highlights the presence of the target antigen.</span></span></span></p>",
    "correct_choice_id": 175477,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 73332,
    "choices": [
      {
        "id": 292281,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacteroides spp.</span></p>"
      },
      {
        "id": 292282,
        "text": "<p><span style=\"font-size:14.0pt;\">Peptostreptococcus spp.</span></p>"
      },
      {
        "id": 292283,
        "text": "<p><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa.</span></p>"
      },
      {
        "id": 292284,
        "text": "<p><span style=\"font-size:14.0pt;\">Serratia.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with diabetes presents with a tender swelling on his forehead. Incision and drainage yield foul-smelling pus that fluoresces red under ultraviolet light. What is the most likely causative organism?</span></p>",
    "unique_key": "Q8222708",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634380,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pseudomonas aeruginosa.&nbsp;</strong></span></p>",
    "correct_choice_id": 292283,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73422,
    "choices": [
      {
        "id": 292637,
        "text": "<p><span style=\"font-size:14.0pt;\">Giardia lamblia</span></p>"
      },
      {
        "id": 292638,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffEntamoeba histolytica</span></p>"
      },
      {
        "id": 292639,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffMicrosporidia</span></p>"
      },
      {
        "id": 292640,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffCryptosopridia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old HIV-positive patient presented with a chronic history of watery diarrhea. Histopathology of the duodenum is shown in the image below. Which of the following is the causative organism?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20174757.jpg\" width=\"356\" height=\"519\"></span></p>",
    "unique_key": "Q1173077",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634396,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Giardia lamblia</strong></span></p>",
    "correct_choice_id": 292637,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 54495,
    "choices": [
      {
        "id": 217449,
        "text": "<p><span style=\"font-size:12.0pt;\">Chromogranin</span></p>"
      },
      {
        "id": 217450,
        "text": "<p><span style=\"font-size:12.0pt;\">NCAM</span></p>"
      },
      {
        "id": 217451,
        "text": "<p><span style=\"font-size:12.0pt;\">Synaptophysin</span></p>"
      },
      {
        "id": 217452,
        "text": "<p><span style=\"font-size:12.0pt;\">INSM</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an intranuclear immuno-histochemistry marker for neuroendocrine tumor?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1072592",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634525,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) INSM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Intranuclear immunohistochemistry markers are specifically located within the nucleus of the cell, unlike cytoplasmic or membranous markers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>INSM (Insulinoma Associated Protein 1)</strong> is a novel intranuclear marker used for the detection of neuroendocrine tumors. It is particularly useful in diagnosing various types of neuroendocrine tumors, including small cell carcinoma of the lung, medullary thyroid cancer, Merkel cell carcinoma, and paraganglioma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Chromogranin</strong>: Incorrect because it is a cytoplasmic marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NCAM</strong>: Incorrect because it is a membranous marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Synaptophysin</strong>: Incorrect because it is a cytoplasmic marker, not intranuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">INSM is an intranuclear marker for neuroendocrine tumors, distinguishing it from other cytoplasmic or membranous markers such as Chromogranin, NCAM, and Synaptophysin.</span></p>",
    "correct_choice_id": 217452,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 29305,
    "choices": [
      {
        "id": 117126,
        "text": "<p><span style=\"font-size:14.0pt;\">Iron deficiency anemia&nbsp;</span></p>"
      },
      {
        "id": 117127,
        "text": "<p><span style=\"font-size:14.0pt;\">Thalassemia minor&nbsp;</span></p>"
      },
      {
        "id": 117128,
        "text": "<p><span style=\"font-size:14.0pt;\">Anemia of chronic disease&nbsp;</span></p>"
      },
      {
        "id": 117129,
        "text": "<p><span style=\"font-size:14.0pt;\">Lead poisoning&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A female patient presented with fatigue. Routine complete blood count analysis showed hemoglobin of 9 g/dL, MCV 60fL, and RBC count of 5.2 million. A peripheral smear showed microcytic hypochromic anemia. Which of the following is the likely diagnosis in this individual?</span></p>",
    "unique_key": "Q8832853",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634541,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Thalassemia minor</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient's laboratory findings show:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Microcytic hypochromic anemia</strong> (MCV = 60 fL, hemoglobin = 9 g/dL).</span></li><li><span style=\"font-size:14.0pt;\">A <strong>high RBC count (5.2 million)</strong>, which is not typical of iron deficiency anemia.</span></li><li><span style=\"font-size:14.0pt;\">To differentiate between <strong>thalassemia minor</strong> and other microcytic anemias, the <strong>Mentzer index</strong> is calculated:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_y4ReFid.png\" width=\"774\" height=\"121\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A Mentzer index <strong>&lt; 13</strong> strongly suggests <strong>thalassemia minor</strong>, while a value <strong>&gt; 13</strong> suggests <strong>iron deficiency anemia</strong>. In thalassemia minor, the microcytosis is disproportionate to the degree of anemia, and the RBC count is typically normal or elevated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iron deficiency anemia:&nbsp;</strong>While this also presents as microcytic hypochromic anemia, the Mentzer index would be <strong>&gt; 13</strong> in iron deficiency anemia. Additionally, iron deficiency is associated with a lower RBC count, which is not seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anemia of chronic disease:</strong> This is most commonly associated with <strong>normocytic normochromic anemia</strong>, and less commonly, microcytic hypochromic anemia. The RBC count is usually decreased, unlike the high RBC count observed here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lead poisoning:&nbsp;</strong>This presents with <strong>sideroblastic anemia</strong> and findings such as <strong>basophilic stippling</strong> on the peripheral smear, along with symptoms like foot drop and neuropathy. These are not mentioned in the given case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Thalassemia minor</strong> is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Microcytic hypochromic anemia</strong> with a <strong>Mentzer index &lt; 13</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>normal or elevated RBC count</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Disproportionately low MCV relative to the degree of anemia.</span></li></ul>",
    "correct_choice_id": 117127,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54531,
    "choices": [
      {
        "id": 217593,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A positive</span></span></span></p>"
      },
      {
        "id": 217594,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">AB negative</span></span></span></p>"
      },
      {
        "id": 217595,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O negative</span></span></span></p>"
      },
      {
        "id": 217596,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O positive</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A male patient suffers a trauma and is being brought to the emergency room of a hospital. Since he needs an emergency lifesaving transfusion, which of the following can be safely transfused in him?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q4028826",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634532,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C) O negative</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In emergency situations where a lifesaving transfusion is needed, and there is no time to determine the patient&#39;s blood type, O negative blood is considered the universal donor and can be safely transfused to any patient. This is because O negative blood does not have any A, B, or Rh antigens on the surface of the red blood cells, minimizing the risk of an adverse reaction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, it is important to note that O negative blood is often in short supply. In extremely critical situations, such as with an older male or a postmenopausal female, or when O negative blood is not available, O positive blood may be used as an alternative. O positive blood can be safely transfused to males and females who are not of childbearing age, as the presence of Rh antigen can cause issues in future pregnancies for females.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. A positive</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A positive blood type contains A and Rh antigens and can only be safely transfused to individuals with A positive, AB positive, or compatible types. It is not a universal donor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. AB negative</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: AB negative blood can only be given to AB negative or AB positive recipients due to the presence of both A and B antigens. It is also not a universal donor.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. O positive</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While O positive blood can be given in critical situations, it is not the first choice for universal emergency transfusions due to the presence of Rh antigen, which can cause complications in Rh-negative individuals, especially females of childbearing age.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In emergency transfusion situations where blood type is unknown, O negative blood is the safest option due to its lack of A, B, and Rh antigens, making it universally compatible.</span></span></span></p>",
    "correct_choice_id": 217595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 44868,
    "choices": [
      {
        "id": 179119,
        "text": "<p><span style=\"font-size:12pt;\">1, 2, 3 and 4</span></p>"
      },
      {
        "id": 179120,
        "text": "<p><span style=\"font-size:12pt;\">1, 3, 2 and 4</span></p>"
      },
      {
        "id": 179121,
        "text": "<p><span style=\"font-size:12pt;\">1, 3, 4 and 2</span></p>"
      },
      {
        "id": 179122,
        "text": "<p><span style=\"font-size:12pt;\">4, 2, 1 and 3</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Many GPCR receptors act via increase in cAMP. There are several steps involved in this mechanism as given below. Which of the following is correct sequence of events in cAMP signal transduction pathway? (</span>INICET May 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steps involved</span></p><p><br><span style=\"font-size:12.0pt;\">1. Activation of adenylate cyclase</span><br><span style=\"font-size:12.0pt;\">2. Activation of PKA</span><br><span style=\"font-size:12.0pt;\">3. Conversion of ATP to cAMP</span><br><span style=\"font-size:12.0pt;\">4. Phosphorylation of target proteins</span></p>",
    "unique_key": "Q2011234",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633397,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence of events in the cAMP signal transduction pathway is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12pt;\">Activation of PKA</span></li><li><span style=\"font-size:12pt;\">Phosphorylation of target proteins</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. 1, 3, 2 and 4</strong></span></p>",
    "correct_choice_id": 179120,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73389,
    "choices": [
      {
        "id": 292505,
        "text": "<p><span style=\"font-size:14.0pt;\">IV Penicillin G&nbsp;</span></p>"
      },
      {
        "id": 292506,
        "text": "<p><span style=\"font-size:14.0pt;\">Oral Amoxicillin&nbsp;</span></p>"
      },
      {
        "id": 292507,
        "text": "<p><span style=\"font-size:14.0pt;\">Oral Azithromycin&nbsp;</span></p>"
      },
      {
        "id": 292508,
        "text": "<p><span style=\"font-size:14.0pt;\">Oral Ampicillin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the drug of choice for the treatment the disease, caused by the organism whose life cycle is shown below?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_slctJhW.png\" width=\"379\" height=\"358\"></p>",
    "unique_key": "Q2481951",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634386,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) IV Penicillin G</strong></span></p>",
    "correct_choice_id": 292505,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73328,
    "choices": [
      {
        "id": 292265,
        "text": "<p><span style=\"font-size:14.0pt;\">Sheep</span></p>"
      },
      {
        "id": 292266,
        "text": "<p><span style=\"font-size:14.0pt;\">Dog</span></p>"
      },
      {
        "id": 292267,
        "text": "<p><span style=\"font-size:14.0pt;\">Human&nbsp;</span></p>"
      },
      {
        "id": 292268,
        "text": "<p><span style=\"font-size:14.0pt;\">No intermediate host</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the intermediate host of the following condition</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20142715.jpg\" width=\"412\" height=\"413\"></span></p>",
    "unique_key": "Q2627550",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634378,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Sheep</strong></span></p>",
    "correct_choice_id": 292265,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 31809,
    "choices": [
      {
        "id": 127106,
        "text": "<p><span style=\"font-size:12pt;\">Cycloserine</span></p>"
      },
      {
        "id": 127107,
        "text": "<p><span style=\"font-size:12pt;\">Ethionamide</span></p>"
      },
      {
        "id": 127108,
        "text": "<p><span style=\"font-size:12pt;\">Streptomycin</span></p>"
      },
      {
        "id": 127109,
        "text": "<p><span style=\"font-size:12pt;\">Pyrazinamide</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young patient undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) presents with symptoms of weight gain, cold intolerance, and lethargy. Laboratory investigations reveal high levels of thyroid-stimulating hormone (TSH) and low levels of T3 (triiodothyronine) and T4 (thyroxine). Which of the following drugs is likely responsible for these symptoms? (INICET NOV 2023)</span></p>",
    "unique_key": "Q8481746",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633378,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ethionamide.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line antitubercular agent used in the treatment of MDR-TB, is known to cause hypothyroidism as a side effect. This condition is characterized by an underactive thyroid gland, leading to symptoms such as weight gain, cold intolerance, and lethargy. The laboratory findings of elevated TSH and low levels of T3 and T4 further support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cycloserine:</strong> Cycloserine is used in the treatment of MDR-TB, but its side effects are more commonly neurological, including mood changes and seizures. It is not typically associated with thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Streptomycin:</strong> Streptomycin, an aminoglycoside antibiotic, is used in TB treatment and is known for its potential ototoxicity and nephrotoxicity, rather than effects on thyroid function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pyrazinamide:</strong> Pyrazinamide is a first-line anti-TB medication. Its side effects include hepatotoxicity and hyperuricemia but not typically hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB), can cause hypothyroidism, characterized by symptoms such as weight gain, cold intolerance, lethargy, elevated TSH, and low T3 and T4 levels.</span></p>",
    "correct_choice_id": 127107,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 44023,
    "choices": [
      {
        "id": 175751,
        "text": "<p><span style=\"font-size:12pt;\">HSV2</span></p>"
      },
      {
        "id": 175752,
        "text": "<p><span style=\"font-size:12pt;\">Molluscum</span></p>"
      },
      {
        "id": 175753,
        "text": "<p><span style=\"font-size:12pt;\">HPV</span></p>"
      },
      {
        "id": 175754,
        "text": "<p><span style=\"font-size:12pt;\">HIV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with pain in the genital area and a painful vesicle on examination, accompanied by painful lymphadenopathy. What is the diagnosis? (INICET NOV 2023)</span></p>",
    "unique_key": "Q4140507",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633810,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) HSV2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Herpes Simplex Virus Type 2 (HSV2) typically presents with painful genital vesicles and can cause painful lymphadenopathy. HSV2 is a common cause of genital herpes and is known for causing recurrent outbreaks of painful vesicular lesions in the genital area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Molluscum:&nbsp;</strong>Molluscum contagiosum causes painless, pearly papules, which are typically umbilicated. These lesions are not vesicular and do not cause painful lymphadenopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>HPV: </strong>Human Papillomavirus infection results in the formation of warts, which are generally painless. HPV warts can appear on the genital area but do not present with vesicles or painful lymphadenopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>HIV: </strong>Human Immunodeficiency Virus does not present with genital vesicles. HIV infection leads to systemic symptoms such as fever, weight loss, and generalized lymphadenopathy, rather than localized painful vesicles in the genital area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">HSV2 infection is characterized by painful genital vesicles and can be associated with painful lymphadenopathy.</span></p>",
    "correct_choice_id": 175751,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 6483,
    "choices": [
      {
        "id": 25901,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazide inhibits the metabolism of lithium</span></p>"
      },
      {
        "id": 25902,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazides act as an add-on drug to lithium</span></p>"
      },
      {
        "id": 25903,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazides increase the tubular resorption of lithium</span></p>"
      },
      {
        "id": 25904,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazides cause water loss thereby increasing lithium levels</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male with a long-standing history of bipolar disorder has been stable on lithium therapy. Recently, he was diagnosed with hypertension and started on thiazide diuretics. After a few days, he presented with coarse tremors and other symptoms suggestive of lithium toxicity. What is the likely mechanism of this interaction between lithium and thiazides?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
    "unique_key": "Q3652678",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633417,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Thiazides increase the tubular resorption of lithium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazides reduce the excretion of sodium in the renal tubules. Lithium is reabsorbed in a manner similar to sodium, leading to its increased reabsorption and elevated blood levels, resulting in potential toxicity. In this clinical case, the patient's symptoms of lithium toxicity are most likely due to the thiazide-induced increase in tubular reabsorption of lithium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thiazide inhibits the metabolism of lithium:</strong> Lithium is primarily excreted unchanged by the kidneys, not metabolized. Thiazides don't affect lithium's metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thiazides act as an add-on drug to lithium:</strong> There's no evidence that thiazides synergistically increase the toxic or therapeutic effects of lithium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Thiazides cause water loss thereby increasing lithium levels:</strong> Thiazides do act as diuretics, but the primary mechanism of increasing lithium levels is through enhanced tubular reabsorption rather than water loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thiazide diuretics increase the tubular reabsorption of lithium, leading to elevated blood levels and potential toxicity. This interaction is crucial to consider when prescribing thiazides to patients on lithium therapy.</span></p>",
    "correct_choice_id": 25903,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 44027,
    "choices": [
      {
        "id": 175767,
        "text": "<p><span style=\"font-size:12pt;\">Diphtheria</span></p>"
      },
      {
        "id": 175768,
        "text": "<p><span style=\"font-size:12pt;\">Clostridium</span></p>"
      },
      {
        "id": 175769,
        "text": "<p><span style=\"font-size:12pt;\">Bacillus</span></p>"
      },
      {
        "id": 175770,
        "text": "<p><span style=\"font-size:12pt;\">Vibrio</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which bacterial toxin acts by interfering with EF-2 function? (INICET NOV 2023)</span></p>",
    "unique_key": "Q6983143",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633812,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Diphtheria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diphtheria toxin inhibits protein synthesis by ADP-ribosylating elongation factor 2 (EF-2), blocking its function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Clostridium</strong>: Produces toxins, but they do not target EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Bacillus</strong>: Associated with different toxins not affecting EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Vibrio</strong>: Known for cholera toxin affecting intestinal secretion, not EF-2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Diphtheria toxin uniquely targets EF-2, crucial for understanding its mechanism of action in causing disease by inhibiting protein synthesis.</span></p>",
    "correct_choice_id": 175767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 26604,
    "choices": [
      {
        "id": 106358,
        "text": "<p><span style=\"font-size:14.0pt;\">Subendothelial deposits</span></p>"
      },
      {
        "id": 106359,
        "text": "<p><span style=\"font-size:14.0pt;\">Subepithelial deposits&nbsp;</span></p>"
      },
      {
        "id": 106360,
        "text": "<p><span style=\"font-size:14.0pt;\">Crescents in glomeruli</span></p>"
      },
      {
        "id": 106361,
        "text": "<p><span style=\"font-size:14.0pt;\">Mesangial deposits&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 10-year-old child presented with cola colored urine and had a history of skin infection few days back. His creatinine value was initially 2.5 mg/dl but even after 3 weeks of treatment it increased to 4.5 mg/dl. Which of the following is a likely kidney biopsy finding on electron microscopy?</span></p>",
    "unique_key": "Q3336785",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634562,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Subepithelial deposits</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A child with skin infection followed by passage of cola colored urine is suggestive of post streptococcal glomerulonephritis. The worsening of creatinine from 2.5mg/dl to 4.5 mg/dl is suggestive of worsen of his condition in a short span of time. This prompts a diagnosis of rapidly progressive glomerulonephritis (RPGN).</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><p><span style=\"font-size:14.0pt;\">Rapidly Progressive Glomerulonephritis (RPGN):</span></p><p><span style=\"font-size:14.0pt;\">&nbsp;</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pathology: RPGN is characterized by the presence of crescents in the glomeruli, which are formed by the proliferation of parietal epithelial cells and infiltration of monocytes and macrophages.</span></li><li><span style=\"font-size:14.0pt;\">Clinical Features: Rapid deterioration of renal function, often following an infection such as streptococcal throat or skin infection.</span></li><li><span style=\"font-size:14.0pt;\">Crescents can be seen on light microscopy in RPGN (especially crescentic PSGN).</span></li><li><span style=\"font-size:14.0pt;\">But electron microscopy (EM) will still show subepithelial deposits, which is diagnostic of PSGN.</span></li><li><span style=\"font-size:14.0pt;\">So, even though the clinical course is RPGN, the question asked what you see on EM - hence the correct answer is Subepithelial deposits</span><ul><li><span style=\"font-size:14.0pt;\"><strong>Type I</strong>: Anti-GBM disease (Goodpasture syndrome)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Type II</strong>: Immune complex-mediated (e.g., PSGN, lupus nephritis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Type III</strong>: Pauci-immune (e.g., Granulomatosis with Polyangiitis, also known as Wegener\u2019s)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Subendothelial deposits:</strong> Seen in conditions like lupus nephritis and membranoproliferative glomerulonephritis, not typical for RPGN following PSGN.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Crescents in glomeruli:</strong> Suggest RPGN, but the specific hallmark of PSGN is subepithelial humps (crescents may appear if it evolves into RPGN, but not diagnostic)</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mesangial deposits:</strong> Commonly seen in IgA nephropathy and other mesangioproliferative glomerulonephritis, not specific for RPGN</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of crescents in the glomeruli on kidney biopsy is characteristic of rapidly progressive glomerulonephritis (RPGN), especially in a patient with worsening renal function following an episode of post-streptococcal glomerulonephritis.</span></p>",
    "correct_choice_id": 106359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73453,
    "choices": [
      {
        "id": 292761,
        "text": "<p><span style=\"font-size:14.0pt;\">Widal test</span></p>"
      },
      {
        "id": 292762,
        "text": "<p><span style=\"font-size:14.0pt;\">Microscopic agglutination test</span></p>"
      },
      {
        "id": 292763,
        "text": "<p><span style=\"font-size:14.0pt;\">Weil felix reaction</span></p>"
      },
      {
        "id": 292764,
        "text": "<p><span style=\"font-size:14.0pt;\">Paul Bunnell test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 16-year-old boy is admitted with fever, icterus, conjunctival suffusion, and hematuria for 15 days. Which serological test should be done for diagnosis?</span></p>",
    "unique_key": "Q8657728",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634402,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Microscopic agglutination test</strong></span></p>",
    "correct_choice_id": 292762,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44025,
    "choices": [
      {
        "id": 175759,
        "text": "<p><span style=\"font-size:12pt;\">GP120</span></p>"
      },
      {
        "id": 175760,
        "text": "<p><span style=\"font-size:12pt;\">CCR5</span></p>"
      },
      {
        "id": 175761,
        "text": "<p><span style=\"font-size:12pt;\">GP41</span></p>"
      },
      {
        "id": 175762,
        "text": "<p><span style=\"font-size:12pt;\">CXCR4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which component of the HIV genome is necessary for the virus to enter the host cell membrane? (INICET NOV 2023)</span></p>",
    "unique_key": "Q2701020",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633811,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) GP120</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">GP120 is a glycoprotein on the HIV envelope that binds to the CD4 receptors on host cells. This binding is crucial for the initial attachment of the virus to the host cell, facilitating the subsequent steps that lead to viral entry. GP120 interacts specifically with the CD4 receptor, which is predominantly found on the surface of T-helper cells, macrophages, and dendritic cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. CCR5: </strong>CCR5 is a co-receptor on the host cell surface that HIV uses in conjunction with the CD4 receptor to enter the cell. However, it is not a component of the HIV genome but rather a part of the host cell.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. GP41: </strong>GP41 is another glycoprotein found on the HIV envelope that assists in the fusion of the viral membrane with the host cell membrane after GP120 has bound to the CD4 receptor. It facilitates the entry of the viral core into the host cell cytoplasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CXCR4: </strong>CXCR4 is another co-receptor used by HIV to enter host cells, particularly in later stages of infection. Like CCR5, it is a part of the host cell and not a component of the viral genome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">GP120, a glycoprotein on the HIV envelope, is necessary for binding to CD4 receptors on host cells, facilitating viral entry.</span></p>",
    "correct_choice_id": 175759,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 29297,
    "choices": [
      {
        "id": 117094,
        "text": "<p><span style=\"font-size:14.0pt;\">Follicular carcinoma</span></p>"
      },
      {
        "id": 117095,
        "text": "<p><span style=\"font-size:14.0pt;\">Papillary carcinoma</span></p>"
      },
      {
        "id": 117096,
        "text": "<p><span style=\"font-size:14.0pt;\">Toxic nodular goitre</span></p>"
      },
      {
        "id": 117097,
        "text": "<p><span style=\"font-size:14.0pt;\">Medullary carcinoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">What is the probable diagnosis for a patient with a midline neck swelling and histopathological findings of Orphan Annie eye nuclei on biopsy as shown below?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/04/picture1_pxMJXzg.jpg\" alt=\"\" width=\"300\" height=\"175\"></span></p>",
    "unique_key": "Q7912197",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634537,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Papillary carcinoma&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The histopathological image shows <strong>Orphan Annie eye nuclei</strong>, which are clear nuclei with empty-appearing centers, a hallmark feature of <strong>papillary thyroid carcinoma (PTC)</strong>. These nuclei result from chromatin margination along the nuclear membrane, giving them a ground-glass appearance. This type of thyroid cancer is the most common, especially in younger patients, and is associated with good prognosis due to its slow progression and lymphatic spread.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Additionally, <strong>psammoma bodies</strong>, which are concentrically laminated calcified structures, are commonly seen in PTC. These features distinguish papillary carcinoma from other thyroid pathologies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Follicular carcinoma:&nbsp;</strong>This type of thyroid cancer typically shows <strong>hematogenous spread</strong> (to lungs and liver) rather than lymphatic spread. It does not feature Orphan Annie eye nuclei or psammoma bodies. FNAC (Fine Needle Aspiration Cytology) is often insufficient to differentiate between follicular adenoma and carcinoma because the distinction depends on capsular and vascular invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Toxic nodular goitre:&nbsp;</strong>This is a benign condition characterized by hyperthyroidism due to autonomous functioning nodules. It is not associated with the specific nuclear features seen in papillary thyroid carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Medullary carcinoma:&nbsp;</strong>This arises from <strong>parafollicular (C cells)</strong> and is associated with <strong>calcitonin as a tumor marker</strong> and amyloid deposits, not Orphan Annie eye nuclei or psammoma bodies. It is also linked to MEN (Multiple Endocrine Neoplasia) syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The hallmark histological features of <strong>papillary thyroid carcinoma</strong> include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Orphan Annie eye nuclei</strong> (clear nuclei).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Psammoma bodies</strong> (laminated calcifications).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lymphatic spread</strong> and <strong>good prognosis</strong>.</span><br><span style=\"font-size:14.0pt;\">This information is critical for distinguishing PTC from other thyroid lesions.</span></li></ul>",
    "correct_choice_id": 117095,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73306,
    "choices": [
      {
        "id": 292177,
        "text": "<p><span style=\"font-size:14.0pt;\">West Nile virus</span></p>"
      },
      {
        "id": 292178,
        "text": "<p><span style=\"font-size:14.0pt;\">Meningococci</span></p>"
      },
      {
        "id": 292179,
        "text": "<p><span style=\"font-size:14.0pt;\">Strep pneumoniae</span></p>"
      },
      {
        "id": 292180,
        "text": "<p><span style=\"font-size:14.0pt;\">Enterovirus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient presented with meningitis with a history of fever for 4 days and erythematous rashes on the chest. There was no history of travel and tick bite. His CSF findings showed increased protein, normal glucose, mild lymphocytosis and few RBCs. Which of the following is the most likely organism to cause this clinical picture?&nbsp;</span></p>",
    "unique_key": "Q6445183",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634414,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Enterovirus&nbsp;</strong></span></p>",
    "correct_choice_id": 292180,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26602,
    "choices": [
      {
        "id": 106350,
        "text": "<p><span style=\"font-size:14.0pt;\">Atleast 10 groups of minimum 6 follicular cells each&nbsp;</span></p>"
      },
      {
        "id": 106351,
        "text": "<p><span style=\"font-size:14.0pt;\">Atleast 6 groups of minimum 10 follicular cells each</span></p>"
      },
      {
        "id": 106352,
        "text": "<p><span style=\"font-size:14.0pt;\">Atleast 3 groups of minimum 10 follicular cells each</span></p>"
      },
      {
        "id": 106353,
        "text": "<p><span style=\"font-size:14.0pt;\">Atleast 10 groups of minimum 10 follicular cells each</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">In case of a FNAC thyroid, which of the following is a standard criteria for calling it as an adequate sample?</span></p>",
    "unique_key": "Q1640999",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634561,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Atleast 6 groups of minimum 10 follicular cells each</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Fine Needle Aspiration Cytology (FNAC) is widely used for evaluating thyroid nodules. However, the adequacy of the sample plays a crucial role in determining its diagnostic reliability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to the <strong>Bethesda System for Reporting Thyroid Cytopathology</strong>, an FNAC sample is considered <strong>adequate</strong> if it contains <strong>at least 6 groups of follicular cells, with each group containing at least 10 follicular cells</strong>. This criterion ensures a sufficient cellular sample for accurate cytological evaluation and classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Furthermore, FNAC is <strong>not</strong> useful in distinguishing between <strong>benign and malignant follicular neoplasms</strong>. <strong>Follicular adenoma</strong> and <strong>follicular carcinoma</strong> can only be differentiated based on <strong>capsular or vascular invasion</strong>, which requires histopathological examination of an excised specimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Bethesda System for Thyroid Cytopathology</strong> defines an adequate FNAC sample as having <strong>at least 6 groups of follicular cells, each containing at least 10 follicular cells</strong>. This criterion ensures sufficient cellularity for accurate cytological assessment and classification.</span></p>",
    "correct_choice_id": 106351,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 31799,
    "choices": [
      {
        "id": 127066,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Initiate an insulin intravenous infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127067,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Give an insulin stat dose of 0.1 units/kg intravenously, followed by an infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127068,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Administer normal saline for the first hour followed by insulin infusion at 0.1 units/kg/hour </span></span></span></p>"
      },
      {
        "id": 127069,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#343541\">Continue with intravenous fluids without insulin administration</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#343541\">A 10-year-old child with a known history of Type 1 Diabetes Mellitus presents to the emergency department with symptoms of increased thirst, frequent urination, abdominal pain, and confusion. On examination, the child appears dehydrated and is breathing rapidly. Laboratory tests reveal a blood glucose level of 400 mg/dl and blood gas analysis is indicative of acidosis. Initial treatment with intravenous fluids has been started. What is the most appropriate next step in the management of this patient? </span></span></span></p>",
    "unique_key": "Q7902893",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633164,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ans. C) <span style=\"color:#343541\">Administer normal saline for the first hour followed by insulin infusion at 0.1 units/kg/hour</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation is suggestive of diabetic ketoacidosis (DKA), which is an acute, life-threatening complication of diabetes mellitus that typically requires IV fluids and insulin administration to correct hyperglycemia and halt ketogenesis. According to latest guidelines for management of DKA in children first IV fulids are administered for one hour, then insulin is adminsitered by IV infusion at a rate of 0.1 U/kg/hour.&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other options:</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Give an insulin stat dose of 0.1 units/kg intravenously, followed by an infusion at 0.1 units/kg/hour:</strong> According to new guidelines, bolus dose of insulin is not used for treatment of DKA particularly in children as it increases the risk of cerebral edema in many children.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Initiate an insulin intravenous infusion at 0.1 units/kg/hour:</strong> While insulin infusion is an essential part of DKA management, according to new guidelines, it&#39;s typically given one hour after the adminsitration of IV fluids.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Continue with intravenous fluids without insulin administration:</strong> This would not address the hyperglycemia and ketosis and is therefore inadequate for the treatment of DKA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">According to latest guidelines for management of DKA in children first IV fulids are administered for one hour, then insulin is adminsitered by IV infusion at a rate of 0.1 U/kg/hour.&nbsp;</span></span></p>",
    "correct_choice_id": 127068,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 29325,
    "choices": [
      {
        "id": 117206,
        "text": "<p><span style=\"font-size:14.0pt;\">Lymphangioma</span></p>"
      },
      {
        "id": 117207,
        "text": "<p><span style=\"font-size:14.0pt;\">Hemangioma</span></p>"
      },
      {
        "id": 117208,
        "text": "<p><span style=\"font-size:14.0pt;\">Telangiectasia</span></p>"
      },
      {
        "id": 117209,
        "text": "<p><span style=\"font-size:14.0pt;\">Angiosarcoma</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 8-year-old boy is brought to the physician with complaints of a 3 cms spongy dull circumscribed swelling on upper outer Lt. arm present since infancy. A biopsy was done and image is shown below. What is your diagnosis?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/04/picture6.jpg\" alt=\"\" width=\"300\" height=\"201\"></span></p>",
    "unique_key": "Q1224005",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634551,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Hemangioma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The biopsy image shows capillaries filled with red blood cells (RBCs), consistent with the histological findings of a <strong>hemangioma</strong>. Key features of the presentation include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Congenital onset (since infancy)</strong>: Hemangiomas are typically present from birth or appear early in life.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Spongy, dull, circumscribed swelling</strong>: This describes the characteristic appearance of a hemangioma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histological findings</strong>: Capillary-like spaces filled with RBCs.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hemangiomas are benign vascular tumors that often grow during early infancy and later regress spontaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lymphangioma:</strong> Lymphangiomas involve dilated lymphatic vessels and typically appear as cystic spaces, often seen in the <strong>posterior neck (cystic hygroma)</strong>. The biopsy would not show RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Telangiectasia:</strong> Telangiectasias are dilated superficial blood vessels that appear as flat red spots on the skin, not spongy swellings. Histologically, they show dilated capillaries without the proliferation seen in hemangiomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Angiosarcoma:</strong> Angiosarcomas are malignant vascular tumors that show aggressive endothelial proliferation. They typically present later in life and are not associated with congenital onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hemangiomas</strong> are:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Benign vascular tumors seen in infancy.</span></li><li><span style=\"font-size:14.0pt;\">Characterized histologically by capillary or cavernous spaces filled with RBCs.</span></li><li><span style=\"font-size:14.0pt;\">Often self-limiting, with many cases regressing spontaneously during childhood.</span></li></ul>",
    "correct_choice_id": 117207,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73280,
    "choices": [
      {
        "id": 292073,
        "text": "<p><span style=\"font-size:14.0pt;\">Catalase negative, oxidase positive</span></p>"
      },
      {
        "id": 292074,
        "text": "<p><span style=\"font-size:14.0pt;\">Pili is a virulence factor</span></p>"
      },
      {
        "id": 292075,
        "text": "<p><span style=\"font-size:14.0pt;\">Facultative intracellular organism</span></p>"
      },
      {
        "id": 292076,
        "text": "<p><span style=\"font-size:14.0pt;\">Shows twitching motility</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old man presents with a history of urethral discharge for the last three days. A gram stain smear of the discharge is shown below. All of the following are true regarding the likely etiology except:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_WOEIEZQ.png\" width=\"803\" height=\"436\"></span></p>",
    "unique_key": "Q2993849",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634408,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Catalase negative, oxidase positive</strong></span></p>",
    "correct_choice_id": 292073,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 26619,
    "choices": [
      {
        "id": 106418,
        "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;</span></p>"
      },
      {
        "id": 106419,
        "text": "<p><span style=\"font-size:14.0pt;\">B</span></p>"
      },
      {
        "id": 106420,
        "text": "<p><span style=\"font-size:14.0pt;\">C</span></p>"
      },
      {
        "id": 106421,
        "text": "<p><span style=\"font-size:14.0pt;\">D</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">You are working in a PHC and have to send a sample for blood glucose estimation. Which of the following vacutainers will you use for sending your sample?&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_U1U6BP7.png\" width=\"1177\" height=\"336\"></span></p>",
    "unique_key": "Q7914108",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634570,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) It contains potassium oxalate + sodium fluoride</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>blood glucose estimation</strong>, it is essential to <strong>prevent glycolysis</strong> (the breakdown of glucose by red blood cells), which <strong>lowers glucose levels falsely</strong> if the sample is not processed immediately.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>gray-top vacutainer (D)</strong> contains <strong>sodium fluoride (NaF)</strong> and <strong>potassium oxalate</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Sodium fluoride</strong> inhibits <strong>enolase</strong>, an enzyme in glycolysis, preventing glucose degradation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Potassium oxalate</strong> acts as an <strong>anticoagulant</strong> to prevent clot formation.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This ensures an <strong>accurate blood glucose measurement</strong>, even if the sample processing is delayed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blue-top vacutainer (Citrate tube):</strong> Incorrect. Contains <strong>sodium citrate</strong>, used for <strong>coagulation studies (PT, aPTT, D-dimer)</strong>, <strong>not for glucose estimation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Red-top vacutainer (Plain tube):</strong> Incorrect. Contains <strong>no anticoagulant or glycolysis inhibitor</strong>. It allows blood to clot, leading to <strong>serum separation</strong>, but <strong>does not prevent glucose breakdown</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Purple-top vacutainer (EDTA tube):</strong> Incorrect. Contains <strong>EDTA (ethylenediaminetetraacetic acid)</strong>, which is used for <strong>CBC, blood smears, and hematology studies</strong>. It <strong>does not prevent glycolysis</strong>, making it unsuitable for glucose estimation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For blood glucose estimation, always use a gray-top vacutainer containing sodium fluoride (glycolysis inhibitor) and potassium oxalate (anticoagulant).</span></li><li><span style=\"font-size:14.0pt;\">Other vacutainers (blue, red, purple) are used for coagulation studies, biochemistry, or hematology, but do not prevent glucose degradation.</span></li></ul>",
    "correct_choice_id": 106421,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 94366,
    "choices": [
      {
        "id": 375680,
        "text": "<p><span style=\"font-size:14.0pt;\">Ertapenem</span></p>"
      },
      {
        "id": 375681,
        "text": "<p><span style=\"font-size:14.0pt;\">Imipenem</span></p>"
      },
      {
        "id": 375682,
        "text": "<p><span style=\"font-size:14.0pt;\">Meropenem</span></p>"
      },
      {
        "id": 375683,
        "text": "<p><span style=\"font-size:14.0pt;\">Doripenem</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following Carbapenems is not recommended for treatment of nosocomial infections?</span></p>",
    "unique_key": "Q1242430",
    "question_audio": null,
    "question_video": null,
    "map_id": 34662324,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ertapenem</strong></span></p>",
    "correct_choice_id": 375680,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26607,
    "choices": [
      {
        "id": 106370,
        "text": "<p><span style=\"font-size:14.0pt;\">RUNX1-RUNX1T1 is associated with core-binding factor AML and is considered an adverse prognostic factor.&nbsp;</span></p>"
      },
      {
        "id": 106371,
        "text": "<p><span style=\"font-size:14.0pt;\">RUNX1-RUNX1T1 is associated with core-binding factor AML and is considered a favorable prognostic factor.&nbsp;</span></p>"
      },
      {
        "id": 106372,
        "text": "<p><span style=\"font-size:14.0pt;\">RUNX1-RUNX1T1 is associated with AML-M5 subtype and is characterized by the presence of Auer rods.</span></p>"
      },
      {
        "id": 106373,
        "text": "<p><span style=\"font-size:14.0pt;\">RUNX1-RUNX1T1 is associated with AML-M3 subtype and is characterized by a t(15;17) translocation.</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 60-year-old patient presents with fatigue, pallor, and petechiae. Physical examination reveals splenomegaly. Peripheral blood smear shows myeloblasts comprising more than 20% of the total white blood cells. A bone marrow biopsy confirms the diagnosis of acute myeloid leukemia (AML). Further molecular testing reveals the presence of a fusion gene involving the RUNX1-RUNX1T1 translocation. Which of the following statements best describes this genetic abnormality in AML?</span></p>",
    "unique_key": "Q8869259",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634564,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) RUNX1-RUNX1T1 is associated with core-binding factor AML and is considered a favorable prognostic factor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Acute Myeloid Leukemia (AML) is classified based on genetic and cytogenetic abnormalities. The <strong>RUNX1-RUNX1T1 fusion gene</strong> results from the <strong>t(8;21) translocation</strong>, which is part of the <strong>core-binding factor (CBF) AML subtypes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>t(8;21) (RUNX1-RUNX1T1) is associated with AML-M2 (AML with maturation).</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>It falls under the category of Core Binding Factor AML</strong>, which generally <strong>carries a favorable prognosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Core Binding Factor AML includes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>t(8;21) RUNX1-RUNX1T1</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>inv(16) or t(16;16) (CBFB-MYH11)</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Patients with <strong>core-binding factor AML</strong> respond <strong>well to chemotherapy</strong> and have <strong>better survival rates</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the correct answer is that <strong>RUNX1-RUNX1T1 is associated with core-binding factor AML and is considered a favorable prognostic factor</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. RUNX1-RUNX1T1 is associated with core-binding factor AML and is considered an adverse prognostic factor:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Core-binding factor AML (including <strong>t(8;21) and inv(16))</strong> is associated with a <strong>favorable prognosis</strong>, <strong>not</strong> an adverse one.</span></li><li><span style=\"font-size:14.0pt;\">However, additional mutations (like <strong>KIT mutations</strong>) may worsen prognosis in some cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. RUNX1-RUNX1T1 is associated with AML-M5 subtype and is characterized by the presence of Auer rods:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>AML-M5 (acute monocytic leukemia)</strong> is <strong>not</strong> associated with <strong>RUNX1-RUNX1T1</strong>.</span></li><li><span style=\"font-size:14.0pt;\">AML-M5 is characterized by <strong>monocytic proliferation</strong>, <strong>gum hypertrophy</strong>, and <strong>CD14/CD11c positivity</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Auer rods</strong> can be seen in <strong>AML-M2 (t(8;21)) and AML-M3 (APL)</strong>, but they are <strong>not exclusive to AML-M5</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. RUNX1-RUNX1T1 is associated with AML-M3 subtype and is characterized by a t(15;17) translocation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>AML-M3 (Acute Promyelocytic Leukemia, APL)</strong> is characterized by <strong>t(15;17), PML-RARA fusion gene</strong>, and is treated with <strong>ATRA (All-Trans Retinoic Acid)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>RUNX1-RUNX1T1 has NO role in AML-M3</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>AML with t(8;21) (RUNX1-RUNX1T1) is a core-binding factor AML with a favorable prognosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>AML-M3 (APL) is characterized by t(15;17) (PML-RARA)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>AML-M5 (acute monocytic leukemia) is not associated with RUNX1-RUNX1T1</strong>.</span></li></ul>",
    "correct_choice_id": 106371,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26678,
    "choices": [
      {
        "id": 106654,
        "text": "<p><span style=\"font-size:14.0pt;\">Entosis&nbsp;</span></p>"
      },
      {
        "id": 106655,
        "text": "<p><span style=\"font-size:14.0pt;\">Efferocytosis&nbsp;</span></p>"
      },
      {
        "id": 106656,
        "text": "<p><span style=\"font-size:14.0pt;\">Emperipolesis&nbsp;</span></p>"
      },
      {
        "id": 106657,
        "text": "<p><span style=\"font-size:14.0pt;\">Encleisis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following cell within cell phenomenon is associated with cellular process in which one cell enters into another cell without being degraded or destroyed?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/14/untitled-378.jpg\" alt=\"\" width=\"300\" height=\"257\"></span></p>",
    "unique_key": "Q3539800",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634577,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Emperipolesis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Emperipolesis</strong> is a phenomenon where one cell enters another cell without being degraded or destroyed.</span></li><li><span style=\"font-size:14.0pt;\">This process differs from <strong>phagocytosis</strong>, where the engulfed cell is digested.</span></li><li><span style=\"font-size:14.0pt;\">It is commonly seen in conditions like <strong>Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy)</strong> and <strong>some leukemias and lymphomas.</strong></span></li><li><span style=\"font-size:14.0pt;\">Histologically, it appears as <strong>intact lymphocytes, neutrophils, or plasma cells within the cytoplasm of larger cells (histiocytes or megakaryocytes).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Entosis&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>entosis</strong>, one live cell enters another and is later degraded.</span></li><li><span style=\"font-size:14.0pt;\">This occurs in some cancers and is associated with cell competition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Efferocytosis&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This process involves the clearance of <strong>apoptotic cells by macrophages</strong> to prevent inflammation.</span></li><li><span style=\"font-size:14.0pt;\">It is a part of normal immune system function.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Encleisis&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A rare term, encleisis describes <strong>partial engulfment without digestion</strong>, but it is not commonly used in pathology.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Emperipolesis is a process in which one cell enters another without being degraded.</span></li><li><span style=\"font-size:14.0pt;\">It is seen in Rosai-Dorfman disease, leukemias, and some hematologic disorders.</span></li><li><span style=\"font-size:14.0pt;\">It differs from entosis (which leads to degradation) and efferocytosis (which clears apoptotic cells).</span></li></ul>",
    "correct_choice_id": 106656,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 26625,
    "choices": [
      {
        "id": 106442,
        "text": "<p><span style=\"font-size:14.0pt;\">Interleukin-1 (IL-1)&nbsp;</span></p>"
      },
      {
        "id": 106443,
        "text": "<p><span style=\"font-size:14.0pt;\">Interleukin-6 (IL-6)&nbsp;</span></p>"
      },
      {
        "id": 106444,
        "text": "<p><span style=\"font-size:14.0pt;\">Interleukin-12 (IL-12)&nbsp;</span></p>"
      },
      {
        "id": 106445,
        "text": "<p><span style=\"font-size:14.0pt;\">Tumor necrosis factor-alpha (TNF-alpha)</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following cytokines is primarily responsible for the formation of non-caseating granulomas in sarcoidosis?</span></p>",
    "unique_key": "Q5598870",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634573,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Tumor necrosis factor-alpha (TNF-alpha)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">D Tumor necrosis factor-alpha (TNF-alpha) is preferred over C. Interleukin-12 (IL-12</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sarcoidosis is a <strong>granulomatous inflammatory disease</strong> characterized by <strong>non-caseating granulomas</strong> composed of <strong>activated macrophages (epithelioid histiocytes) and multinucleated giant cells</strong>. The cytokine <strong>tumor necrosis factor-alpha (TNF-alpha)</strong> plays a <strong>crucial role</strong> in <strong>granuloma formation and maintenance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathogenesis of Granuloma Formation in Sarcoidosis:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Antigenic trigger activates alveolar macrophages.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Dendritic cells release IL-12, which stimulates Th1 differentiation.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Th1 cells secrete IFN-gamma, activating macrophages.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>TNF-alpha promotes aggregation and maintenance of granulomas.</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Significance of TNF-alpha in Sarcoidosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Increased TNF-alpha levels correlate with disease severity.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>TNF-alpha inhibitors (e.g., infliximab) are used for refractory sarcoidosis.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Before initiating anti-TNF therapy, latent tuberculosis (TB) must be ruled out, as TNF-alpha is critical for controlling TB infections.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Interleukin-1 (IL-1)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IL-1 plays a role in <strong>inflammation and fever</strong> but is not the key driver of granuloma formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Interleukin-6 (IL-6)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IL-6 is involved in <strong>acute phase reactions and systemic inflammation</strong>, but it does not drive granuloma formation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Interleukin-12 (IL-12)</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IL-12 <strong>activates Th1 cells</strong>, leading to <strong>IFN-gamma release</strong>, which promotes macrophage activation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>However, TNF-alpha is the primary cytokine responsible for granuloma maintenance.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>TNF-alpha is the primary cytokine responsible for granuloma formation in sarcoidosis.</strong></span></li><li><span style=\"font-size:14.0pt;\">Th1 response (IL-12 \u2192 IFN-gamma \u2192 TNF-alpha) is critical for granuloma development.</span></li><li><span style=\"font-size:14.0pt;\">TNF-alpha inhibitors (e.g., infliximab) are used in refractory sarcoidosis but require tuberculosis screening before administration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_YIKymNf.png\" width=\"916\" height=\"1258\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Ref: https://twitter.com/AbhijitSurgPath</strong></span></p>",
    "correct_choice_id": 106445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29293,
    "choices": [
      {
        "id": 117078,
        "text": "<p><span style=\"font-size:14.0pt;\">Coagulative necrosis&nbsp;</span></p>"
      },
      {
        "id": 117079,
        "text": "<p><span style=\"font-size:14.0pt;\">Fibrinoid necrosis&nbsp;</span></p>"
      },
      {
        "id": 117080,
        "text": "<p><span style=\"font-size:14.0pt;\">Caseous necrosis&nbsp;</span></p>"
      },
      {
        "id": 117081,
        "text": "<p><span style=\"font-size:14.0pt;\">Gangrenous necrosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old female presented with patches of thick skin in the forearm, dysphagia on and off. She presented with oliguria and decreased renal function for 1 week. Renal biopsy was performed. Which of the following findings can be seen in this condition?</span></p>",
    "unique_key": "Q3160320",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634535,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Fibrinoid necrosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with a clinical picture consistent with <strong>scleroderma</strong>, a condition characterized by thickened skin, dysphagia due to esophageal involvement, and renal impairment. The renal involvement in scleroderma often leads to <strong>scleroderma renal crisis</strong>, characterized by malignant hypertension. This condition damages small blood vessels, resulting in fibrinoid necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In fibrinoid necrosis, immune complexes and fibrin are deposited in vessel walls, causing structural damage. This is commonly associated with conditions involving severe hypertension or immune-mediated vascular damage, as seen in scleroderma renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Additional relevant points:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Scleroderma renal crisis</strong> can lead to acute kidney injury.</span></li><li><span style=\"font-size:14.0pt;\">Treatment often involves ACE inhibitors like captopril or lisinopril, which reduce the effects of excessive renin-angiotensin system activation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Coagulative necrosis:</strong> Coagulative necrosis is typically associated with ischemic events in solid organs like the heart or spleen. For instance, splenic infarcts in sickle cell anemia may show coagulative necrosis. However, this is not relevant to the vascular damage seen in scleroderma renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Caseous necrosis:&nbsp;</strong>Caseous necrosis is most characteristic of tuberculosis, such as in Pott's spine (tuberculosis of the spine). This type of necrosis does not occur in scleroderma or its complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Gangrenous necrosis:</strong> Gangrenous necrosis is associated with ischemia leading to tissue death, particularly in extremities, and can be classified as wet or dry gangrene. It is unrelated to the vascular damage in scleroderma renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Fibrinoid necrosis</strong> occurs due to immune-mediated or hypertensive damage to small blood vessels, as seen in scleroderma renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The case describes Systemic sclerosis (scleroderma) and the characteristic renal features include: Fibrin thrombi with fibrinoid necrosis, mostly in interlobular arteries. Interlobular arteries with \u201conion skin\u201d concentric appearance with luminal narrowing are seen in the chronic stage of the disease.</span></p>",
    "correct_choice_id": 117079,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35918,
    "choices": [
      {
        "id": 143467,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gemfibrozil </span></span></span></p>"
      },
      {
        "id": 143468,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atorvastatin </span></span></span></p>"
      },
      {
        "id": 143469,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ezetimibe </span></span></span></p>"
      },
      {
        "id": 143470,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Niacin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following anti-dyslipidemic drug works by stimulating Peroxisome proliferator activated receptor (PPAR) alpha? </span></span></span></p>",
    "unique_key": "Q3069504",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633428,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Gemfibrozil </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibrates are a class of hypolipidemic drugs. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They include Gemfibrozil, Fenofibrate, Clofibrate. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are mainly used in Hypertriglyceridemia and chylomicronemia syndromes. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibrates bind to the PPAR alpha and stimulates Lipoprotein lipase thus, enhancing the clearance of VLDL. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Their <strong>important side effects</strong> include: Gallstones formation and Myopathy.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options (All are hypolipidemic drugs):</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Atorvastatin.</strong> HMG CoA Reductase inhibitor</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Ezetimibe</strong>. Decreases the absorption of cholesterol from small intestine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. <strong>Niacin</strong>. Decreases Hormone Sensitive Lipase activity, leading to a decrease in LDL and maximally increases HDL.</span></span></span></p>",
    "correct_choice_id": 143467,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73355,
    "choices": [
      {
        "id": 292369,
        "text": "<p><span style=\"font-size:14.0pt;\">dRNA enveloped virus</span></p>"
      },
      {
        "id": 292370,
        "text": "<p><span style=\"font-size:14.0pt;\">ssDNA non-enveloped virus&nbsp;</span></p>"
      },
      {
        "id": 292371,
        "text": "<p><span style=\"font-size:14.0pt;\">dsDNA non-enveloped virus&nbsp;</span></p>"
      },
      {
        "id": 292372,
        "text": "<p><span style=\"font-size:14.0pt;\">SSRNA nonenveloped virus&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the nature of the causative virus of pharyngoconjunctival fever?</span></p>",
    "unique_key": "Q1248521",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634473,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) dsDNA non-enveloped virus</strong></span></p>",
    "correct_choice_id": 292371,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74152,
    "choices": [
      {
        "id": 295537,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium disodium EDTA (CaNa\u2082EDTA) alone</span></p>"
      },
      {
        "id": 295538,
        "text": "<p><span style=\"font-size:14.0pt;\">Dimercaprol (BAL) + Calcium disodium EDTA</span></p>"
      },
      {
        "id": 295539,
        "text": "<p><span style=\"font-size:14.0pt;\">Penicillamine</span></p>"
      },
      {
        "id": 295540,
        "text": "<p><span style=\"font-size:14.0pt;\">Deferoxamine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;4-year-old child&nbsp;is brought to the emergency department with complaints of&nbsp;irritability, poor appetite, and abdominal pain. On examination, the child has&nbsp;pallor, cognitive delay, and a bluish line on the gums (Burton\u2019s line). Blood investigations reveal a&nbsp;microcytic hypochromic anemia&nbsp;with a&nbsp;blood lead level of 75 \u00b5g/dL. Which of the following is the most appropriate treatment?</span></p>",
    "unique_key": "Q6340114",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633402,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Dimercaprol (BAL) + Calcium disodium EDTA</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The child has&nbsp;<strong>severe lead poisoning</strong>&nbsp;(Blood lead level&nbsp;<strong>&gt;70 \u00b5g/dL</strong>) with&nbsp;<strong>neurological symptoms</strong>&nbsp;(irritability, cognitive delay).</span></li><li><span style=\"font-size:14.0pt;\">The&nbsp;<strong>standard treatment for severe lead poisoning</strong>&nbsp;is&nbsp;<strong>IM BAL followed by IV EDTA</strong>, as BAL prevents lead redistribution to the brain, and EDTA enhances renal excretion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of Lead Poisoning</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ez18Apk.png\" width=\"958\" height=\"550\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Calcium disodium EDTA (CaNa\u2082EDTA) alone:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Used in moderate cases (lead level&nbsp;<strong>45-69 \u00b5g/dL</strong>) but&nbsp;<strong>not sufficient for severe poisoning</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Penicillamine:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Used for&nbsp;<strong>mild cases</strong>&nbsp;but is&nbsp;<strong>not first-line in severe poisoning</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deferoxamine:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Used for&nbsp;<strong>iron poisoning</strong>, not lead.</span></p>",
    "correct_choice_id": 295538,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 3067,
    "choices": [
      {
        "id": 12253,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></span></span></span></p>"
      },
      {
        "id": 12254,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></span></span></p>"
      },
      {
        "id": 12255,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></span></span></p>"
      },
      {
        "id": 12256,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenobarbitone</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male is brought to the emergency department after ingesting an overdose of a medication. In order to enhance drug clearance, you consider the modification of urinary pH as a therapeutic measure. Knowing that manipulating the urinary pH can increase the excretion of certain drugs by altering their ionization state, which of the following drugs would not have its excretion increased by alkalinization of the urine?</span></span></span></span></p>",
    "unique_key": "Q8560066",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633427,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Morphine </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Morphine </strong>is a <strong>basic drug</strong>. <strong>Alkalizing the urine </strong>would actually <strong>decrease its excretion </strong>because it would be <strong>less ionized </strong>and <strong>more readily reabsorbed in the renal tubules</strong>. <strong>Acidifying the urine </strong>would <strong>increase morphine excretion</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aspirin</strong>: <strong>Aspirin </strong>(acetylsalicylic acid) is an <strong>acidic drug</strong>. Alkalinizing the urine with agents such as sodium bicarbonate can enhance its ionization and excretion.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Methotrexate</strong>: This is also an <strong>acidic drug</strong>, and <strong>alkalinization of the urine will increase its ionization</strong>, decreasing reabsorption and increasing elimination.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenobarbitone</strong>: This is an <strong>acidic drug</strong>, and like <strong>aspirin and methotrexate</strong>, it is more ionized in alkaline urine, leading to increased excretion.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of <strong>drug overdose</strong>, <strong>urinary alkalinization </strong>is utilized to <strong>increase the excretion of acidic drugs </strong>by <strong>enhancing their ionization</strong>, which does not apply to basic drugs like morphine that are better excreted in acidic conditions. Remember, the drugs ending with &lsquo;ine&rsquo; are basic.</span></span></span></span></p>",
    "correct_choice_id": 12255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 44031,
    "choices": [
      {
        "id": 175783,
        "text": "<p><span style=\"font-size:12pt;\">Integrin</span></p>"
      },
      {
        "id": 175784,
        "text": "<p><span style=\"font-size:12pt;\">Cadherin</span></p>"
      },
      {
        "id": 175785,
        "text": "<p><span style=\"font-size:12pt;\">Occludens</span></p>"
      },
      {
        "id": 175786,
        "text": "<p><span style=\"font-size:12pt;\">None of the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which extracellular cell adhesion is disrupted by Vibrio cholerae? (INICET NOV 2023)</span></p>",
    "unique_key": "Q6616611",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633814,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Occludens</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae disrupts occludens, specifically targeting tight junctions between intestinal epithelial cells, which impairs their barrier function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Integrin</strong>: Primarily involved in cell-extracellular matrix adhesion, not typically disrupted by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Cadherin</strong>: Important for cell-cell adhesion in adherens junctions, not the main target of Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. None of the above</strong>: Incorrect, as occludens are indeed affected by Vibrio cholerae.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vibrio cholerae specifically targets occludens, which are crucial components of tight junctions, thereby compromising intestinal epithelial barrier functions.</span></p>",
    "correct_choice_id": 175785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73260,
    "choices": [
      {
        "id": 291997,
        "text": "<p><span style=\"font-size:14.0pt;\">Buffy coat is used to diagnose the parasite</span></p>"
      },
      {
        "id": 291998,
        "text": "<p><span style=\"font-size:14.0pt;\">It is an obligate extracellular parasite</span></p>"
      },
      {
        "id": 291999,
        "text": "<p><span style=\"font-size:14.0pt;\">Promastigote forms are seen in the bone marrow</span></p>"
      },
      {
        "id": 292000,
        "text": "<p><span style=\"font-size:14.0pt;\">Stibogluconate is the first line of treatment in India</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Bone marrow aspirate of a patient shows the following features. Which of the following is true?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_qAltzSF.png\" width=\"511\" height=\"403\"></span></p>",
    "unique_key": "Q5640074",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634405,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Buffy coat is used to diagnose the parasite</strong></span></p>",
    "correct_choice_id": 291997,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 43966,
    "choices": [
      {
        "id": 175527,
        "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-D, 3-C, 4-B</span></p>"
      },
      {
        "id": 175528,
        "text": "<p><span style=\"font-size:12.0pt;\">1-D, 2-A, 3-C, 4-B</span></p>"
      },
      {
        "id": 175529,
        "text": "<p><span style=\"font-size:12.0pt;\">1-C, 2-A, 3-D, 4-B</span></p>"
      },
      {
        "id": 175530,
        "text": "<p><span style=\"font-size:12.0pt;\">1-A, 2-D, 3-B, 4-C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Match the mode of inheritance with the disorder in the appropriate column:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151820.JPG\" alt=\"\" width=\"700\" height=\"199\"></span></p>",
    "unique_key": "Q5456992",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634477,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1-D, 2-A, 3-C, 4-B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Autosomal Dominant - &nbsp;D. Myotonia dystrophica</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Autosomal dominant disorders are typically inherited from one affected parent. Myotonia dystrophica, characterized by muscle stiffness and other systemic symptoms, exhibits this pattern of inheritance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. X-Linked Recessive \u2013 A. Duchene Muscular Dystrophy</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">X-linked recessive disorders mainly affect males and are passed on by carrier mothers. Duchene Muscular Dystrophy, which leads to muscle degeneration and weakness, is a classic example.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Autosomal Recessive \u2013 C. Cystic fibrosis</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Autosomal recessive disorders require both parents to pass on a faulty gene. Cystic fibrosis, which causes severe damage to the respiratory and digestive systems, is inherited this way.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Mitochondrial \u2013 B. Leber's Hereditary Optic Neuropathy (Leber's disease)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Mitochondrial diseases are inherited through mutations in mitochondrial DNA, typically passed from mother to all offspring. Leber's disease leads to sudden vision loss primarily in young adults.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Each genetic disorder has a specific pattern of inheritance that affects its transmission and manifestation in individuals.</span></p>",
    "correct_choice_id": 175528,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 33869,
    "choices": [
      {
        "id": 135314,
        "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
      },
      {
        "id": 135315,
        "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
      },
      {
        "id": 135316,
        "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
      },
      {
        "id": 135317,
        "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the preferred drug for treatment of post-menopausal breast cancer?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
    "unique_key": "Q6623130",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633426,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. D. Anastrozole</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Aromatase inhibitors like anastrozole and letrozole are&nbsp; considered the preferred drugs for the treatment of hormone receptor-positive breast cancer in post-menopausal women whereas tamoxifen is considered drug of choice in pre-menopausal women. Anastrozole is an aromatase inhibitor whereas tamoxifen works as a selective estrogen receptor modulator (SERM), both are effective in blocking the effects of estrogen on breast cancer cells. Methotrexate may be used in breast cancer treatment, however it is not a first line drug. On the other hand, raloxifene is a SERM used for treatment of osteoporosis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Methotrexate:</strong> Methotrexate is a chemotherapy drug used in the treatment of various cancers, including some types of breast cancer. However, it is not typically the first-line choice for post-menopausal breast cancer.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Raloxifene:</strong> Raloxifene is a selective estrogen receptor modulator (SERM) primarily used for osteoporosis and the prevention of breast cancer, rather than its treatment.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Tamoxifen:</strong> Tamoxifen is a widely used medication for the treatment of hormone receptor-positive breast cancer in both pre-menopausal and post-menopausal women. It is often the preferred choice for breast cancer in pre-menopausal female.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Anastrozole is an aromatase inhibitor and is drug of choice for treatment of breast cancer (which is estrogen receptor positive) in post-menopausal females.</span></p>",
    "correct_choice_id": 135317,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 74150,
    "choices": [
      {
        "id": 295529,
        "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone</span></p>"
      },
      {
        "id": 295530,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide</span></p>"
      },
      {
        "id": 295531,
        "text": "<p><span style=\"font-size:14.0pt;\">Furosemide</span></p>"
      },
      {
        "id": 295532,
        "text": "<p><span style=\"font-size:14.0pt;\">Acetazolamide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male with hypertension and chronic kidney disease (CKD) stage 3 presents with recurrent hyperkalemia on routine blood tests. He is currently on an ACE inhibitor for hypertension. Which of the following diuretics would be the most appropriate choice for managing his hypertension?</span></p>",
    "unique_key": "Q9889041",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633401,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Furosemide</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Why?</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient has&nbsp;<strong>CKD with recurrent hyperkalemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Loop diuretics like furosemide</strong>&nbsp;are preferred in CKD as they&nbsp;<strong>promote potassium excretion</strong>&nbsp;and help manage&nbsp;<strong>fluid overload</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thiazide diuretics (hydrochlorothiazide) are ineffective in advanced CKD</strong>&nbsp;(GFR &lt;30 mL/min).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Potassium-sparing diuretics (spironolactone) and carbonic anhydrase inhibitors (acetazolamide) are not suitable</strong>&nbsp;due to their effects on potassium balance.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Spironolactone:&nbsp;</strong>Incorrect.<strong> Aldosterone antagonist, potassium-sparing,&nbsp;</strong>can worsen hyperkalemia, especially in CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hydrochlorothiazide:</strong>&nbsp;Incorrect.&nbsp;<strong>Thiazide diuretic</strong>, but&nbsp;<strong>less effective in CKD (GFR &lt;30)</strong>&nbsp;and does not significantly lower potassium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acetazolamide:</strong>&nbsp;Incorrect.&nbsp;<strong>Carbonic anhydrase inhibitor</strong>, causes&nbsp;<strong>bicarbonate loss and metabolic acidosis</strong>, and does not effectively manage&nbsp;<strong>hypertension or hyperkalemia</strong>.</span></p>",
    "correct_choice_id": 295531,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54541,
    "choices": [
      {
        "id": 217633,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 2</span></span></span></p>"
      },
      {
        "id": 217634,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 and 3</span></span></span></p>"
      },
      {
        "id": 217635,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 and 4</span></span></span></p>"
      },
      {
        "id": 217636,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 3</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is a criteria for making a diagnosis of an anaphylactic reaction?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Swollen lips and urticaria</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hypertension</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Breathing difficulty</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Persistent abdominal pain and vomiting</span></span></span></li>\r\n</ol>",
    "unique_key": "Q2863467",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634534,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) 1 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactic reaction is a severe, life-threatening allergic reaction that is classified as a type I hypersensitivity reaction. This reaction involves the rapid release of histamine and other mediators from mast cells and basophils, leading to a variety of symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Key Criteria for Anaphylactic Reaction:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Swollen lips and urticaria</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are common manifestations of anaphylaxis due to histamine release causing increased vascular permeability and vasodilation, leading to swelling and hives.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Breathing difficulty</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The release of leukotrienes and other mediators can cause bronchospasm, leading to respiratory distress and difficulty in breathing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Hypertension</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaphylactic reactions typically cause hypotension (low blood pressure) due to widespread vasodilation and increased capillary permeability, not hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Persistent abdominal pain and vomiting</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">While abdominal pain and vomiting can occur in anaphylaxis, they are not the most typical or defining features. Persistent symptoms are less commonly associated with anaphylaxis compared to the more acute and severe symptoms like swelling and breathing difficulty.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The presence of swollen lips and urticaria along with breathing difficulty are key criteria for diagnosing an anaphylactic reaction, while hypertension and persistent abdominal pain are not typical features.</span></span></span></p>",
    "correct_choice_id": 217636,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 74175,
    "choices": [
      {
        "id": 295629,
        "text": "<p><span style=\"font-size:14.0pt;\">Amoxicillin</span></p>"
      },
      {
        "id": 295630,
        "text": "<p><span style=\"font-size:14.0pt;\">Erythromycin</span></p>"
      },
      {
        "id": 295631,
        "text": "<p><span style=\"font-size:14.0pt;\">Rifampicin</span></p>"
      },
      {
        "id": 295632,
        "text": "<p><span style=\"font-size:14.0pt;\">Tetracycline</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child is found to be an asymptomatic carrier of Corynebacterium diphtheriae during a school health screening. He has no signs of pharyngitis or systemic illness. To prevent transmission to others, he is started on an antibiotic to eradicate the bacteria from his nasopharynx. What is the drug of choice for this patient?</span></p>",
    "unique_key": "Q4189809",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633414,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Erythromycin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Erythromycin (oral or IM) is the drug of choice for eradicating the carrier state of&nbsp;Corynebacterium diphtheriae.</strong></span></li><li><span style=\"font-size:14.0pt;\">Alternative:&nbsp;<strong>Penicillin G benzathine IM followed by Penicillin V orally for 10 days.</strong></span></li><li><span style=\"font-size:14.0pt;\">The goal of treatment in carriers is&nbsp;<strong>eliminating the bacteria to prevent transmission</strong>, even in asymptomatic individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Amoxicillin:</strong> Not effective in eliminating&nbsp;C. diphtheriae&nbsp;carriers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rifampicin:</strong> Although it has activity against&nbsp;Corynebacterium diphtheriae, it is not the preferred choice for carrier eradication.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tetracycline:</strong> Not used for diphtheria treatment or carrier state due to limited efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Point:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Erythromycin for 7\u201310 days</strong>&nbsp;is the preferred regimen for diphtheria carriers.</span></p>",
    "correct_choice_id": 295630,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73455,
    "choices": [
      {
        "id": 292769,
        "text": "<p><span style=\"font-size:14.0pt;\">73 degrees Celsius for 20 minutes</span></p>"
      },
      {
        "id": 292770,
        "text": "<p><span style=\"font-size:14.0pt;\">63 degrees Celsius for 30 minutes</span></p>"
      },
      {
        "id": 292771,
        "text": "<p><span style=\"font-size:14.0pt;\">72 degrees Celsius for 30 seconds</span></p>"
      },
      {
        "id": 292772,
        "text": "<p><span style=\"font-size:14.0pt;\">63 degree Celsius for 10 minutes</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Pasteurization is done at?</span></p>",
    "unique_key": "Q2605559",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634403,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 63 degrees Celsius for 30 minutes</strong></span></p>",
    "correct_choice_id": 292770,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74154,
    "choices": [
      {
        "id": 295545,
        "text": "<p><span style=\"font-size:14.0pt;\">Upregulation of \u03b12-receptors in the CNS</span></p>"
      },
      {
        "id": 295546,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased norepinephrine release due to loss of presynaptic inhibition</span></p>"
      },
      {
        "id": 295547,
        "text": "<p><span style=\"font-size:14.0pt;\">Reflex activation of the renin-angiotensin-aldosterone system (RAAS)</span></p>"
      },
      {
        "id": 295548,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased sensitivity of vascular smooth muscle to circulating catecholamines</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;45-year-old hypertensive male&nbsp;has been on an antihypertensive drug for several months. He reports&nbsp;persistent drowsiness, dry mouth, and lethargy&nbsp;but continued the medication. However, after&nbsp;forgetting to take it for 3 days, he presents to the ER with&nbsp;severe hypertension, tachycardia, diaphoresis, and anxiety. Which of the following best explains the mechanism of his&nbsp;rebound hypertension?</span></p>",
    "unique_key": "Q1542151",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633403,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Increased norepinephrine release due to loss of presynaptic inhibition</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient was most likely taking&nbsp;<strong>Clonidine</strong>, a&nbsp;<strong>centrally acting \u03b12-agonist</strong>&nbsp;that inhibits sympathetic outflow.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Chronic use suppresses norepinephrine (NE) release</strong>&nbsp;via&nbsp;<strong>presynaptic \u03b12-receptor activation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stopping clonidine suddenly</strong>&nbsp;\u2192&nbsp;<strong>loss of presynaptic inhibition</strong>&nbsp;\u2192&nbsp;<strong>excess NE release</strong>&nbsp;\u2192&nbsp;<strong>severe rebound hypertension</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Upregulation of \u03b12-receptors in the CNS:&nbsp;</strong>No evidence that \u03b12-receptors significantly upregulate; the issue is&nbsp;<strong>NE overactivity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Reflex activation of the RAAS:</strong>&nbsp;<strong>RAAS</strong>&nbsp;does play a role in hypertension, but&nbsp;<strong>not the primary cause of clonidine withdrawal crisis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased sensitivity of vascular smooth muscle to circulating catecholamines:&nbsp;</strong>Seen in&nbsp;<strong>\u03b2-blocker withdrawal</strong>, not&nbsp;<strong>clonidine withdrawal</strong>.</span></p>",
    "correct_choice_id": 295546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74146,
    "choices": [
      {
        "id": 295513,
        "text": "<p><span style=\"font-size:14.0pt;\">Flumazenil</span></p>"
      },
      {
        "id": 295514,
        "text": "<p><span style=\"font-size:14.0pt;\">Naloxone</span></p>"
      },
      {
        "id": 295515,
        "text": "<p><span style=\"font-size:14.0pt;\">Physostigmine</span></p>"
      },
      {
        "id": 295516,
        "text": "<p><span style=\"font-size:14.0pt;\">Diazepam</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old&nbsp;hiker&nbsp;is brought to the emergency department by his friends after&nbsp;eating wild berries&nbsp;during a trek. He is&nbsp;agitated, confused, and hallucinating, attempting to grab imaginary objects in the air. His&nbsp;skin is dry and flushed, pupils are&nbsp;bilaterally dilated, and he has&nbsp;urinary retention. His heart rate is&nbsp;120 bpm, and his temperature is&nbsp;39.5\u00b0C (103\u00b0F). Which of the following drugs is the best treatment for his condition?</span></p>",
    "unique_key": "Q4865504",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633399,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Physostigmine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient has&nbsp;<strong>anticholinergic toxicity</strong>, most likely from&nbsp;<strong>ingesting Dhatura or other plants containing belladonna alkaloids</strong>. The classic toxidrome includes:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hallucinations, agitation, delirium (\"mad as a hatter\")</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Dry, flushed skin (\"red as a beet, dry as a bone\")</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Mydriasis with blurred vision (\"blind as a bat\")</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Hyperthermia (\"hot as a hare\")</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Urinary retention (\"full as a flask\")</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Physostigmine</strong>, a&nbsp;<strong>cholinesterase inhibitor</strong>, reverses anticholinergic toxicity by increasing&nbsp;<strong>acetylcholine levels</strong>, counteracting the muscarinic blockade.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Flumazenil:</strong> Used for&nbsp;<strong>benzodiazepine overdose</strong>, not effective in anticholinergic toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Naloxone:</strong> Used for&nbsp;<strong>opioid overdose</strong>, which presents with&nbsp;<strong>pinpoint pupils and respiratory depression</strong>, not hyperthermia or hallucinations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Diazepam:</strong> Can help with&nbsp;<strong>seizures or agitation</strong>, but does&nbsp;<strong>not reverse the underlying toxicity</strong>.</span></p>",
    "correct_choice_id": 295515,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74172,
    "choices": [
      {
        "id": 295617,
        "text": "<p><span style=\"font-size:14.0pt;\">It is an irreversible P2Y12 receptor inhibitor</span></p>"
      },
      {
        "id": 295618,
        "text": "<p><span style=\"font-size:14.0pt;\">It is a pro-drug requiring hepatic activation</span></p>"
      },
      {
        "id": 295619,
        "text": "<p><span style=\"font-size:14.0pt;\">It has a faster onset of action than clopidogrel</span></p>"
      },
      {
        "id": 295620,
        "text": "<p><span style=\"font-size:14.0pt;\">It is affected by CYP2C19 inhibitors like omeprazole, reducing its efficacy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;64-year-old male&nbsp;with a history of&nbsp;hypertension, type 2 diabetes, and recent myocardial infarction (MI)&nbsp;undergoes&nbsp;percutaneous coronary intervention (PCI) with stent placement. He is prescribed&nbsp;dual antiplatelet therapy (DAPT)consisting of&nbsp;aspirin and ticagrelor&nbsp;to prevent stent thrombosis. Which of the following statements is&nbsp;true&nbsp;about ticagrelor?</span></p>",
    "unique_key": "Q4007357",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633412,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>C) It has a faster onset of action than clopidogrel</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ticagrelor is a direct and reversible P2Y12 receptor inhibitor</strong>, unlike clopidogrel and prasugrel, which are irreversible.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Ticagrelor does not require hepatic activation</strong>, making it&nbsp;<strong>faster-acting than clopidogrel</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It is not a pro-drug</strong>, so its effect is more predictable and not affected by genetic variations in CYP2C19 metabolism.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Unlike clopidogrel, ticagrelor is not significantly affected by omeprazole or CYP2C19 inhibitors</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is an irreversible P2Y12 receptor inhibitor:</strong> Ticagrelor is a reversible P2Y12 inhibitor, unlike clopidogrel and prasugrel, which are irreversible.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It is a pro-drug requiring hepatic activation</strong>: Ticagrelor is an active drug and does not require hepatic activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is affected by CYP2C19 inhibitors like omeprazole, reducing its efficacy:</strong> Unlike clopidogrel, ticagrelor is not significantly affected by CYP2C19 inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ticagrelor is a reversible, direct-acting P2Y12 inhibitor with a faster onset and more consistent action than clopidogrel, making it a preferred choice in ACS patients undergoing PCI.</span></p>",
    "correct_choice_id": 295619,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26683,
    "choices": [
      {
        "id": 106674,
        "text": "<p><span style=\"font-size:14.0pt;\">Parkinsonism&nbsp;</span></p>"
      },
      {
        "id": 106675,
        "text": "<p><span style=\"font-size:14.0pt;\">Alzheimer\u2019s disease</span></p>"
      },
      {
        "id": 106676,
        "text": "<p><span style=\"font-size:14.0pt;\">Frontotemporal lobar degeneration</span></p>"
      },
      {
        "id": 106677,
        "text": "<p><span style=\"font-size:14.0pt;\">Huntington\u2019s disease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not classified as a taupathy?&nbsp;</span></p>",
    "unique_key": "Q4550043",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634578,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Huntington\u2019s disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tauopathies</strong> are <strong>neurodegenerative disorders characterized by the abnormal aggregation of tau protein</strong> within neurons, leading to cell dysfunction and death.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Tau</strong> is a microtubule-associated protein involved in stabilizing neuronal cytoskeleton structures.</span></li><li><span style=\"font-size:14.0pt;\">The major tauopathies include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Alzheimer\u2019s disease</strong> \u2013 Presence of neurofibrillary tangles composed of hyperphosphorylated tau.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Frontotemporal lobar degeneration (FTLD-tau)</strong> \u2013 Tau accumulation in frontotemporal regions, causing progressive dementia.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Parkinsonism (including Progressive Supranuclear Palsy and Corticobasal Degeneration)</strong> \u2013 Some forms of parkinsonian syndromes show tau pathology.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Huntington\u2019s disease (HD), however, is NOT a tauopathy.</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>HD is caused by CAG trinucleotide repeats on chromosome 4</strong>, leading to toxic accumulation of mutant huntingtin protein, <strong>not tau protein.</strong></span></li><li><span style=\"font-size:14.0pt;\">The primary pathology in <strong>HD</strong> involves <strong>striatal degeneration and loss of medium spiny neurons.</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Parkinsonism:&nbsp;</strong>Parkinson's disease is primarily associated with <strong>\u03b1-synuclein</strong> aggregates in Lewy bodies, but <strong>certain atypical parkinsonian syndromes (e.g., Progressive Supranuclear Palsy, Corticobasal Degeneration) are tauopathies.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Alzheimer\u2019s disease:&nbsp;</strong>Alzheimer\u2019s features <strong>neurofibrillary tangles composed of hyperphosphorylated tau</strong>, along with \u03b2-amyloid plaques.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Frontotemporal Lobar Degeneration (FTLD-tau):&nbsp;</strong>FTLD-tau is a major cause of <strong>frontotemporal dementia (FTD)</strong> and is characterized by tau inclusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tauopathies are neurodegenerative disorders characterized by tau protein accumulation.</span></li><li><span style=\"font-size:14.0pt;\">Alzheimer\u2019s disease, FTLD-tau, and some atypical Parkinsonian syndromes (PSP, CBD) are tauopathies.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Huntington\u2019s disease is NOT a tauopathy; it is caused by CAG trinucleotide repeat expansion in the huntingtin gene (HTT) on chromosome 4.</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zrtAlV5.png\" width=\"1147\" height=\"668\"></p>",
    "correct_choice_id": 106677,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54512,
    "choices": [
      {
        "id": 217517,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyper IgE syndrome</span></p>"
      },
      {
        "id": 217518,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease</span></p>"
      },
      {
        "id": 217519,
        "text": "<p><span style=\"font-size:12.0pt;\">Bruton disease</span></p>"
      },
      {
        "id": 217520,
        "text": "<p><span style=\"font-size:12.0pt;\">Wiskott Aldrich syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following immunodeficiency disorders has a high chance of catalase positive organisms causing infections?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q4196446",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634529,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chronic granulomatous disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease (CGD) is an immunodeficiency disorder characterized by a defect in the NADPH oxidase complex. This defect impairs the ability of phagocytes to produce reactive oxygen species, which are crucial for killing certain bacteria and fungi. As a result, individuals with CGD are particularly susceptible to infections by catalase-positive organisms, which can neutralize hydrogen peroxide and thus evade destruction by the impaired phagocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyper IgE syndrome:</strong> Also known as Job syndrome, this disorder is characterized by high levels of IgE, recurrent skin abscesses, pneumonia, and characteristic facial features. It is not specifically associated with increased infections by catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bruton disease:</strong> Also known as X-linked agammaglobulinemia, this condition affects B cell development, leading to low levels of immunoglobulins and increased susceptibility to bacterial infections, but not specifically to catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wiskott Aldrich syndrome:</strong> This is an X-linked recessive disorder characterized by eczema, thrombocytopenia, and immunodeficiency. While patients have an increased risk of infections, the susceptibility to catalase-positive organisms is not as pronounced as in CGD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease is associated with a high risk of infections by catalase-positive organisms due to a defect in the NADPH oxidase complex, which impairs the killing of these organisms by phagocytes.</span></p>",
    "correct_choice_id": 217518,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73426,
    "choices": [
      {
        "id": 292653,
        "text": "<p><span style=\"font-size:14.0pt;\">Klebsiella</span></p>"
      },
      {
        "id": 292654,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffEscherichia coli</span></p>"
      },
      {
        "id": 292655,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffPseudomonas aeruginosa</span></p>"
      },
      {
        "id": 292656,
        "text": "<p><span style=\"font-size:14.0pt;\">\ufeff\ufeff\ufeffSalmonella</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient admitted with 50% burns develops an infection at the burn site. The swab was cultured, the isolate &nbsp;is a strict aerobe and the test that is shown in the image is positive. What is the likely etiology of the burn infection?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20174919.jpg\" width=\"763\" height=\"394\"></span></p>",
    "unique_key": "Q5613578",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634397,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Pseudomonas aeruginosa</strong></span></p>",
    "correct_choice_id": 292655,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 26600,
    "choices": [
      {
        "id": 106342,
        "text": "<p><span style=\"font-size:14.0pt;\">Bone marrow aspirate</span></p>"
      },
      {
        "id": 106343,
        "text": "<p><span style=\"font-size:14.0pt;\">Fluorescent in situ hybridization (FISH)&nbsp;</span></p>"
      },
      {
        "id": 106344,
        "text": "<p><span style=\"font-size:14.0pt;\">Flow cytometry</span></p>"
      },
      {
        "id": 106345,
        "text": "<p><span style=\"font-size:14.0pt;\">Polymerase chain reaction</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 62-year-old elderly male presented with persistent fatigue and lymph total leucocyte count of 50,000/ul. His peripheral smear was done and had the findings as shown. Which of the following is the next best step in the management of this patient?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/13/picture1.jpg\" alt=\"\" width=\"300\" height=\"202\"></span></p>",
    "unique_key": "Q6025821",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634560,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Flow cytometry</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The image provided shows the presence of smudge cells, which are characteristic of Chronic Lymphocytic Leukemia (CLL). Smudge cells appear due to the fragility of leukemic cells, which easily break during slide preparation. The fragility is attributed to a defect in vimentin, a cytoskeletal protein. This results in the presence of crushed lymphocytes, a hallmark finding in CLL.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To confirm the diagnosis of CLL, the investigation of choice is flow cytometry. Flow cytometry is used to analyze cell surface markers, specifically looking for CD5 and CD23 positivity, which are characteristic markers of CLL. The presence of these markers differentiates CLL from other lymphoproliferative disorders, such as mantle cell lymphoma, which is CD5 positive but CD23 negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Bone marrow aspirate:</strong> While a bone marrow aspirate can provide additional information, it is not the first-line test for diagnosing CLL. CLL primarily involves the peripheral blood and lymph nodes, with relatively less involvement of the bone marrow in early stages. Thus, bone marrow aspirate is not the preferred diagnostic test at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fluorescent in situ hybridization (FISH):</strong> FISH is useful for detecting chromosomal abnormalities and translocations in hematologic malignancies. It is particularly useful in Chronic Myeloid Leukemia (CML) to detect BCR-ABL translocation. However, in CLL, FISH is not the first diagnostic step but may be used later for prognostic evaluation (e.g., detecting deletion 17p for poor prognosis).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Polymerase chain reaction (PCR):</strong> PCR is primarily used for detecting specific gene mutations or translocations in hematologic malignancies. For instance, it is useful for detecting BCR-ABL in CML. However, PCR is not the preferred initial test for CLL, as it does not provide the necessary immunophenotypic characterization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The presence of smudge cells in the peripheral blood smear suggests Chronic Lymphocytic Leukemia (CLL). The best initial test for confirming the diagnosis of CLL is flow cytometry, which identifies characteristic markers CD5 and CD23 positivity.</span></p>",
    "correct_choice_id": 106344,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 52128,
    "choices": [
      {
        "id": 208013,
        "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
      },
      {
        "id": 208014,
        "text": "<p><span style=\"font-size:12.0pt;\">Chancroid</span></p>"
      },
      {
        "id": 208015,
        "text": "<p><span style=\"font-size:12.0pt;\">Donovanosis</span></p>"
      },
      {
        "id": 208016,
        "text": "<p><span style=\"font-size:12.0pt;\">Gonorrhea</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Drug resistance is seen in which of the following STDs:&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q8278799",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Gonorrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gonorrhea, caused by Neisseria gonorrhoeae, has exhibited significant drug resistance over the years. Initially, penicillin was the treatment of choice for gonorrhea. However, the emergence of penicillin-resistant strains necessitated a shift to other antibiotics. Fluoroquinolones were subsequently used, but resistance to these agents also developed. Currently, third-generation cephalosporins, such as ceftriaxone, are the recommended treatment. The issue of antibiotic resistance in Neisseria gonorrhoeae is a major public health concern, and ongoing surveillance and development of new treatments are crucial.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Syphilis</strong>: Syphilis, caused by Treponema pallidum, has not shown significant drug resistance. It remains highly sensitive to penicillin, which is still the first-line treatment for all stages of syphilis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Chancroid</strong>: Chancroid, caused by Haemophilus ducreyi, has not shown widespread drug resistance. It is typically treated with azithromycin, ceftriaxone, ciprofloxacin, or erythromycin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Donovanosis</strong>: Donovanosis, caused by Klebsiella granulomatis, is treated with antibiotics such as azithromycin, doxycycline, ciprofloxacin, or trimethoprim-sulfamethoxazole. Drug resistance is not a significant issue with donovanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae, the causative agent of gonorrhea, has developed resistance to multiple antibiotics, including penicillin and fluoroquinolones, making third-generation cephalosporins the current treatment of choice.</span></p>",
    "correct_choice_id": 208016,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 74168,
    "choices": [
      {
        "id": 295601,
        "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone 100 mg IV every 8 hours for 48 hours</span></p>"
      },
      {
        "id": 295602,
        "text": "<p><span style=\"font-size:14.0pt;\">Methylprednisolone 16 mg IM once daily for 2 days</span></p>"
      },
      {
        "id": 295603,
        "text": "<p><span style=\"font-size:14.0pt;\">Betamethasone 12 mg IM every 24 hours for 2 doses</span></p>"
      },
      {
        "id": 295604,
        "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone 12 mg IM every 24 hours for 2 doses</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;28-year-old pregnant woman at 30 weeks of gestation&nbsp;is admitted with&nbsp;preterm labor. To&nbsp;enhance fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome (RDS), the obstetrician decides to administer a corticosteroid. Which of the following&nbsp;regimens&nbsp;is the most appropriate choice?</span></p>",
    "unique_key": "Q5188365",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633410,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Betamethasone 12 mg IM every 24 hours for 2 doses</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For&nbsp;<strong>fetal lung maturation in preterm labor (24\u201334 weeks gestation), corticosteroids</strong>&nbsp;like <strong>betamethasone</strong> or&nbsp;<strong>dexamethasone</strong>&nbsp;are administered to&nbsp;<strong>stimulate surfactant production</strong>, reducing&nbsp;<strong>neonatal RDS, intraventricular hemorrhage, and necrotizing enterocolitis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The&nbsp;<strong>recommended regimens are</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Betamethasone 12 mg IM every 24 hours for 2 doses</strong>&nbsp;(Correct answer)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dexamethasone 6 mg IM every 12 hours for 4 doses</strong>&nbsp;(<strong>not the option given, but correct alternative</strong>)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the question,&nbsp;<strong>Dexamethasone 12 mg IM every 24 hours for 2 doses</strong>&nbsp;(<strong>Option D</strong>) is incorrect because the correct regimen involves&nbsp;<strong>four doses of 6 mg each</strong>&nbsp;rather than two 12 mg doses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hydrocortisone 100 mg IV every 8 hours for 48 hours:</strong> Used for&nbsp;<strong>adrenal insufficiency</strong>, not for fetal lung maturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methylprednisolone 16 mg IM once daily for 2 days:</strong>&nbsp;<strong>Does not cross the placenta effectively</strong>, making it&nbsp;<strong>ineffective for fetal lung maturation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dexamethasone 12 mg IM every 24 hours for 2 doses:&nbsp;</strong>Incorrect<strong> dosing regimen</strong>; correct regimen is&nbsp;<strong>6 mg IM every 12 hours for 4 doses</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For&nbsp;<strong>fetal lung maturation in preterm labor</strong>, the preferred corticosteroids are:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Betamethasone 12 mg IM every 24 hours (2 doses)</span></li><li><span style=\"font-size:14.0pt;\">Dexamethasone 6 mg IM every 12 hours (4 doses)</span></li></ul>",
    "correct_choice_id": 295603,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73338,
    "choices": [
      {
        "id": 292305,
        "text": "<p><span style=\"font-size:14.0pt;\">Pathogen shows autoinfection</span></p>"
      },
      {
        "id": 292306,
        "text": "<p><span style=\"font-size:14.0pt;\">Oocysts are not immediately infective after being excreted in stool</span></p>"
      },
      {
        "id": 292307,
        "text": "<p><span style=\"font-size:14.0pt;\">The organism may show auto-fluorescence&nbsp;</span></p>"
      },
      {
        "id": 292308,
        "text": "<p><span style=\"font-size:14.0pt;\">Nitazoxanide is the treatment of choice</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient who underwent a renal transplant 3 months ago comes with complaints of diarrhea for the last 9 days. The stool sample was subject to Kinyoun stain revealing structures shown below. Which of the following is true about the organism?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20143056.jpg\" width=\"306\" height=\"456\"></span></p>",
    "unique_key": "Q3066944",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634382,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The organism may show auto-fluorescence</strong></span></p>",
    "correct_choice_id": 292307,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 29321,
    "choices": [
      {
        "id": 117190,
        "text": "<p><span style=\"font-size:14.0pt;\">Rectum is not involved</span></p>"
      },
      {
        "id": 117191,
        "text": "<p><span style=\"font-size:14.0pt;\">Continuous lesion visualized in endoscopy</span></p>"
      },
      {
        "id": 117192,
        "text": "<p><span style=\"font-size:14.0pt;\">Non caseating granulomas</span></p>"
      },
      {
        "id": 117193,
        "text": "<p><span style=\"font-size:14.0pt;\">Cobblestone appearance</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which statement is not true regarding crohn's disease?</span></p>",
    "unique_key": "Q2464163",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634549,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Continuous lesion visualized in endoscopy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Crohn's disease</strong> is a chronic inflammatory bowel disease characterized by <strong>discontinuous lesions</strong> (also called <strong>skip lesions</strong>) in the gastrointestinal tract. This makes option <strong>b</strong> incorrect, as Crohn's disease does not present with continuous lesions on endoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rectum is not involved:&nbsp;</strong>True. In Crohn\u2019s disease, the rectum is often spared, unlike ulcerative colitis where rectal involvement is typical.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Non-caseating granulomas:</strong> True. Non-caseating granulomas are a histological hallmark of Crohn's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cobblestone appearance:</strong> True. This is a classic feature seen during endoscopy in Crohn's disease due to alternating inflamed and normal mucosa.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Crohn's disease is characterized by <strong>skip lesions</strong>, <strong>non-caseating granulomas</strong>, <strong>cobblestone appearance</strong>, and <strong>rectal sparing</strong>. In contrast, <strong>continuous lesions</strong> are a hallmark of <strong>ulcerative colitis</strong>.</span></p>",
    "correct_choice_id": 117191,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29335,
    "choices": [
      {
        "id": 117246,
        "text": "<p><span style=\"font-size:14.0pt;\">Plasma homocysteine levels</span></p>"
      },
      {
        "id": 117247,
        "text": "<p><span style=\"font-size:14.0pt;\">Peripheral smear showing megaloblasts&nbsp;</span></p>"
      },
      {
        "id": 117248,
        "text": "<p><span style=\"font-size:14.0pt;\">High value of mean cell volume&nbsp;</span></p>"
      },
      {
        "id": 117249,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum methylmalonic acid levels</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following test best differentiates cobalamin and folate deficiency?</span></p>",
    "unique_key": "Q9924989",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634556,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Serum methylmalonic acid levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Methylmalonic acid (MMA)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In B12 deficiency, <strong>MMA levels are elevated</strong> because B12 is required to convert methylmalonyl-CoA to succinyl-CoA.</span></li><li><span style=\"font-size:14.0pt;\">In folate deficiency, MMA levels remain <strong>normal</strong> as folate is not involved in this pathway.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Plasma homocysteine levels:&nbsp;</strong>Incorrect. Elevated homocysteine levels are seen in both B12 and folate deficiencies, making it nonspecific for differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Peripheral smear showing megaloblasts:&nbsp;</strong>Incorrect. Megaloblastic changes occur in both deficiencies, including hypersegmented neutrophils, so it cannot differentiate between the two.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. High value of mean cell volume:&nbsp;</strong>Incorrect. Both B12 and folate deficiencies result in macrocytosis, reflected as high MCV, but it does not distinguish between the two.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Serum methylmalonic acid (MMA)</strong> levels are <strong>elevated in cobalamin deficiency</strong> and <strong>normal in folate deficiency</strong>, making it the best test to differentiate between the two.</span></li><li><span style=\"font-size:14.0pt;\">Homocysteine levels are elevated in both, and megaloblasts or high MCV are nonspecific findings.</span></li></ul>",
    "correct_choice_id": 117249,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26617,
    "choices": [
      {
        "id": 106410,
        "text": "<p><span style=\"font-size:14.0pt;\">Ulcerative colitis&nbsp;</span></p>"
      },
      {
        "id": 106411,
        "text": "<p><span style=\"font-size:14.0pt;\">Grave\u2019s disease&nbsp;</span></p>"
      },
      {
        "id": 106412,
        "text": "<p><span style=\"font-size:14.0pt;\">Rheumatoid arthritis&nbsp;</span></p>"
      },
      {
        "id": 106413,
        "text": "<p><span style=\"font-size:14.0pt;\">SLE</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not an autoimmune disorder?&nbsp;</span></p>",
    "unique_key": "Q5840212",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634569,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ulcerative colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">An <strong>autoimmune disorder</strong> is characterized by an <strong>immune system attack against specific self-antigens</strong>, leading to <strong>tissue damage</strong>. To classify a disease as <strong>autoimmune</strong>, a well-defined <strong>autoantigen or autoantibody</strong> must be identified.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ulcerative colitis (UC) is an inflammatory disorder</strong>, but <strong>no specific autoantigen has been identified</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It is part of Inflammatory Bowel Disease (IBD), which results from immune dysregulation rather than a direct autoimmune attack.</strong></span></li><li><span style=\"font-size:14.0pt;\">While <strong>immune system abnormalities</strong> contribute to <strong>chronic inflammation in the colon</strong>, the absence of a <strong>well-defined autoantigen</strong> excludes it from classical autoimmune diseases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Grave\u2019s disease</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Autoimmune attack on the TSH receptor</strong> leads to <strong>thyroid hormone overproduction (hyperthyroidism)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>TSH receptor antibodies (TRAb)</strong> are characteristic.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Rheumatoid arthritis (RA):</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Autoimmune attack against synovial joints</strong> leads to <strong>chronic joint inflammation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies</strong> are present.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Systemic lupus erythematosus (SLE):</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Multi-system autoimmune disease</strong> affecting skin, kidneys, joints, and blood cells.</span></li><li><span style=\"font-size:14.0pt;\">Characterized by <strong>antinuclear antibodies (ANA), anti-dsDNA, and anti-Smith antibodies</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ulcerative colitis is an immune-mediated disorder but lacks a well-defined autoantigen, so it is not classified as an autoimmune disease.</span></li><li><span style=\"font-size:14.0pt;\">True autoimmune diseases (e.g., Grave\u2019s disease, RA, SLE) involve a specific autoantigen and autoantibodies.</span></li><li><span style=\"font-size:14.0pt;\">Inflammatory Bowel Disease (IBD) includes Crohn\u2019s disease and ulcerative colitis, both driven by immune dysregulation rather than direct autoimmune mechanisms.</span></li></ul>",
    "correct_choice_id": 106410,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73288,
    "choices": [
      {
        "id": 292105,
        "text": "<p><span style=\"font-size:14.0pt;\">I-A, II-B, III-D, IV-C</span></p>"
      },
      {
        "id": 292106,
        "text": "<p><span style=\"font-size:14.0pt;\">I-D, II-A, III-B, IV-C</span></p>"
      },
      {
        "id": 292107,
        "text": "<p><span style=\"font-size:14.0pt;\">I-B, II-A, III-D, IV-C</span></p>"
      },
      {
        "id": 292108,
        "text": "<p><span style=\"font-size:14.0pt;\">I-C, II-B, III-D, IV-A</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Match the following conditions with their causative agents:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_pKX7v5t.png\" width=\"1091\" height=\"235\"></span></p>",
    "unique_key": "Q3148131",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634410,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) I-D, II-A, III-B, IV-C</strong></span></p>",
    "correct_choice_id": 292106,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 29295,
    "choices": [
      {
        "id": 117086,
        "text": "<p><span style=\"font-size:14.0pt;\">Iron stain</span></p>"
      },
      {
        "id": 117087,
        "text": "<p><span style=\"font-size:14.0pt;\">PAS stain</span></p>"
      },
      {
        "id": 117088,
        "text": "<p><span style=\"font-size:14.0pt;\">Reticulin stain</span></p>"
      },
      {
        "id": 117089,
        "text": "<p><span style=\"font-size:14.0pt;\">Masson's trichrome stain</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 30-year-old woman undergoes a liver biopsy for a lesion suspected to be focal nodular hyperplasia (FNH) based on imaging studies. She has no significant medical history and normal liver function tests. Which special stain would be most useful in confirming the diagnosis of FNH in this patient?</span></p>",
    "unique_key": "Q1395371",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634536,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Reticulin stain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Focal Nodular Hyperplasia (FNH)</strong> is a benign liver lesion often diagnosed based on imaging and biopsy. It is characterized by a central stellate scar and a well-preserved reticulin network in the liver. The reticulin stain highlights the reticulin framework, which remains intact in FNH, distinguishing it from malignant conditions like hepatocellular carcinoma, where the reticulin framework is disrupted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Imaging studies, such as CT or MRI, typically reveal a <strong>stellate scar</strong> in FNH, but biopsy with a reticulin stain provides a definitive confirmation by demonstrating the preserved reticulin network.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Iron stain:&nbsp;</strong>Iron stains, such as <strong>Prussian blue</strong>, are used to identify iron deposits in conditions like hemochromatosis. FNH does not involve abnormal iron accumulation, so this stain is not relevant here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. PAS stain:&nbsp;</strong>The <strong>Periodic Acid-Schiff (PAS) stain</strong> is a nonspecific stain used to detect glycogen, mucopolysaccharides, and certain fungal elements. It does not assist in confirming FNH, as glycogen and mucopolysaccharides are not diagnostic markers for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Masson\u2019s trichrome stain:&nbsp;</strong>This stain highlights connective tissue, particularly <strong>collagen</strong>, and is useful for assessing fibrosis. While it can show the fibrous central scar in FNH, it does not specifically distinguish FNH from other liver lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reticulin stain</strong> is the most useful tool for diagnosing <strong>Focal Nodular Hyperplasia (FNH)</strong> as it demonstrates the intact reticulin framework, which is preserved in this benign liver lesion.</span></p>",
    "correct_choice_id": 117088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29317,
    "choices": [
      {
        "id": 117174,
        "text": "<p><span style=\"font-size:14.0pt;\">Graves' disease</span></p>"
      },
      {
        "id": 117175,
        "text": "<p><span style=\"font-size:14.0pt;\">Hashimoto's thyroiditis</span></p>"
      },
      {
        "id": 117176,
        "text": "<p><span style=\"font-size:14.0pt;\">Subacute granulomatous thyroiditis&nbsp;</span></p>"
      },
      {
        "id": 117177,
        "text": "<p><span style=\"font-size:14.0pt;\">Toxic multinodular goiter</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 35-year-old female presents with a painful, swollen neck and fever. Physical examination reveals a tender and enlarged thyroid gland. Laboratory tests show an elevated erythrocyte sedimentation rate and thyrotoxicosis with an increased serum concentration of free thyroxine (T4). Which of the following is the most likely diagnosis?</span></p>",
    "unique_key": "Q5687497",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634547,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Subacute granulomatous thyroiditis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Subacute granulomatous thyroiditis</strong> (also called <strong>de Quervain thyroiditis</strong>) is characterized by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Painful, swollen thyroid</strong>: The presence of neck pain and fever, along with tenderness on palpation, is a hallmark feature.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Thyrotoxicosis</strong>: Initially, thyroid hormone levels are elevated due to the release of preformed T3 and T4 from damaged thyroid follicles.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Elevated ESR</strong>: Suggestive of an inflammatory process, a common finding in subacute thyroiditis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Self-limiting course</strong>: The condition typically resolves on its own, and the thyrotoxicosis phase is followed by a transient hypothyroid phase.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Pathogenesis</strong>: It is thought to be triggered by a <strong>viral infection</strong>, leading to an inflammatory response in the thyroid gland. The disease is self-limiting, and management is symptomatic with NSAIDs or corticosteroids for pain and inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Graves' disease:&nbsp;</strong>Graves' disease causes <strong>painless thyrotoxicosis</strong>, not associated with fever or a tender thyroid gland. Histologically, Graves' disease shows <strong>scalloping of colloid</strong> and <strong>papillary hyperplasia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hashimoto's thyroiditis:</strong> Hashimoto's is a chronic autoimmune thyroiditis typically associated with <strong>painless thyroid enlargement</strong> and hypothyroidism. It is characterized by <strong>anti-TPO antibodies</strong> and lymphocytic infiltration on histology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Toxic multinodular goiter</strong>: Toxic multinodular goiter is a cause of hyperthyroidism due to autonomous nodules in the thyroid. It is typically painless and not associated with systemic inflammation, fever, or elevated ESR.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Subacute granulomatous thyroiditis (de Quervain thyroiditis)</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Presents with <strong>painful thyroid swelling</strong>, fever, and thyrotoxicosis.</span></li><li><span style=\"font-size:14.0pt;\">Laboratory findings include <strong>elevated ESR</strong> and <strong>elevated free T4</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Self-limiting, with management focused on <strong>symptomatic relief</strong> using NSAIDs or corticosteroids.</span></li><li><span style=\"font-size:14.0pt;\">It is distinct from <strong>Graves' disease</strong> and <strong>Hashimoto's thyroiditis</strong>, which are painless thyroid conditions.</span></li></ul>",
    "correct_choice_id": 117176,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54499,
    "choices": [
      {
        "id": 217465,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intact cell organelle</span></span></span></p>"
      },
      {
        "id": 217466,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Altered cell shape</span></span></span></p>"
      },
      {
        "id": 217467,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enzyme mediated degradation</span></span></span></p>"
      },
      {
        "id": 217468,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internal organelle disintegration with lipid change</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not helpful for differentiating between necrosis and apoptosis?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q7848453",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634526,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B) Altered cell shape</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Necrosis and apoptosis are two distinct types of cell death, each with its own characteristics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Altered cell shape</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While cell shape can change in both necrosis and apoptosis, it is not a reliable indicator to differentiate between the two. The more useful parameter is cell size: in necrosis, cells swell, whereas in apoptosis, cells shrink. Therefore, altered cell shape is not particularly helpful in distinguishing necrosis from apoptosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Intact cell organelle</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: During apoptosis, cell organelles remain intact until the late stages when apoptotic bodies form. These bodies contain tightly packed cytoplasmic components and organelles. In contrast, necrosis is characterized by the breakdown and disintegration of organelles. Thus, the presence of intact organelles helps differentiate apoptosis from necrosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Enzyme mediated degradation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a hallmark of necrosis. In necrosis, enzymes digest cellular components, leading to the breakdown of organelles and other structures. This feature is not seen in apoptosis, where cellular components are typically preserved until the cell is packaged into apoptotic bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Internal organelle disintegration with lipid change</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Necrosis involves the disintegration of organelles and changes in lipids, leading to the loss of cell membrane integrity. This is not a feature of apoptosis, where the membrane remains intact until late stages.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The key features to differentiate necrosis from apoptosis include the state of cell organelles (intact in apoptosis, disintegrated in necrosis), enzyme-mediated degradation (present in necrosis), and internal organelle disintegration with lipid changes (present in necrosis). Altered cell shape alone is not a useful parameter for differentiation.</span></span></span></p>",
    "correct_choice_id": 217466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 44833,
    "choices": [
      {
        "id": 178979,
        "text": "<p><span style=\"font-size:12pt;\">It should not be given with pyrazinamide</span></p>"
      },
      {
        "id": 178980,
        "text": "<p><span style=\"font-size:12pt;\">It should be taken empty stomach</span></p>"
      },
      {
        "id": 178981,
        "text": "<p><span style=\"font-size:12pt;\">It is given as a loading dose</span></p>"
      },
      {
        "id": 178982,
        "text": "<p><span style=\"font-size:12pt;\">It requires therapeutic drug monitoring</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 50-year-old male patient with a history of chronic pulmonary aspergillosis is being treated with voriconazole. He has been on the medication for two weeks and comes to the clinic for a follow-up. During the visit, he asks about the specific guidelines and considerations for taking voriconazole to ensure its effectiveness and safety. Which of the following statements is true about voriconazole? (</span>INICET May 2024)</p>",
    "unique_key": "Q9467334",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633393,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) It is given as a loading dose</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">Voriconazole requires a loading dose to rapidly achieve therapeutic levels in the body. This is a crucial aspect of its administration, especially in acute settings where rapid antifungal activity is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>It should not be given with pyrazinamide</strong>: There is no significant interaction between voriconazole and pyrazinamide. Voriconazole does interact with many other medications due to its effect on cytochrome P450 enzymes, but pyrazinamide is not one of the primary concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. It should be taken empty stomach</strong>: Voriconazole can be taken either with or without food, but it is generally recommended to take it one hour before or one hour after a meal to ensure optimal absorption. While this is important, it is not the most critical consideration compared to therapeutic drug monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>It requires therapeutic drug monitoring</strong>: While therapeutic drug monitoring can be important for voriconazole, especially in certain patient populations, it is not as universally mandated or emphasized as the initial loading dose regimen in standard treatment protocols.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the statement that voriconazole \"is given as a loading dose\" is the most universally applicable and critical aspect of its administration, especially for ensuring rapid therapeutic levels in treating fungal infections.</span></p>",
    "correct_choice_id": 178981,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 44862,
    "choices": [
      {
        "id": 179095,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin</span></span></span></p>"
      },
      {
        "id": 179096,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></span></span></p>"
      },
      {
        "id": 179097,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fondaparinux</span></span></span></p>"
      },
      {
        "id": 179098,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anticoagulant requires coagulation profile monitoring? (</span></span></span>INICET May 2024)</p>",
    "unique_key": "Q9926497",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633396,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lepirudin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct thrombin inhibitor that typically requires regular monitoring of anticoagulant effect via activated partial thromboplastin time (aPTT).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(a low molecular weight heparin), <strong>Fondaparinux</strong> (a synthetic pentasaccharide), and <strong>Dabigatran</strong> (a direct thrombin inhibitor) generally do not require regular monitoring in most patients, although there may be specific clinical situations where monitoring is needed.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 179096,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 74156,
    "choices": [
      {
        "id": 295553,
        "text": "<p><span style=\"font-size:14.0pt;\">Cisapride&nbsp;</span></p>"
      },
      {
        "id": 295554,
        "text": "<p><span style=\"font-size:14.0pt;\">Cetirizine&nbsp;</span></p>"
      },
      {
        "id": 295555,
        "text": "<p><span style=\"font-size:14.0pt;\">Loratadine&nbsp;</span></p>"
      },
      {
        "id": 295556,
        "text": "<p><span style=\"font-size:14.0pt;\">Promethazine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs, when given with ketoconazole, can cause QT prolongation and Torsades\u2019 de pointes?&nbsp;</span></p>",
    "unique_key": "Q8635350",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633404,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cisapride</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cisapride is the correct answer because it is a prokinetic agent that blocks hERG potassium channels, causing QT prolongation.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Cisapride is metabolized by CYP3A4.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Ketoconazole is a strong CYP3A4 inhibitor, leading to increased levels of cisapride.</strong></span></li><li><span style=\"font-size:14.0pt;\">This increases the risk of&nbsp;<strong>QT prolongation and Torsades de Pointes (TdP).</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Cisapride was withdrawn from many markets due to this life-threatening risk.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cetirizine: Does not cause significant QT prolongation</strong>&nbsp;and has a better cardiac safety profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Loratadine:&nbsp;</strong>Loratadine is metabolized by CYP3A4 but has&nbsp;<strong>minimal effects on the QT interval.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Promethazine:&nbsp;</strong>While it is a first-generation antihistamine with anticholinergic effects,&nbsp;<strong>it does not significantly prolong the QT interval.</strong></span></p>",
    "correct_choice_id": 295553,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73342,
    "choices": [
      {
        "id": 292321,
        "text": "<p><span style=\"font-size:14.0pt;\">Bacterial endotoxin&nbsp;</span></p>"
      },
      {
        "id": 292322,
        "text": "<p><span style=\"font-size:14.0pt;\">Pertussis-like exotoxin&nbsp;</span></p>"
      },
      {
        "id": 292323,
        "text": "<p><span style=\"font-size:14.0pt;\">Intestinal biofilm production&nbsp;</span></p>"
      },
      {
        "id": 292324,
        "text": "<p><span style=\"font-size:14.0pt;\">Intestinal mucosal invasion</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old man comes to the OPD for a follow-up appointment. The patient recently returned from a 10-day trip to Thailand. On the fifth day of his trip, he developed malaise, anorexia, and abdominal cramps, quickly followed by watery diarrhea. The patient had 5 or 6 stools daily but no fever. The patient felt better after 2 days and has had no additional symptoms since.&nbsp; Which of the following factors was most likely involved in the pathogenesis of this patient's gastrointestinal symptoms?</span></p>",
    "unique_key": "Q8256651",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634469,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Pertussis-like exotoxin</strong></span></p>",
    "correct_choice_id": 292322,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44841,
    "choices": [
      {
        "id": 179011,
        "text": "<p><span style=\"font-size:12pt;\">Sugammadex</span></p>"
      },
      {
        "id": 179012,
        "text": "<p><span style=\"font-size:12pt;\">Neostigmine</span></p>"
      },
      {
        "id": 179013,
        "text": "<p><span style=\"font-size:12pt;\">Edrophonium</span></p>"
      },
      {
        "id": 179014,
        "text": "<p><span style=\"font-size:12pt;\">Atropine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 60-year-old male patient underwent surgery under general anaesthesia. Rocuronium was used as a muscle relaxant during the procedure. After the surgery, the patient has not regained muscle function, indicating prolonged muscle paralysis. The medical team needs to reverse the effects of rocuronium quickly to ensure patient safety and recovery. Which of the following can result in the fastest reversal? (INICET MAY 2024)</span></p>",
    "unique_key": "Q2279563",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633394,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sugammadex</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Neostigmine</strong>: Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Edrophonium</strong>: Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Atropine</strong>: Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sugammadex is the most effective and fastest-acting agent for reversing the effects of rocuronium, making it the best choice in this clinical scenario.</span></p>",
    "correct_choice_id": 179011,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 54490,
    "choices": [
      {
        "id": 217429,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryoprecipitate</span></p>"
      },
      {
        "id": 217430,
        "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Fresh frozen plasma</span></p>"
      },
      {
        "id": 217431,
        "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Recombinant factor 8</span></p>"
      },
      {
        "id": 217432,
        "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Cryo poor plasma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is useful for a patient having Haemophilia B?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q9903543",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634524,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Fresh frozen plasma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Haemophilia B is characterized by a deficiency in factor IX. The treatment for haemophilia B focuses on supplementing the deficient factor IX. Fresh frozen plasma (FFP) is an excellent source of factor IX and is therefore useful in treating haemophilia B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cryoprecipitate:&nbsp;</strong>Incorrect. Cryoprecipitate is rich in factor VIII and is primarily used for treating haemophilia A, not haemophilia B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Recombinant factor 8:&nbsp;</strong>Incorrect. Recombinant factor VIII is used to treat haemophilia A, which is a deficiency in factor VIII, not factor IX.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cryo poor plasma:&nbsp;</strong>Incorrect. Although cryo poor plasma can still contain some factor IX, it is not the best choice compared to fresh frozen plasma. Cryo poor plasma is more commonly used for treating thrombotic thrombocytopenic purpura.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Hemophilia B</strong> is a <strong>genetic deficiency of Factor IX</strong>, also called <strong>Christmas disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">It is an <strong>X-linked recessive bleeding disorder</strong>, causing:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Easy bruising</span></li><li><span style=\"font-size:16px;\">Hemarthroses</span></li><li><span style=\"font-size:16px;\">Prolonged bleeding after injury or surgery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For the treatment of haemophilia B, fresh frozen plasma is an effective source of factor IX. Recombinant factor IX would be the best treatment option if available.</span></p>",
    "correct_choice_id": 217430,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 35229,
    "choices": [
      {
        "id": 140727,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha-1 agonist action leading to peripheral vasoconstriction</span></span></span></span></p>"
      },
      {
        "id": 140728,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in renal perfusion due to agonist action on D1 receptors</span></span></span></span></p>"
      },
      {
        "id": 140729,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Releases noradrenaline and causes positive inotropic effect</span></span></span></span></p>"
      },
      {
        "id": 140730,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct action on heart via beta-1 receptors</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the following properties of dopamine, which of them is not helpful in acute shock? </span></span></span></span></p>",
    "unique_key": "Q6057341",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633809,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Increase in renal perfusion due to agonist action on D1 receptors</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine is an inotropic agent, with action on D1-receptors as well as beta-1-adrenergic receptors. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At low infusion rate (2</span></span></em></strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ndash;<strong>10 mcg/kg per minute): </strong></span></span></em></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The action is mainly on D1-receptors. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It causes vasodilation. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low dose infusion of dopamine causes an increase in GER and renal blood flow. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At intermediate infusion rates (2&ndash;10 mcg/kg per minute)</span></span></em></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine stimulates both D1 and beta-1 receptors.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine exerts a positive inotropic effect on myocardium via its action on beta-1 adrenergic receptors. This increases systolic BP. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At high infusion rates (10&ndash;20 mcg/kg per minute)</span></span></em></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dopamine stimulates D1, beta-1 and alpha-1 receptors.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It also augments norepinephrine release from nerve terminals. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These actions are useful in treatment of shock with oligourea (Dopamine is DOC).</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiostimulant (beta 1) and vasopressor (alpha 1) action along with release of NA from nerve terminals is useful for increasing blood pressure in acute shock. Renal vasodilator action does not increase BP but help in reversing oligourea. </span></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 140728,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 43962,
    "choices": [
      {
        "id": 175511,
        "text": "<p><span style=\"font-size:12.0pt;\">Low mechanical fragility, high osmotic fragility</span></p>"
      },
      {
        "id": 175512,
        "text": "<p><span style=\"font-size:12.0pt;\">High mechanical fragility, high osmotic fragility</span></p>"
      },
      {
        "id": 175513,
        "text": "<p><span style=\"font-size:12.0pt;\">Low mechanical fragility, low osmotic fragility</span></p>"
      },
      {
        "id": 175514,
        "text": "<p><span style=\"font-size:12.0pt;\">High mechanical fragility, low osmotic fragility</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about red blood cells in Sickle cell anemia:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p>",
    "unique_key": "Q8107597",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634521,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) High mechanical fragility, low osmotic fragility</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In sickle cell anemia, red blood cells (RBCs) have abnormal hemoglobin (HbS) that causes the cells to sickle under low oxygen conditions. These sickled cells are more prone to mechanical damage as they pass through the microcirculation, leading to increased mechanical fragility. However, their osmotic fragility is lower compared to normal RBCs because the sickling and subsequent damage to the cell membrane makes them less prone to osmotic lysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sickle cells exhibit high mechanical fragility due to their abnormal shape and membrane characteristics under stress but display low osmotic fragility because they are less prone to rupture in varying osmotic conditions compared to normal red blood cells.</span></p>",
    "correct_choice_id": 175514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73392,
    "choices": [
      {
        "id": 292517,
        "text": "<p><span style=\"font-size:14.0pt;\">Direct spread from mesenteric lymph nodes</span></p>"
      },
      {
        "id": 292518,
        "text": "<p><span style=\"font-size:14.0pt;\">Hematogenous spread</span></p>"
      },
      {
        "id": 292519,
        "text": "<p><span style=\"font-size:14.0pt;\">Feco-oral route</span></p>"
      },
      {
        "id": 292520,
        "text": "<p><span style=\"font-size:14.0pt;\">Direct contact with infected animal</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Mode of transmission of abdominal TB includes all except?&nbsp;</span></p>",
    "unique_key": "Q7170299",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634387,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Feco-oral route</strong></span></p>",
    "correct_choice_id": 292519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 94364,
    "choices": [
      {
        "id": 375672,
        "text": "<p><span style=\"font-size:14.0pt;\">Blood agar</span></p>"
      },
      {
        "id": 375673,
        "text": "<p><span style=\"font-size:14.0pt;\">Philip\u2019s medium</span></p>"
      },
      {
        "id": 375674,
        "text": "<p><span style=\"font-size:14.0pt;\">CLED medium</span></p>"
      },
      {
        "id": 375675,
        "text": "<p><span style=\"font-size:14.0pt;\">Trypticase serum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Culture medium used for Entamoeba histolytica is:</span></p>",
    "unique_key": "Q9717917",
    "question_audio": null,
    "question_video": null,
    "map_id": 34662222,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Philip\u2019s medium</strong></span></p>",
    "correct_choice_id": 375673,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44783,
    "choices": [
      {
        "id": 178779,
        "text": "<p><span style=\"font-size:16px;\">Osteonecrosis of jaw bone</span></p>"
      },
      {
        "id": 178780,
        "text": "<p><span style=\"font-size:16px;\">Osteosarcoma</span></p>"
      },
      {
        "id": 178781,
        "text": "<p><span style=\"font-size:16px;\">Subtrochanteric fracture</span></p>"
      },
      {
        "id": 178782,
        "text": "<p><span style=\"font-size:16px;\">Loss of bone mass</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is an adverse effect with the long-term use of intermittent teriparatide for treatment of osteoporosis?</span></p>",
    "unique_key": "Q9508508",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633386,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Osteosarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Osteosarcoma is a rare but serious potential adverse effect associated with the long-term use of teriparatide. This risk was identified in animal studies where high doses of teriparatide caused osteosarcoma in rats. Although this effect has not been conclusively demonstrated in humans, the potential risk has led to caution in prescribing teriparatide for long durations, usually limited to a maximum of 2 years of use.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Osteonecrosis of the jaw bone</strong>:&nbsp;Osteonecrosis of the jaw is more commonly associated with bisphosphonates and denosumab, not with teriparatide. Teriparatide, being a parathyroid hormone analog, does not typically cause this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Subtrochanteric fracture</strong>:&nbsp;Subtrochanteric fractures are more commonly associated with long-term use of bisphosphonates rather than teriparatide. Teriparatide, by stimulating new bone formation, is less likely to cause these types of fractures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Loss of bone mass</strong>:&nbsp;Teriparatide is used to increase bone mass and strength by stimulating bone formation. Loss of bone mass is not a recognized adverse effect of teriparatide; rather, the medication is prescribed to counteract this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In summary, the most significant potential adverse effect associated with the long-term use of teriparatide is the development of osteosarcoma, albeit this risk is based primarily on animal studies. Therefore, clinicians are advised to limit the duration of teriparatide therapy and monitor patients closely.</span></p>",
    "correct_choice_id": 178780,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 43964,
    "choices": [
      {
        "id": 175519,
        "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
      },
      {
        "id": 175520,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemochromatosis</span></p>"
      },
      {
        "id": 175521,
        "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
      },
      {
        "id": 175522,
        "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Low transferrin saturation is seen in:</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2023)</span></p>",
    "unique_key": "Q8018144",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634522,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Iron deficiency anemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Low transferrin saturation is indicative of inadequate iron within the body to fully saturate transferrin, which is the main protein in the blood that binds to iron and transports it throughout the body. This condition is a hallmark of iron deficiency anemia, where there is a decreased level of total body iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Transferrin Saturation (%) = (Serum Iron / Total Iron-Binding Capacity) \u00d7 100</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Normal</strong>: ~20\u201345%</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low</strong>: Indicates not enough iron bound to transferrin</span></li><li><span style=\"font-size:12.0pt;\"><strong>High</strong>: Indicates excess circulating iron</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemochromatosis:&nbsp;</strong>Incorrect because this is characterized by increased iron levels in the body, typically leading to high transferrin saturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia</strong>: Incorrect because this is a genetic disorder that affects the production of hemoglobin, not primarily associated with iron deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Megaloblastic anemia</strong>: Incorrect as this anemia type is usually due to deficiencies in vitamin B12 or folate, not iron.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V7GtPbF.png\" width=\"1184\" height=\"363\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Low transferrin saturation is a significant marker for diagnosing iron deficiency anemia, reflecting a shortfall in available iron for red blood cell production.</span></p>",
    "correct_choice_id": 175519,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 74164,
    "choices": [
      {
        "id": 295585,
        "text": "<p><span style=\"font-size:14.0pt;\">Losartan</span></p>"
      },
      {
        "id": 295586,
        "text": "<p><span style=\"font-size:14.0pt;\">Ramipril</span></p>"
      },
      {
        "id": 295587,
        "text": "<p><span style=\"font-size:14.0pt;\">Aliskiren</span></p>"
      },
      {
        "id": 295588,
        "text": "<p><span style=\"font-size:14.0pt;\">Sacubitril</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male with a history of&nbsp;chronic heart failure with reduced ejection fraction (HFrEF)&nbsp;presents to the clinic for routine follow-up. He is currently on&nbsp;carvedilol, furosemide, and enalapril&nbsp;but continues to have&nbsp;dyspnea on exertion and fatigue. His physician decides to replace his ACE inhibitor with a newer drug that enhances&nbsp;natriuretic peptide activity&nbsp;and improves&nbsp;vasodilation and natriuresis. Which of the following drugs works through this mechanism?</span></p>",
    "unique_key": "Q5249813",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633408,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Sacubitril</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient with&nbsp;<strong>HFrEF</strong>&nbsp;is being switched from an&nbsp;<strong>ACE inhibitor (enalapril)</strong>&nbsp;to a drug that&nbsp;<strong>enhances natriuretic peptides</strong>, suggesting&nbsp;<strong>Sacubitril</strong>.&nbsp;<strong>Sacubitril</strong>, used in combination with&nbsp;<strong>Valsartan</strong>&nbsp;as&nbsp;<strong>ARNI (Angiotensin Receptor-Neprilysin Inhibitor)</strong>, inhibits&nbsp;<strong>neprilysin</strong>, leading to increased&nbsp;<strong>BNP/ANP levels</strong>, causing&nbsp;<strong>vasodilation, natriuresis, and reduced cardiac remodeling</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sacubitril is a&nbsp;<strong>neprilysin inhibitor</strong>, which increases natriuretic peptides and provides additional benefits in&nbsp;<strong>heart failure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Losartan:</strong> An&nbsp;<strong>angiotensin II receptor blocker (ARB)</strong>, does not inhibit neprilysin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ramipril:</strong> An&nbsp;<strong>ACE inhibitor</strong>, but&nbsp;<strong>ACE inhibitors are replaced by ARNIs in symptomatic HFrEF patients</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Aliskiren:</strong> A&nbsp;<strong>direct renin inhibitor</strong>, but renin inhibition does not enhance natriuretic peptides.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sacubitril (part of ARNI therapy) improves outcomes in HFrEF by inhibiting neprilysin, increasing natriuretic peptide levels, and reducing cardiac remodeling.</span></p>",
    "correct_choice_id": 295588,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73346,
    "choices": [
      {
        "id": 292337,
        "text": "<p><span style=\"font-size:14.0pt;\">Mycetoma</span></p>"
      },
      {
        "id": 292338,
        "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma</span></p>"
      },
      {
        "id": 292339,
        "text": "<p><span style=\"font-size:14.0pt;\">Diabetic foot</span></p>"
      },
      {
        "id": 292340,
        "text": "<p><span style=\"font-size:14.0pt;\">Chromoblastomycosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A farmer presents with a swollen foot and multiple sinuses. MRI is shown below. What is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vj6KHKx.png\" width=\"560\" height=\"400\"></span></p>",
    "unique_key": "Q5632345",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634471,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Mycetoma&nbsp;</strong></span></p>",
    "correct_choice_id": 292337,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 44034,
    "choices": [
      {
        "id": 175791,
        "text": "<p><span style=\"font-size:12pt;\">XDR-TB</span></p>"
      },
      {
        "id": 175792,
        "text": "<p><span style=\"font-size:12pt;\">Salmonella</span></p>"
      },
      {
        "id": 175793,
        "text": "<p><span style=\"font-size:12pt;\">Ebola</span></p>"
      },
      {
        "id": 175794,
        "text": "<p><span style=\"font-size:12pt;\">Congo Crimean fever</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is classified under Biosafety level -3 infections? (INICET NOV 2023)</span></p>",
    "unique_key": "Q6030009",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633815,
    "difficulty_level": "intermediate",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) XDR-TB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">XDR-TB (Extensively Drug-Resistant Tuberculosis) requires BSL-3 (Biosafety Level 3) containment due to its high risk of airborne transmission and severe disease potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Salmonella</strong>: Generally handled under BSL-2 due to lower risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ebola</strong>: Handled under BSL-4, given its high risk and lethality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Congo Crimean Fever</strong>: Also requires BSL-4 due to high fatality rates and transmission risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The classification of pathogens is according to biosafety levels. XDR-TB is managed under BSL-3 conditions due to its airborne risks and drug resistance challenges.</span></p>",
    "correct_choice_id": 175791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73429,
    "choices": [
      {
        "id": 292665,
        "text": "<p><span style=\"font-size:14.0pt;\">17D</span></p>"
      },
      {
        "id": 292666,
        "text": "<p><span style=\"font-size:14.0pt;\">Nakayama vaccine</span></p>"
      },
      {
        "id": 292667,
        "text": "<p><span style=\"font-size:14.0pt;\">Weigl's vaccine</span></p>"
      },
      {
        "id": 292668,
        "text": "<p><span style=\"font-size:14.0pt;\">Jeryl Lynn strain</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A photographer who recently returned from Africa presents to the emergency department with abdominal pain, hepatomegaly, and hemorrhagic manifestations. He died despite treatment, and an autopsy revealed intranuclear Torres bodies in the liver. Which of the following vaccines could have prevented it?&nbsp;</span></p>",
    "unique_key": "Q7097794",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634398,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 17D</strong></span></p>",
    "correct_choice_id": 292665,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29319,
    "choices": [
      {
        "id": 117182,
        "text": "<p><span style=\"font-size:14.0pt;\">IFN gamma</span></p>"
      },
      {
        "id": 117183,
        "text": "<p><span style=\"font-size:14.0pt;\">IL- 2</span></p>"
      },
      {
        "id": 117184,
        "text": "<p><span style=\"font-size:14.0pt;\">IL- 12</span></p>"
      },
      {
        "id": 117185,
        "text": "<p><span style=\"font-size:14.0pt;\">IL- 4</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following cytokines is not involved in Th1 response?</span></p>",
    "unique_key": "Q5816857",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634548,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) IL- 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Th1 response</strong> is a subtype of the immune response mediated by <strong>CD4 T-helper 1 (Th1) cells</strong>, primarily involved in fighting intracellular pathogens and contributing to <strong>type IV hypersensitivity reactions</strong>. The cytokines involved in the Th1 response include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>IFN-gamma</strong>: Activates macrophages and promotes granuloma formation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IL-2</strong>: Stimulates T-cell proliferation and differentiation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IL-12</strong>: Promotes Th1 differentiation and enhances IFN-gamma production.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>IL-4</strong>, on the other hand, is secreted by <strong>Th2 cells</strong> and is involved in the Th2 response, which mediates <strong>type I hypersensitivity reactions</strong> and is associated with eosinophilic inflammation and antibody production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IFN gamma:&nbsp;</strong>Correctly involved in Th1 response. It activates macrophages and contributes to granuloma formation, playing a critical role in the immune defense against intracellular pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IL-2:&nbsp;</strong>Correctly involved in Th1 response. It promotes T-cell proliferation and supports cytotoxic T-cell and NK-cell activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IL-12:&nbsp;</strong>Correctly involved in Th1 response. It is produced by macrophages and dendritic cells to induce Th1 differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Th1 response</strong> is characterized by <strong>IFN-gamma</strong>, <strong>IL-2</strong>, and <strong>IL-12</strong>, which drive cellular immunity, granuloma formation, and delayed-type hypersensitivity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>IL-4</strong> is associated with the <strong>Th2 response</strong>, mediating type I hypersensitivity and antibody production.</span></li></ul>",
    "correct_choice_id": 117185,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29313,
    "choices": [
      {
        "id": 117158,
        "text": "<p><span style=\"font-size:14.0pt;\">EBV Negative</span></p>"
      },
      {
        "id": 117159,
        "text": "<p><span style=\"font-size:14.0pt;\">CD 30 Negative</span></p>"
      },
      {
        "id": 117160,
        "text": "<p><span style=\"font-size:14.0pt;\">CD 20 positive</span></p>"
      },
      {
        "id": 117161,
        "text": "<p><span style=\"font-size:14.0pt;\">Poor prognosis compared to classical HL</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 28-year-old male presents with painless lymphadenopathy, night sweats, and weight loss. A lymph node biopsy is done following which a diagnosis of nodular lymphocyte-predominant Hodgkin lymphoma is made. Which of the following statements about this condition is false?</span></p>",
    "unique_key": "Q4523824",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634545,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Poor prognosis compared to classical HL&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is false. NLPHL has an <strong>excellent prognosis</strong> compared to classical Hodgkin lymphoma due to its less aggressive nature. It is typically indolent and responds well to treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. EBV Negative:&nbsp;</strong>This is true. Unlike classical Hodgkin lymphoma (cHL), NLPHL is not associated with <strong>Epstein-Barr Virus (EBV)</strong> infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. CD 30 Negative:&nbsp;</strong>This is true. The Reed-Sternberg-like cells in NLPHL (known as <strong>popcorn cells</strong> or <strong>lymphohistiocytic (LH) cells</strong>) are <strong>CD 30 negative</strong> and <strong>CD 15 negative</strong>, which distinguishes them from classical Hodgkin lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. CD 20 Positive:&nbsp;</strong>This is true. The Reed-Sternberg-like cells in NLPHL are <strong>CD 20 positive</strong>, a key diagnostic feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Markers:</strong> CD 20 positive, CD 30 negative, CD 15 negative.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histological feature:</strong> <strong>Popcorn cells</strong> (lymphohistiocytic cells).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Association:</strong> EBV negative.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prognosis:</strong> Better than classical Hodgkin lymphoma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Common presentation:</strong> Painless lymphadenopathy, often in cervical or axillary regions.</span></li></ul>",
    "correct_choice_id": 117161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73349,
    "choices": [
      {
        "id": 292345,
        "text": "<p><span style=\"font-size:14.0pt;\">Drug resistant falciparum is seen in India</span></p>"
      },
      {
        "id": 292346,
        "text": "<p><span style=\"font-size:14.0pt;\">Presence of duffy blood group antigen is protective against vivax</span></p>"
      },
      {
        "id": 292347,
        "text": "<p><span style=\"font-size:14.0pt;\">Severe malaria with shock is called algid malaria</span></p>"
      },
      {
        "id": 292348,
        "text": "<p><span style=\"font-size:14.0pt;\">Relapse is seen in P. ovale due to hypnozoites</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Choose the wrong statement about Plasmodium species:&nbsp;</span></p>",
    "unique_key": "Q4440276",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634472,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Presence of duffy blood group antigen is protective against vivax</strong></span></p>",
    "correct_choice_id": 292346,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44790,
    "choices": [
      {
        "id": 178807,
        "text": "<p><span style=\"font-size:12pt;\">SGLT2 inhibitors</span></p>"
      },
      {
        "id": 178808,
        "text": "<p><span style=\"font-size:12pt;\">Finerenone</span></p>"
      },
      {
        "id": 178809,
        "text": "<p><span style=\"font-size:12pt;\">Hydrochlorthiazide</span></p>"
      },
      {
        "id": 178810,
        "text": "<p><span style=\"font-size:12.0pt;\">Angiotensin receptor blockers</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 55-year-old patient presents to the clinic with a history of hyperglycemia and has had positive urine glucose tests on two separate occasions in the last six months. The patient has been diagnosed with type 2 diabetes mellitus. The physician is considering various medications to manage the patient's condition and prevent potential complications, including renal involvement. Which of the following drugs will not delay renal involvement? (</span>INICET May 2024)</p>",
    "unique_key": "Q1724241",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633387,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hydrochlorothiazide</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Hydrochlorothiazide is a thiazide diuretic used to treat hypertension.&nbsp;</span></li><li><span style=\"font-size:12pt;\">While effective at lowering blood pressure, it does not have specific renal protective effects and may not delay the progression of renal disease in diabetic patients.&nbsp;</span></li><li><span style=\"font-size:12pt;\">In fact, in some cases, thiazide diuretics can increase the risk of developing hyperglycemia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>SGLT2 inhibitors</strong>: SGLT2 inhibitors (e.g., canagliflozin, dapagliflozin) are a class of medications used to lower blood sugar in patients with type 2 diabetes. They work by promoting glucose excretion through the urine. Importantly, SGLT2 inhibitors have been shown to provide renal protection and delay the progression of diabetic kidney disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Finerenone: </strong>It is a non-steroidal mineralocorticoid receptor antagonist that reduces inflammation and fibrosis in the kidneys. Clinical trials have demonstrated that finerenone can reduce the risk of kidney disease progression in patients with chronic kidney disease and type 2 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Angiotensin receptor blockers (ARBs)</strong>: ARBs (e.g., losartan, valsartan) are another class of medications used to manage hypertension and heart failure. Like ACE inhibitors, ARBs have been shown to provide renal protection and delay the progression of diabetic nephropathy by reducing proteinuria and lowering intraglomerular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In summary, while SGLT2 inhibitors, ACE inhibitors, and ARBs have renal protective properties and can help delay renal involvement in diabetic patients, hydrochlorothiazide does not have these specific protective effects and is the correct answer in this context.</span></p>",
    "correct_choice_id": 178809,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 29331,
    "choices": [
      {
        "id": 117230,
        "text": "<p><span style=\"font-size:14.0pt;\">Regular exercise like walking for 30 minutes</span></p>"
      },
      {
        "id": 117231,
        "text": "<p><span style=\"font-size:14.0pt;\">Decreasing stress</span></p>"
      },
      {
        "id": 117232,
        "text": "<p><span style=\"font-size:14.0pt;\">Decrease calorie by 30%</span></p>"
      },
      {
        "id": 117233,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase food intake</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following will increase life span?</span></p>",
    "unique_key": "Q1597888",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634554,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Decrease calorie by 30%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Caloric restriction (decreasing calorie intake by ~30%) has been shown to <strong>increase lifespan</strong> and improve health in various animal models. The mechanism involves:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Activation of sirtuins</strong>: Proteins associated with improved metabolism, cellular repair, and longevity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reduction in metabolic stress</strong>: Lower calorie intake reduces the production of reactive oxygen species (ROS) and inflammation, which are linked to aging and chronic diseases.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Enhanced autophagy</strong>: Caloric restriction promotes cellular repair mechanisms by clearing damaged proteins and organelles.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Regular exercise like walking for 30 minutes:&nbsp;</strong>Beneficial for overall health and reduces the risk of chronic diseases. However, its direct impact on extending lifespan is less compared to caloric restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Decreasing stress:&nbsp;</strong>Reducing stress improves quality of life and may decrease the risk of stress-related illnesses, but it does not have as significant an impact on lifespan as caloric restriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increase food intake:</strong> Incorrect. Overeating leads to obesity and metabolic diseases, which are associated with a <strong>shortened lifespan</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Caloric restriction</strong> (reducing calorie intake by ~30%) is a scientifically backed method to increase lifespan by activating <strong>sirtuins</strong>, reducing <strong>oxidative stress</strong>, and promoting <strong>autophagy</strong>. Regular exercise and stress reduction contribute to better quality of life and reduced disease risk but do not directly extend lifespan as significantly.</span></p>",
    "correct_choice_id": 117232,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 31830,
    "choices": [
      {
        "id": 127190,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Linezolid: Binds to 30S ribosome and inhibits protein synthesis. </span></span></p>"
      },
      {
        "id": 127191,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rifampicin: Inhibits DNA-dependent RNA polymerase. </span></span></p>"
      },
      {
        "id": 127192,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aztreonam: Inhibits cell wall synthesis. </span></span></p>"
      },
      {
        "id": 127193,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Daptomycin: Causes depolarization of membranes.</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Concerning the mechanism of action of various antimicrobial drugs, which of the following statements is FALSE?&nbsp;</span></span>&nbsp;(INICET Nov 2023)</p>",
    "unique_key": "Q5488899",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633384,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Linezolid: Binds to 30S ribosome and inhibits protein synthesis.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Linezolid is an oxazolidinone antibiotic that actually binds to the 50S subunit of bacterial ribosomes, not the 30S subunit. Its mechanism of action involves the inhibition of protein synthesis by preventing the formation of a functional 70S initiation complex, which is essential for bacterial translation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Rifampicin:</strong> is indeed known to inhibit DNA-dependent RNA polymerase, which is critical for RNA synthesis in bacteria.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Aztreonam:</strong> is a monobactam antibiotic that inhibits cell wall synthesis by binding to penicillin-binding proteins, thereby inhibiting peptidoglycan synthesis.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Daptomycin:</strong> causes depolarization of bacterial cell membranes, leading to the inhibition of all intracellular synthesis, including protein, DNA, and RNA synthesis, and ultimately cell death.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Linezolid binds to the 50S subunit of bacterial ribosomes, not the 30S subunit, making the statement that it binds to the 30S subunit and inhibits protein synthesis false. The other drugs mentioned have their mechanisms correctly stated.</span></span></p>",
    "correct_choice_id": 127190,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 26606,
    "choices": [
      {
        "id": 106366,
        "text": "<p><span style=\"font-size:14.0pt;\">Activation of anti-apoptotic Bcl-2 proteins&nbsp;</span></p>"
      },
      {
        "id": 106367,
        "text": "<p><span style=\"font-size:14.0pt;\">Activation of caspase-3&nbsp;</span></p>"
      },
      {
        "id": 106368,
        "text": "<p><span style=\"font-size:14.0pt;\">Upregulation of pro-apoptotic Fas ligand&nbsp;</span></p>"
      },
      {
        "id": 106369,
        "text": "<p><span style=\"font-size:14.0pt;\">Inhibition of p53</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 50-year-old patient with a history of chronic liver disease presents with abdominal pain, jaundice, and ascites. Laboratory tests reveal elevated liver enzymes and bilirubin levels. A liver biopsy is performed, which shows hepatocyte injury and apoptosis. Which of the following molecular events is most likely responsible for the initiation of the apoptosis in this patient?</span></p>",
    "unique_key": "Q1005182",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634563,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Upregulation of pro-apoptotic Fas ligand</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient\u2019s history of <strong>chronic liver disease</strong> with ongoing <strong>hepatocyte apoptosis</strong> suggests <strong>extrinsic (death receptor-mediated) apoptosis</strong>, which is primarily mediated by the <strong>Fas-Fas ligand (FasL) pathway</strong>.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Fas ligand (FasL) binds to Fas receptor (CD95), leading to apoptosis initiation.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Fas-FasL interaction activates caspase-8</strong>, which then activates downstream executioner caspases such as <strong>caspase-3</strong>, leading to programmed cell death.</span></li><li><span style=\"font-size:14.0pt;\"><strong>This pathway is prominent in liver diseases</strong>, including <strong>viral hepatitis, autoimmune hepatitis, and chronic liver damage</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, <strong>upregulation of Fas ligand</strong> is the key molecular event responsible for initiating apoptosis in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Activation of anti-apoptotic Bcl-2 proteins</strong>: <strong>Bcl-2 is an anti-apoptotic protein</strong> that prevents apoptosis by <strong>stabilizing mitochondrial membranes</strong> and <strong>inhibiting cytochrome c release</strong>. If Bcl-2 were activated, <strong>apoptosis would be suppressed</strong>, not initiated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Activation of caspase-3</strong>: <strong>Caspase-3 is an executioner caspase</strong> and is involved in the <strong>later stages</strong> of apoptosis. The question specifically asks about <strong>initiation</strong> of apoptosis, which occurs <strong>before</strong> caspase-3 activation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhibition of p53: p53 promotes apoptosis in response to DNA damage.</strong> If p53 were inhibited, <strong>apoptosis would be reduced</strong>, which contradicts the presence of ongoing hepatocyte apoptosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fas-Fas ligand interaction (CD95-CD95L) is a key initiator of apoptosis in hepatocyte injury.</strong></span></li></ul>",
    "correct_choice_id": 106368,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35928,
    "choices": [
      {
        "id": 143507,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salbutamol</span></span></span></p>"
      },
      {
        "id": 143508,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ipratropium</span></span></span></p>"
      },
      {
        "id": 143509,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deriphylline</span></span></span></p>"
      },
      {
        "id": 143510,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrocortisone</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs used in the emergency management of asthma does not act by bronchodilation?</span></span></span></p>",
    "unique_key": "Q3782509",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633800,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hydrocortisone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hydrocortisone acts in an acute attack of bronchial asthma by producing anti-inflammatory effect, by decreasing the mucous secretion and by increasing the responsiveness of the &beta;2 receptors to their agonists.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Salbutamol.</strong> It acts as an agonist at beta-2 receptors which causes bronchodilation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Ipratropium.</strong> It acts as a muscarinic agonist at M3 receptors which antagonize smooth muscle contraction, thereby leading to bronchodilation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Deriphylline</strong> is a non-specific phosphodiesterase inhibitor like Theophylline. It increases the effects of steroids by activating histone deacetylase. Increased cAMP levels cause bronchodilation, improved airflow and reduced airway resistance.</span></span></span></p>",
    "correct_choice_id": 143510,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35924,
    "choices": [
      {
        "id": 143491,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metformin</span></span></span></p>"
      },
      {
        "id": 143492,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Potassium chloride</span></span></span></p>"
      },
      {
        "id": 143493,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin and IV fluid</span></span></span></p>"
      },
      {
        "id": 143494,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ringer lactate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient aged 55 years with hyperglycemia and positive ketone bodies in urine comes to you in hospital with altered sensorium. Which of the following drug therapy is most suitable to start?</span></span></span></p>",
    "unique_key": "Q4966102",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633429,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Insulin and IV fluid</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The given case is of diabetic keto-acidosis (DKA). </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Management of DKA:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The mainstay of therapy in DKA is correction of dehydration by giving IV fluids and correction of hyperglycemia and acidosis by giving IV Regular Insulin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If there is development of hypokalemia during infusion of insulin, then Inj. Potassium Chloride can be given. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sometimes, Sodium Bicarbonate can be used to correct the acidosis (if pH &lt;7.1). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is also important to look for the underlying precipitating factor like infections, myocardial infarction etc.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 143493,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29307,
    "choices": [
      {
        "id": 117134,
        "text": "<p><span style=\"font-size:14.0pt;\">Adenocarcinoma</span></p>"
      },
      {
        "id": 117135,
        "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell cancer&nbsp;</span></p>"
      },
      {
        "id": 117136,
        "text": "<p><span style=\"font-size:14.0pt;\">Small cell cancer</span></p>"
      },
      {
        "id": 117137,
        "text": "<p><span style=\"font-size:14.0pt;\">Large cell cancer&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Patient with history of smoking for many years presents with hoarseness of voice and hypocalcemia. He has a lump in the chest radiograph. Which of the following is the most likely histological finding?&nbsp;</span></p>",
    "unique_key": "Q1546294",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634542,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Small cell cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient presents with <strong>hypocalcemia</strong>, a known paraneoplastic syndrome associated with <strong>small cell lung cancer (SCLC)</strong>. Small cell lung cancer is highly linked to smoking, often associated with <strong>paraneoplastic syndromes</strong> such as:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>SIADH (hyponatremia)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>ACTH secretion (Cushing's syndrome)</strong></span></li><li><span style=\"font-size:14.0pt;\">Neurological syndromes (e.g., Lambert-Eaton myasthenic syndrome).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In contrast, <strong>hypercalcemia</strong> would point toward <strong>squamous cell carcinoma</strong> due to its secretion of parathyroid hormone\u2013related protein (PTHrP). SCLC is also aggressive, with a high propensity for metastasis, especially to the brain, and carries a <strong>poor prognosis</strong> despite excellent initial response to chemotherapy and radiotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adenocarcinoma:&nbsp;</strong>The most common lung cancer globally and in non-smokers. It is often associated with <strong>clubbing</strong> and <strong>migratory thrombophlebitis</strong> (Trousseau syndrome). However, it is not typically associated with hypocalcemia or paraneoplastic syndromes like SCLC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Squamous cell cancer:</strong> Strongly linked to smoking and associated with <strong>hypercalcemia</strong> due to PTHrP secretion. It is also characterized by <strong>keratin pearls</strong> on histology and <strong>cavitary lesions</strong> on imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Large cell cancer:&nbsp;</strong>A less common form of lung cancer, associated with poor differentiation. It is not closely linked to specific paraneoplastic syndromes and would not explain the patient\u2019s hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Small cell lung cancer (SCLC)</strong> is strongly associated with:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Smoking.</span></li><li><span style=\"font-size:14.0pt;\">Paraneoplastic syndromes like <strong>hypocalcemia</strong> and <strong>SIADH</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Aggressive progression and a high likelihood of brain metastases.</span></li><li><span style=\"font-size:14.0pt;\">Characteristic histological findings like the <strong>Azzopardi effect</strong> (basophilic staining of vascular walls due to DNA deposition).</span></li></ul>",
    "correct_choice_id": 117136,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73330,
    "choices": [
      {
        "id": 292273,
        "text": "<p><span style=\"font-size:14.0pt;\">Vegetables</span></p>"
      },
      {
        "id": 292274,
        "text": "<p><span style=\"font-size:14.0pt;\">Pig</span></p>"
      },
      {
        "id": 292275,
        "text": "<p><span style=\"font-size:14.0pt;\">Cattle</span></p>"
      },
      {
        "id": 292276,
        "text": "<p><span style=\"font-size:14.0pt;\">No intermediate host&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">What is the intermediate host for the organism shown in the image below?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20142813.jpg\" width=\"512\" height=\"344\"></span></p>",
    "unique_key": "Q9553687",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634379,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) No intermediate host</strong></span></p>",
    "correct_choice_id": 292276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 44029,
    "choices": [
      {
        "id": 175775,
        "text": "<p><span style=\"font-size:12pt;\">Nocardia acid fast stain</span></p>"
      },
      {
        "id": 175776,
        "text": "<p><span style=\"font-size:12pt;\">Streptococcus gram stain</span></p>"
      },
      {
        "id": 175777,
        "text": "<p><span style=\"font-size:12pt;\">Cryptococcus india ink</span></p>"
      },
      {
        "id": 175778,
        "text": "<p><span style=\"font-size:12pt;\">Coccidioidomycosis PAS stain</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism and the staining method used in the provided image. (INICET NOV 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/16/screenshot-2024-05-16-183830.JPG\" alt=\"\" width=\"300\" height=\"215\"></span></p>",
    "unique_key": "Q6861154",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633813,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Nocardia acid fast stain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image shows filamentous bacteria with partial acid-fastness, characteristic of Nocardia species stained using an acid-fast technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Streptococcus gram stain</strong>: Shows gram-positive cocci, not filamentous bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Cryptococcus india ink</strong>: Would reveal spherical yeast forms with a clear halo.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Coccidioidomycosis PAS stain</strong>: Typically shows spherules rather than filamentous structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Nocardia species are identified using an acid-fast stain, which highlights their filamentous and partially acid-fast nature.</span></p>",
    "correct_choice_id": 175775,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased",
      "INICET",
      "InvestigationBased"
    ]
  },
  {
    "id": 43945,
    "choices": [
      {
        "id": 175443,
        "text": "<p><span style=\"font-size:12.0pt;\">Seminoma</span></p>"
      },
      {
        "id": 175444,
        "text": "<p><span style=\"font-size:12.0pt;\">Yolk sac tumor</span></p>"
      },
      {
        "id": 175445,
        "text": "<p><span style=\"font-size:12.0pt;\">Leydig cell tumor</span></p>"
      },
      {
        "id": 175446,
        "text": "<p><span style=\"font-size:12.0pt;\">Sertoli cell tumor</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Reinke crystals are seen in which of the following gonadal tumours: (INICET NOV 2023)</span></p>",
    "unique_key": "Q6749667",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634479,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Leydig cell tumor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Reinke crystals are a specific and distinguishing feature of Leydig cell tumors. These crystals are eosinophilic, rod-shaped, crystalline inclusions found in the cytoplasm of Leydig cells. Leydig cell tumors are non-germ cell, sex cord-stromal tumors of the testicles that are typically benign.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seminoma:&nbsp;</strong>Does not feature Reinke crystals; characterized by uniform cells with clear cytoplasm and central nuclei, often associated with lymphocytic infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Yolk sac Tumor</strong>: Lacks Reinke crystals; known for Schiller-Duval bodies and a pattern resembling endodermal sinus structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sertoli cell Tumor</strong>: Also does not contain Reinke crystals; these tumors may show tubular or trabecular growth patterns and are often clinically silent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reinke crystals are pathognomonic of Leydig cell tumors of the testis and are useful in differentiating these from other testicular neoplasms.</span></p>",
    "correct_choice_id": 175445,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73344,
    "choices": [
      {
        "id": 292329,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 292330,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
      },
      {
        "id": 292331,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 292332,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Phase contrast microscopy is the technique used to study motility in live bacteria.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Interferon-beta (IFN-\u03b2) is a type I interferon, which is predominantly secreted in response to viral infections.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Alveolar echinococcosis can mimic HCC on imaging.</span></li><li><span style=\"font-size:14.0pt;\">Protein A binds the Fc portion of lgG&nbsp;</span></li></ol>",
    "unique_key": "Q8166844",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634470,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2, 3, 4</strong></span></p>",
    "correct_choice_id": 292329,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 31825,
    "choices": [
      {
        "id": 127170,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stop pyrazinamide and continue the rest of the drugs with kidney function test (KFT) monitoring. </span></span></p>"
      },
      {
        "id": 127171,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Add uric acid-lowering drugs and continue antitubercular therapy (ATT) as such with liver function test (LFT) and KFT monitoring. </span></span></p>"
      },
      {
        "id": 127172,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Continue all drugs and monitor serum uric acid level as well as LFT and KFT. </span></span></p>"
      },
      {
        "id": 127173,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stop all ATT drugs until laboratory values return to normal.</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A patient undergoing antitubercular therapy reports joint pain 10 days after initiation of treatment. Laboratory tests reveal normal AST and ALT levels, a serum creatinine of 0.9 mg/dL, and an elevated serum uric acid level of 10 mg/dL. What is the most appropriate next step in managing this patient&#39;s treatment?</span></span></p>",
    "unique_key": "Q9944495",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633383,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Stop pyrazinamide and continue the rest of the drugs with kidney function test (KFT) monitoring.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pyrazinamide is known to increase uric acid levels as a side effect, and hyperuricemia can lead to joint pain, which is suggestive of gout. If the patient&#39;s liver function tests are within normal limits, but they have elevated serum uric acid levels and are experiencing joint pain, the likely culprit is pyrazinamide.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Option A is the best next step because:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stopping pyrazinamide, which is most likely causing the hyperuricemia, should lead to a decrease in uric acid levels and an improvement in joint pain.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The rest of the antitubercular drugs can be continued to ensure the treatment of tuberculosis, with monitoring of kidney function tests to ensure the patient does not develop nephrotoxicity.</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Add uric acid-lowering drugs and continue antitubercular therapy (ATT) as such with liver function test (LFT) and KFT monitoring: </strong>Adding uric acid-lowering drugs might not be necessary immediately if pyrazinamide is discontinued. The primary goal is to identify and stop the drug causing the hyperuricemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Continue all drugs and monitor serum uric acid level as well as LFT and KFT: </strong>Continuing all drugs without modification might not address the underlying issue of hyperuricemia caused by pyrazinamide, potentially worsening the patient&#39;s symptoms.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Stop all ATT drugs until laboratory values return to normal: </strong>Stopping all ATT drugs would not be recommended as it could lead to the development of drug-resistant tuberculosis and could be harmful to the overall treatment of the disease.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pyrazinamide can cause hyperuricemia and joint pain; stopping pyrazinamide while continuing other antitubercular drugs with monitoring is the appropriate management strategy.</span></span></p>",
    "correct_choice_id": 127170,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 29299,
    "choices": [
      {
        "id": 117102,
        "text": "<p><span style=\"font-size:14.0pt;\">SLE (Systemic Lupus Erythematosus)</span></p>"
      },
      {
        "id": 117103,
        "text": "<p><span style=\"font-size:14.0pt;\">Rheumatoid arthritis&nbsp;</span></p>"
      },
      {
        "id": 117104,
        "text": "<p><span style=\"font-size:14.0pt;\">Sjogren syndrome</span></p>"
      },
      {
        "id": 117105,
        "text": "<p><span style=\"font-size:14.0pt;\">Serum sickness</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A female presents with arthralgia, difficulty in swallowing and gritty sensation in the eyes. She has higher titres of ANA. Which of the following is the likely diagnosis?&nbsp;</span></p>",
    "unique_key": "Q8254897",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634538,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Sjogren syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient presents with <strong>arthralgia (joint pain)</strong>, <strong>difficulty swallowing</strong>, and <strong>gritty sensation in the eyes</strong>, which are classic features of <strong>Sj\u00f6gren syndrome</strong>. Sj\u00f6gren syndrome is an autoimmune disorder characterized by <strong>dry eyes (keratoconjunctivitis sicca)</strong> and <strong>dry mouth (xerostomia)</strong> due to lymphocytic infiltration and destruction of the lacrimal and salivary glands. This is often associated with the presence of <strong>anti-Ro/SSA and anti-La/SSB antibodies</strong>, although antinuclear antibodies (ANA) are also commonly positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key diagnostic features of Sj\u00f6gren syndrome include:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Symptoms of dryness (dry eyes, dry mouth)</span></li><li><span style=\"font-size:14.0pt;\">Positive ANA and/or specific antibodies (anti-Ro/SSA, anti-La/SSB)</span></li><li><span style=\"font-size:14.0pt;\">Salivary gland biopsy (definitive diagnosis in unclear cases)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. SLE (Systemic Lupus Erythematosus):</strong> SLE may also present with arthralgia and ANA positivity. However, SLE does not typically involve significant dry eyes and dry mouth. Specific symptoms like malar rash, photosensitivity, and systemic involvement (renal, CNS) help distinguish SLE from Sj\u00f6gren syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Rheumatoid arthritis:</strong> While rheumatoid arthritis may involve arthralgia and sometimes overlap with Sj\u00f6gren syndrome, the hallmark of rheumatoid arthritis is <strong>morning stiffness</strong> and deforming polyarthritis. Dry eyes and mouth are not the primary symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Serum sickness:</strong> This hypersensitivity reaction involves immune complexes and is associated with fever, rash, and arthralgia. It does not cause dry eyes or mouth.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Sj\u00f6gren syndrome is an autoimmune condition characterized by <strong>dry eyes and dry mouth</strong> (Sicca symptoms) due to immune-mediated destruction of lacrimal and salivary glands. It is associated with <strong>anti-Ro/SSA and anti-La/SSB antibodies</strong> and can coexist with other autoimmune diseases like rheumatoid arthritis or lupus.</span></p>",
    "correct_choice_id": 117104,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74177,
    "choices": [
      {
        "id": 295637,
        "text": "<p><span style=\"font-size:14.0pt;\">Granisetron</span></p>"
      },
      {
        "id": 295638,
        "text": "<p><span style=\"font-size:14.0pt;\">Aprepitant</span></p>"
      },
      {
        "id": 295639,
        "text": "<p><span style=\"font-size:14.0pt;\">Metoclopramide</span></p>"
      },
      {
        "id": 295640,
        "text": "<p><span style=\"font-size:14.0pt;\">Domperidone</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old male undergoing chemotherapy for lung cancer develops&nbsp;severe vomiting on the third day after chemotherapy. He had mild nausea on the first day, which was controlled with medications. Now, despite taking oral antiemetics, he continues to have episodes of vomiting. Which of the following is the most effective drug for his condition?</span></p>",
    "unique_key": "Q4110666",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633415,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Aprepitant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Aprepitant</strong>&nbsp;is a&nbsp;<strong>neurokinin-1 (NK1) receptor antagonist</strong>&nbsp;that is specifically effective for&nbsp;<strong>chemotherapy-induced vomiting occurring after 24 hours (delayed phase).</strong></span></li><li><span style=\"font-size:14.0pt;\">The delayed vomiting typically starts&nbsp;<strong>after the first day (like on Day 2 or 3)</strong>&nbsp;and is&nbsp;<strong>not well controlled by 5-HT3 receptor antagonists (like Granisetron).</strong></span></li><li><span style=\"font-size:14.0pt;\">Aprepitant works by blocking&nbsp;<strong>substance P</strong>&nbsp;in the brain, preventing nausea and vomiting in the delayed phase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Granisetron:</strong> A&nbsp;<strong>5-HT3 receptor antagonist</strong>, highly effective for&nbsp;<strong>acute-phase vomiting (within 24 hours)</strong>&nbsp;but&nbsp;<strong>less effective for delayed vomiting</strong>. Many students may select this incorrectly!</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Metoclopramide:</strong> A&nbsp;<strong>dopamine antagonist</strong>, useful in mild nausea but not the most effective for chemotherapy-induced vomiting.</span><br>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Domperidone:</strong> Primarily a&nbsp;<strong>prokinetic drug</strong>, not very effective for chemotherapy-induced vomiting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">While 5-HT3 receptor antagonists (Granisetron, Ondansetron) are commonly used for chemotherapy-induced nausea and vomiting,&nbsp;<strong>delayed vomiting (after 24 hours)</strong>&nbsp;is best managed with&nbsp;<strong>NK1 receptor antagonists like Aprepitant.</strong></span></p>",
    "correct_choice_id": 295638,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 31803,
    "choices": [
      {
        "id": 127082,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous doxycycline only </span></span></p>"
      },
      {
        "id": 127083,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous doxycycline and ceftriaxone </span></span></p>"
      },
      {
        "id": 127084,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous ceftriaxone and azithromycin </span></span></p>"
      },
      {
        "id": 127085,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intravenous doxycycline and azithromycin</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 30-year-old woman with no significant past medical history presents to the emergency department with symptoms that have persisted for five days, including high-grade fever, severe headache, generalized body aches, and a new cough accompanied by mild shortness of breath. She also reports noticing a blackish lesion at the site of an insect bite on her thigh after returning from a camping trip in a region known for chigger infestation. On physical examination, she is found to have a fever of 39&deg;C, regional lymphadenopathy, and a well-defined eschar at the site of the lesion. Lung auscultation reveals mild diffuse rales. Laboratory tests show a normal white blood cell count and elevated liver enzymes. A chest X-ray indicates interstitial infiltrates, suggestive of atypical pneumonia that may be related to her primary infection. What is the most appropriate treatment for this patient?</span></span></p>",
    "unique_key": "Q8973195",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633376,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Intravenous doxycycline only.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The patient&#39;s clinical presentation is consistent with a rickettsial infection, likely contracted from a chigger bite, as evidenced by the eschar at the bite site, symptoms, and regional lymphadenopathy. The recommended treatment for rickettsial infections, such as scrub typhus, is doxycycline. This antibiotic is effective in treating the intracellular pathogens responsible for these infections. The additional symptoms of atypical pneumonia are also suggestive of a rickettsial etiology, which doxycycline can adequately address.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Intravenous doxycycline and ceftriaxone:</strong> Combining doxycycline with ceftriaxone could be considered if there was a high suspicion of a secondary bacterial infection, particularly one that is serious and requires broad-spectrum coverage such as ceftriaxone. However, the patient&#39;s presentation does not strongly indicate such a co-infection.</span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Intravenous ceftriaxone and azithromycin:</strong> This regimen is commonly used for community-acquired pneumonia with the intention to cover both typical and atypical pathogens. While the patient does exhibit signs of atypical pneumonia, the clinical findings are more suggestive of a rickettsial infection, which would not be optimally treated with this combination.</span></span></p>\r\n\r\n<p style=\"margin-left:24px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Intravenous doxycycline and azithromycin:</strong> Azithromycin could be added to doxycycline if there were concerns about atypical pneumonia due to pathogens like Mycoplasma pneumoniae or Chlamydophila pneumoniae. However, in the context of the patient&#39;s clinical presentation and recent exposure history, doxycycline alone should suffice to cover the likely rickettsial pathogen.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Doxycycline is the treatment of choice for rickettsial infections, such as those contracted from chigger bites, and is effective against both the primary infection and associated complications like atypical pneumonia.</span></span></li>\r\n</ul>",
    "correct_choice_id": 127082,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 55069,
    "choices": [
      {
        "id": 219737,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IgG4-related disease</span></span></p>"
      },
      {
        "id": 219738,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hodgkin&#39;s lymphoma</span></span></p>"
      },
      {
        "id": 219739,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Castleman disease</span></span></p>"
      },
      {
        "id": 219740,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Angiolymphoma</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old man presents with a three-month history of abdominal distension and intermittent fever. He denies night sweats or significant weight loss. Physical examination reveals generalized lymphadenopathy, but peripheral blood smear findings are normal. A lymph node biopsy is performed, and the histopathological image is shown below. Based on the clinical presentation and histopathology, what is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/28/screenshot-2024-08-28-125946.png\" style=\"height:200px; width:300px\" /></span></span></p>",
    "unique_key": "Q3748419",
    "question_audio": null,
    "question_video": null,
    "map_id": 34664927,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Castleman disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Castleman disease is a rare lymphoproliferative disorder characterized by enlarged lymph nodes, systemic inflammation, and the overproduction of certain cytokines, such as interleukin-6 (IL-6). </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Histologically, the lymph nodes show follicles with abnormal germinal centers and a characteristic &quot;onion-skin&quot; appearance of the mantle zone, which can be seen in the provided image. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation of abdominal distension, intermittent fever, and normal peripheral smear findings, along with the histological features, is consistent with Castleman disease.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A.&nbsp; IgG4-related disease</span></strong><span style=\"font-size:14.0pt\">: This condition is associated with fibrosis and the infiltration of IgG4-positive plasma cells, which typically involves organs like the pancreas and salivary glands rather than lymph nodes. The histopathology does not match IgG4-related disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Hodgkin&#39;s lymphoma</span></strong><span style=\"font-size:14.0pt\">: Hodgkin&#39;s lymphoma typically presents with Reed-Sternberg cells on histology, which are not seen in the provided image. Although it can present with fever and lymphadenopathy, the histological findings do not support this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Angiolymphoma</span></strong><span style=\"font-size:14.0pt\">: This is not a commonly recognized clinical entity and does not correspond to the described histological or clinical features.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Castleman disease is a lymphoproliferative disorder that presents with systemic symptoms and characteristic histological features, including abnormal germinal centers and an &quot;onion-skin&quot; appearance of the mantle zone.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;It is important to recognize the clinical and histopathological features to differentiate it from other lymphoproliferative disorders.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 219739,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 29329,
    "choices": [
      {
        "id": 117222,
        "text": "<p><span style=\"font-size:14.0pt;\">Congo red is the commonest stain used for diagnosis&nbsp;</span></p>"
      },
      {
        "id": 117223,
        "text": "<p><span style=\"font-size:14.0pt;\">Electron microscopy shows non branching fibrils&nbsp;</span></p>"
      },
      {
        "id": 117224,
        "text": "<p><span style=\"font-size:14.0pt;\">Spectroscopy shows beta pleated structure</span></p>"
      },
      {
        "id": 117225,
        "text": "<p><span style=\"font-size:14.0pt;\">Apple green birefringence with PAS staining</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 65-year-old male presents with numbness and tingling in his hands and feet. He also reports weakness and difficulty walking. Examination reveals enlarged tongue, carpal tunnel syndrome, and a waddling gait. Biopsy of the sural nerve shows deposits of amyloid protein. Which of the following is not correct about this condition?&nbsp;</span></p>",
    "unique_key": "Q1982338",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634553,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Apple green birefringence with PAS staining</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This is false. Apple green birefringence is a diagnostic feature of amyloidosis, but it is observed with Congo red staining under polarized light, not PAS staining.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Congo red is the commonest stain used for diagnosis:</strong> This is correct. Congo red is the standard stain for identifying amyloid deposits in tissue biopsies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Electron microscopy shows non-branching fibrils:</strong> This is correct. Amyloid deposits are characterized by non-branching fibrils under electron microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Spectroscopy shows beta pleated structure:</strong> This is correct. Amyloid fibrils exhibit a beta-pleated sheet structure, which can be identified through spectroscopic techniques.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Amyloidosis is diagnosed by identifying amyloid deposits in tissues using Congo red staining, which shows apple green birefringence under polarized light. The condition is associated with non-branching fibrils and a beta-pleated sheet structure.</span></p>",
    "correct_choice_id": 117225,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 31823,
    "choices": [
      {
        "id": 127162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hydrocortisone </span></span></p>"
      },
      {
        "id": 127163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sodium bicarbonate </span></span></p>"
      },
      {
        "id": 127164,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Insulin </span></span></p>"
      },
      {
        "id": 127165,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hypertonic saline</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was brought to the emergency department in an unconscious state. The patient is dehydrated and the blood pressure of the patient is 90/60 mm Hg. Laboratory investigations revealed the serum potassium level of 6.0 mEq/L, sodium level of 129 mEq/L, and blood glucose level of 40 mg/dL. The patient has a history of rheumatoid arthritis (RA) for which he was prescribed medication by a local physician; however, the patient abruptly discontinued the medication a few weeks ago. Based on the clinical presentation and laboratory findings, which of the following drugs should be administered as a life-saving measure to treat this patient?</span></span></p>",
    "unique_key": "Q5507630",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633382,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Hydrocortisone</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hydrocortisone is indicated as it would treat adrenal insufficiency. It would help to correct hypotension, hyperkalemia, hyponatremia, and hypoglycemia by replacing the deficient cortisol.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical presentation of hypotension, hyperkalemia, hyponatremia, dehydration, and hypoglycemia in a patient who has suddenly stopped taking medication for RA (potentially a corticosteroid) suggests the possibility of adrenal insufficiency or Addisonian crisis. This is particularly likely if the medication the patient was taking for RA was a corticosteroid, which is common in the management of RA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Sodium bicarbonate: </strong>Sodium bicarbonate is used to treat metabolic acidosis, which is not indicated in this case as there is no mention of acidosis in the given scenario.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Insulin: </strong>Insulin is used in the treatment of hyperkalemia to drive potassium into cells, but it would not address the underlying adrenal insufficiency and could potentially worsen the hypoglycemia.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Hypertonic saline: </strong>Hypertonic saline is used to treat severe hyponatremia, which is not present in this case, as the sodium level is within normal limits.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hydrocortisone is the drug of choice for treating adrenal insufficiency or Addisonian crisis, which can present with hypotension, hyperkalemia, hyponatremia, dehydration, and hypoglycemia, especially in patients with a history of corticosteroid use who abruptly discontinue their medication.</span></span></p>",
    "correct_choice_id": 127162,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 73325,
    "choices": [
      {
        "id": 292253,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 292254,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 4</span></p>"
      },
      {
        "id": 292255,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
      },
      {
        "id": 292256,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Listeria monocytogenes uniquely utilizes actin filaments for intracellular movement</span></li><li><span style=\"font-size:14.0pt;\">XDR-TB is managed under BSL-3 conditions</span></li><li><span style=\"font-size:14.0pt;\">Urine lipoarabinomannan (LAM) assay is used for the diagnosis of tuberculosis and leprosy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">E.coli shows acid slant/acid butt with gas production on TSI agar</span></li></ol>",
    "unique_key": "Q1068200",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634377,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2, 4</strong></span></p>",
    "correct_choice_id": 292254,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 55072,
    "choices": [
      {
        "id": 219749,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mucicarmine stain</span></span></p>"
      },
      {
        "id": 219750,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Masson trichrome stain</span></span></p>"
      },
      {
        "id": 219751,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Masson Fontana stain</span></span></p>"
      },
      {
        "id": 219752,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Van Gieson stain</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old woman presents to the OPD with a recently changing, asymmetrical pigmented lesion on her arm. The lesion has irregular borders and variegated coloration. She reports that the lesion has become itchy over the past few weeks. A biopsy of the lesion is performed, and the histopathological examination is shown below. Which of the following stains was most likely used to visualize the tissue sample?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/28/screenshot-2024-08-28-130121.png\" style=\"height:246px; width:300px\" /></span></span></p>",
    "unique_key": "Q2091962",
    "question_audio": null,
    "question_video": null,
    "map_id": 34664979,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) Masson Fontana stain</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The clinical presentation and histopathological findings are suggestive of melanocytic nevus. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Masson Fontana stain is used to identify melanin and is particularly useful in the diagnosis of pigmented lesions, such as melanomas or pigmented nevi as shown in the above image. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The presence of melanin in the tissue is indicated by the black or dark brown coloration, which is characteristic of this stain. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Given the clinical presentation of a changing, asymmetrical pigmented lesion with irregular borders and variegated color, the use of Masson Fontana stain is appropriate to assess the presence of melanin and differentiate between benign and malignant melanocytic lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. Mucicarmine stain</span></strong><span style=\"font-size:14.0pt\">: This stain is primarily used to detect mucin, which is not relevant in the context of pigmented skin lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. Masson trichrome stain</span></strong><span style=\"font-size:14.0pt\">: This stain is used to differentiate between collagen and muscle fibers, often in the context of fibrosis or muscle pathology. It is not used to identify melanin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Van Gieson stain</span></strong><span style=\"font-size:14.0pt\">: This is used to differentiate collagen and other connective tissue fibers, which is not relevant for diagnosing pigmented skin lesions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Masson Fontana stain is specifically used to detect melanin in tissue samples, making it the appropriate choice for evaluating pigmented skin lesions, particularly in the context of suspected melanoma or atypical nevi.</span></span></span></p>",
    "correct_choice_id": 219751,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 6461,
    "choices": [
      {
        "id": 25813,
        "text": "<p><span style=\"font-size:12.0pt;\">Timolol</span></p>"
      },
      {
        "id": 25814,
        "text": "<p><span style=\"font-size:12.0pt;\">Brimonidine</span></p>"
      },
      {
        "id": 25815,
        "text": "<p><span style=\"font-size:12.0pt;\">Latanoprost</span></p>"
      },
      {
        "id": 25816,
        "text": "<p><span style=\"font-size:12.0pt;\">Dorzolamide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A pediatric patient is brought to the emergency department with signs of ocular hypotension and apnea. The parents are concerned about the child's condition and have provided a history of recent medication use. It is crucial to determine which drug may have caused these symptoms in the infant. Drug capable of causing ocular hypotension with apnea in infants is:</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2019)</span></p>",
    "unique_key": "Q2462319",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633413,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Brimonidine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brimonidine is an alpha-2 adrenergic agonist used to lower intraocular pressure in conditions such as glaucoma. It acts by decreasing the production of aqueous humor and increasing its outflow, thereby reducing intraocular pressure. While brimonidine is generally well-tolerated, it can have systemic side effects, particularly in infants. The most concerning systemic side effect in this context is central nervous system depression, which can manifest as symptoms like apnea (temporary cessation of breathing). Infants, especially premature ones, are more susceptible to such side effects. Therefore, brimonidine is the drug most likely responsible for causing ocular hypotension with apnea in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Timolol:</strong> Timolol is a beta-blocker commonly used to lower intraocular pressure. While it can have systemic side effects, including bradycardia and bronchospasm, it is not typically associated with apnea in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Latanoprost:</strong> Latanoprost is a prostaglandin analog that lowers intraocular pressure by increasing the outflow of aqueous humor. It can cause side effects such as changes in iris color and eyelash growth. However, it is not known to cause apnea in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dorzolamide:</strong> Dorzolamide is a carbonic anhydrase inhibitor used in ophthalmology to reduce intraocular pressure. While it can cause ocular hypotension, it is not a common cause of apnea, especially in infants.</span></p>",
    "correct_choice_id": 25814,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "OlderNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 31821,
    "choices": [
      {
        "id": 127154,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Memantine </span></span></p>"
      },
      {
        "id": 127155,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Donepezil </span></span></p>"
      },
      {
        "id": 127156,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rivastigmine </span></span></p>"
      },
      {
        "id": 127157,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Galantamine</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A 72-year-old patient with a confirmed diagnosis of mild to moderate Alzheimer&#39;s dementia has shown aversion and non-compliance to oral medications. The patient&#39;s caregiver reports difficulty in administering the oral drugs due to the patient&#39;s refusal to swallow pills. Considering the need for continued treatment, which of the following medications could be prescribed in a form that does not require oral administration?</span></span></p>",
    "unique_key": "Q3330988",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633381,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>C) Rivastigmine</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rivastigmine is an acetylcholinesterase inhibitor used in the treatment of mild to moderate dementia in Alzheimer&#39;s disease. Unlike memantine, donepezil, and galantamine, rivastigmine has the advantage of being available in a transdermal patch form. The transdermal patch allows for continuous delivery of the medication through the skin, which is beneficial for patients who are non-compliant with oral medications or have difficulty swallowing pills.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Memantine: </strong>Memantine is used in moderate to severe dementia and is usually administered orally. To date, there is no alternative route of administration available for memantine.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Donepezil: </strong>Donepezil is typically administered orally and is used in all stages of Alzheimer&#39;s disease. There is an orally disintegrating tablet form, but it still requires the ability to manage oral intake.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Galantamine: </strong>Galantamine is also used for mild to moderate Alzheimer&#39;s dementia and is administered orally. There is no non-oral formulation available for galantamine.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In conclusion, for a patient who refuses oral medication, rivastigmine can be prescribed in a patch form, providing an alternative route of administration that ensures the patient can continue to receive their dementia management therapy.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">For a patient with Alzheimer&#39;s dementia who refuses oral medication, rivastigmine can be prescribed in a transdermal patch form, providing an alternative route of administration that ensures the patient can continue to receive their dementia management therapy.</span></span></p>",
    "correct_choice_id": 127156,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 29303,
    "choices": [
      {
        "id": 117118,
        "text": "<p><span style=\"font-size:14.0pt;\">Nasopharyngeal carcinoma&nbsp;</span></p>"
      },
      {
        "id": 117119,
        "text": "<p><span style=\"font-size:14.0pt;\">Byssinosis</span></p>"
      },
      {
        "id": 117120,
        "text": "<p><span style=\"font-size:14.0pt;\">Bagassosis</span></p>"
      },
      {
        "id": 117121,
        "text": "<p><span style=\"font-size:14.0pt;\">Asbestosis</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A person is working with a cardboard factory for last 30 years. He developed breathlessness and mottling in the lungs. This presentation is likely to be associated with which of the following conditions?</span></p>",
    "unique_key": "Q2073106",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634540,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Bagassosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Bagassosis</strong> is a hypersensitivity pneumonitis caused by inhalation of <strong>moldy sugarcane dust</strong>, which is often used in cardboard manufacturing. The mold responsible for this condition is typically <strong>Thermoactinomyces sacchari</strong>, a type of thermophilic actinomycete. Chronic exposure to this moldy dust causes an allergic inflammatory response in the lungs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Key clinical features:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Breathlessness</strong>: Worsens with continued exposure.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mottling in the lungs</strong>: Seen on chest imaging due to inflammation and fibrosis.</span></li><li><span style=\"font-size:14.0pt;\">Chronic exposure can lead to <strong>restrictive lung disease</strong>.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nasopharyngeal carcinoma</strong>: Associated with Epstein-Barr Virus (EBV) infection and risk factors like smoking, but not with sugarcane or cardboard exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Byssinosis</strong>: Known as \"textile worker\u2019s disease,\" caused by inhalation of cotton dust in textile mills. It does not involve mold exposure or cardboard factories.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Asbestosis</strong>: Associated with prolonged exposure to asbestos in cement, shipyard, or insulation industries. It leads to <strong>pleural plaques, ferruginous bodies</strong>, and increases the risk of <strong>bronchogenic carcinoma</strong> and <strong>mesothelioma</strong>, but is unrelated to cardboard factories.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Bagassosis</strong> is a form of hypersensitivity pneumonitis caused by <strong>moldy sugarcane dust exposure</strong>, commonly seen in industries like cardboard manufacturing.</span></p>",
    "correct_choice_id": 117120,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 52126,
    "choices": [
      {
        "id": 208005,
        "text": "<p><span style=\"font-size:12.0pt;\">Chronic granulomatous disease</span></p>"
      },
      {
        "id": 208006,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyper IgM syndrome</span></p>"
      },
      {
        "id": 208007,
        "text": "<p><span style=\"font-size:12.0pt;\">Job syndrome</span></p>"
      },
      {
        "id": 208008,
        "text": "<p><span style=\"font-size:12.0pt;\">Chediak-Higashi syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Patients with which of the following conditions are more susceptible to infections caused by catalase-positive organisms:&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q5764982",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633821,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chronic granulomatous disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic Granulomatous Disease (CGD) is an immunodeficiency disorder that makes patients particularly susceptible to infections by catalase-positive organisms. This condition arises from a defect in the NADPH oxidase complex in phagocytes, which is crucial for the production of reactive oxygen species used to kill ingested pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key points about CGD:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Pathophysiology:</strong> In CGD, phagocytes (e.g., neutrophils and macrophages) are unable to produce reactive oxygen species due to a defective NADPH oxidase enzyme. This impairs the killing of certain bacteria and fungi.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Catalase-positive organisms:</strong> These organisms can neutralize hydrogen peroxide (H2O2), a reactive oxygen species that the host cells might produce. Catalase-positive bacteria include <i>Staphylococcus aureus</i>, <i>Serratia marcescens</i>, <i>Aspergillus species</i>, <i>Nocardia</i>, and <i>Pseudomonas</i>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent Infections:</strong> Patients with CGD frequently suffer from recurrent bacterial and fungal infections, particularly with catalase-positive organisms due to their inability to effectively kill these pathogens.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hyper IgM syndrome</strong>: This immunodeficiency disorder is characterized by elevated levels of IgM and low levels of other immunoglobulins due to defects in class-switch recombination. Patients are more prone to infections but not specifically with catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Job syndrome (Hyper-IgE syndrome)</strong>: Patients with Job syndrome have elevated levels of IgE and suffer from recurrent staphylococcal skin abscesses, pneumonia, and other infections. However, their susceptibility is not specifically related to catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chediak-Higashi syndrome</strong>: This is a rare autosomal recessive disorder characterized by defects in lysosomal trafficking, leading to impaired phagocytosis and recurrent bacterial infections. While patients are prone to infections, their susceptibility is not specifically to catalase-positive organisms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic Granulomatous Disease (CGD) is an immunodeficiency disorder that makes patients particularly susceptible to infections by catalase-positive organisms due to a defect in the NADPH oxidase enzyme in phagocytes.</span></p>",
    "correct_choice_id": 208005,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 44852,
    "choices": [
      {
        "id": 179055,
        "text": "<p><span style=\"font-size:12pt;\">1, 2 and 4</span></p>"
      },
      {
        "id": 179056,
        "text": "<p><span style=\"font-size:12pt;\">1, 3 and 4</span></p>"
      },
      {
        "id": 179057,
        "text": "<p><span style=\"font-size:12pt;\">1, 2 and 3</span></p>"
      },
      {
        "id": 179058,
        "text": "<p><span style=\"font-size:12pt;\">2, 3 and 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following drug is/are used for cyanide poisoning?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Amyl nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium thiosulfate</span></li><li><span style=\"font-size:12pt;\">Glyceryl trinitrate</span></li></ol>",
    "unique_key": "Q8757926",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633395,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cyanide poisoning, the following treatments are commonly used:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1.</strong>&nbsp;<strong>Amyl nitrite</strong>: This is an inhalant that induces methemoglobinemia, which binds cyanide ions and forms cyanmethemoglobin, helping to detoxify cyanide.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">2&nbsp;<strong>Sodium nitrite</strong>: This intravenous agent also induces methemoglobinemia, which helps to bind and neutralize cyanide.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3.</strong>&nbsp;<strong>Sodium thiosulfate</strong>: This acts as a sulfur donor, converting cyanide to the less toxic thiocyanate, which is excreted by the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4.</strong>&nbsp;<strong>Glyceryl trinitrate</strong> (commonly known as nitroglycerin) is not typically used for cyanide poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Based on the options provided, the correct combination of drugs used for cyanide poisoning is:&nbsp;<strong>1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. 1, 2, and 3</strong></span></p>",
    "correct_choice_id": 179057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73319,
    "choices": [
      {
        "id": 292229,
        "text": "<p><span style=\"font-size:14.0pt;\">Glycoprotein-G</span></p>"
      },
      {
        "id": 292230,
        "text": "<p><span style=\"font-size:14.0pt;\">Matrix protein</span></p>"
      },
      {
        "id": 292231,
        "text": "<p><span style=\"font-size:14.0pt;\">Nucleocapsid protein</span></p>"
      },
      {
        "id": 292232,
        "text": "<p><span style=\"font-size:14.0pt;\">L protein&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following components of the following virus can be used to prepare vaccines?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20141952.jpg\" width=\"618\" height=\"451\"></span></p>",
    "unique_key": "Q1518873",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634374,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Glycoprotein-G&nbsp;</strong></span></p>",
    "correct_choice_id": 292229,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 43947,
    "choices": [
      {
        "id": 175451,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interferon gamma</span></span></span></p>"
      },
      {
        "id": 175452,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complement 5a protein</span></span></span></p>"
      },
      {
        "id": 175453,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Histamine</span></span></span></p>"
      },
      {
        "id": 175454,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prostaglandin</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with fever, cough, weight loss, histology of the pathology is as shown below. What is the most likely cytokine involved? (INICET NOV 2023)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/13/screenshot-2024-05-13-151657.JPG\" style=\"height:256px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q2741770",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634475,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Interferon gamma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IFN-</span><span dir=\"ltr\" lang=\"EL\" style=\"font-size:12.0pt\">&gamma; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is crucial in the immune response against intracellular pathogens, including the activation of macrophages and the formation of granulomas, as seen in tuberculosis and other granulomatous diseases. It is produced primarily by T-helper cells (Th1) and is critical for orchestrating the cellular immune response that results in the granuloma formation evident in the provided histology.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Complement 5a protein</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Involved in the inflammatory process, enhancing the immune response by attracting immune cells to sites of infection, but not directly involved in granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Histamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A mediator in allergic reactions, involved in vasodilation and increased vascular permeability, not typically associated with chronic inflammatory or granulomatous responses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Prostaglandin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: These are lipid compounds that mediate inflammation. Like histamine, they are more often associated with immediate inflammatory responses and pain, rather than chronic inflammation or granuloma formation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interferon gamma is key in managing intracellular infections and is responsible for the activation of macrophages and other immune cells that culminate in granuloma formation, a central feature in controlling persistent pathogens such as those seen in tuberculosis.</span></span></span></p>",
    "correct_choice_id": 175451,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 73420,
    "choices": [
      {
        "id": 292629,
        "text": "<p><span style=\"font-size:14.0pt;\">Trichomonas</span></p>"
      },
      {
        "id": 292630,
        "text": "<p><span style=\"font-size:14.0pt;\">Chlamydia</span></p>"
      },
      {
        "id": 292631,
        "text": "<p><span style=\"font-size:14.0pt;\">Gonococcus</span></p>"
      },
      {
        "id": 292632,
        "text": "<p><span style=\"font-size:14.0pt;\">H.ducreyi</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not involved in urethritis?&nbsp;</span></p>",
    "unique_key": "Q2120229",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634395,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) H.ducreyi</strong></span></p>",
    "correct_choice_id": 292632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26611,
    "choices": [
      {
        "id": 106386,
        "text": "<p><span style=\"font-size:14.0pt;\">Follicular lymphoma</span></p>"
      },
      {
        "id": 106387,
        "text": "<p><span style=\"font-size:14.0pt;\">Hairy cell leukemia</span></p>"
      },
      {
        "id": 106388,
        "text": "<p><span style=\"font-size:14.0pt;\">Mantle cell lymphoma</span></p>"
      },
      {
        "id": 106389,
        "text": "<p><span style=\"font-size:14.0pt;\">Marginal zone lymphoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man presents with low grade fever, malaise and enlarged cervical and supraclavicular lymph nodes. The biopsy from one of the cervical nodes shows effaced architecture and sheet-like growth of small sized lymphocytes with irregular nuclear contours (as in image). Immunohistochemical analysis shows positivity for pan B cell markers, CD5 and cyclin D1. The diagnosis in this case is.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/13/picture2.jpg\" alt=\"\" width=\"300\" height=\"211\"></span></p>",
    "unique_key": "Q5512830",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634566,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Mantle cell lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The provided <strong>histopathological image</strong> shows a <strong>monotonous proliferation of small lymphocytes with irregular nuclear contours</strong>, which is <strong>highly suggestive of mantle cell lymphoma (MCL)</strong>. The <strong>immunophenotypic markers</strong> confirm the diagnosis:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>CD5 positivity</strong> \u2013 MCL is a <strong>CD5-positive</strong> B-cell lymphoma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cyclin D1 positivity</strong> \u2013 <strong>A hallmark of MCL</strong>, resulting from <strong>t(11;14) translocation</strong>, leading to <strong>overexpression of cyclin D1</strong>, which promotes uncontrolled cell proliferation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Effaced lymph node architecture</strong> \u2013 A typical feature of aggressive lymphomas, including MCL.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">MCL typically presents in <strong>middle-aged or older men</strong> with <strong>generalized lymphadenopathy, splenomegaly, and bone marrow involvement</strong>. It is <strong>more aggressive than other small B-cell lymphomas</strong>, with a <strong>poor prognosis</strong> despite initial responsiveness to chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Follicular lymphoma:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Follicular lymphoma <strong>lacks CD5 and cyclin D1 expression</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It typically <strong>shows follicular growth patterns</strong>, unlike the <strong>sheet-like</strong> growth in this case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hairy cell leukemia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hairy cell leukemia is a <strong>CD5-negative B-cell neoplasm</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is characterized by <strong>TRAP (tartrate-resistant acid phosphatase) positivity</strong> and a <strong>fried egg appearance</strong> of cells on histology, which is absent here.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Marginal zone lymphoma</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Marginal zone lymphoma is <strong>associated with chronic inflammation</strong> (e.g., H. pylori infection in gastric MALT lymphoma).</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>CD5-negative</strong> and <strong>cyclin D1-negative</strong>, making it unlikely in this case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Mantle cell lymphoma is characterized by CD5 and cyclin D1 positivity</strong>, due to <strong>t(11;14) translocation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>It is more aggressive than other small B-cell lymphomas</strong>, with a <strong>poor prognosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Differential diagnosis includes follicular lymphoma (CD5-negative), hairy cell leukemia (CD5-negative, TRAP-positive), and marginal zone lymphoma (CD5-negative, associated with chronic inflammation).</strong></span></li></ul>",
    "correct_choice_id": 106388,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 26667,
    "choices": [
      {
        "id": 106610,
        "text": "<p><span style=\"font-size:14.0pt;\">Necrosis&nbsp;</span></p>"
      },
      {
        "id": 106611,
        "text": "<p><span style=\"font-size:14.0pt;\">Necroptosis</span></p>"
      },
      {
        "id": 106612,
        "text": "<p><span style=\"font-size:14.0pt;\">Ferroptosis&nbsp;</span></p>"
      },
      {
        "id": 106613,
        "text": "<p><span style=\"font-size:14.0pt;\">Pyroptosis&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">An elderly patient dies due to a cancer and his cells in the cancer affected area were examined. Ultra structurally, the most prominent features found are the loss of mitochondrial cristae and ruptured outer mitochondrial membrane. Which of the following best can be the pattern of cell death here?</span></p>",
    "unique_key": "Q2660233",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634575,
    "difficulty_level": "difficult",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ferroptosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ferroptosis</strong> is an <strong>iron-dependent</strong> form of <strong>regulated cell death</strong> characterized by <strong>free radical-induced mitochondrial damage</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>loss of mitochondrial cristae</strong> and <strong>ruptured outer mitochondrial membrane</strong> seen ultrastructurally are <strong>hallmark features</strong> of ferroptosis.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key features of ferroptosis include:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Iron accumulation leading to oxidative stress</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Lipid peroxidation</strong> causing cell membrane damage</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glutathione peroxidase (GPX4) deficiency</strong>, which fails to neutralize oxidative stress</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This mechanism is particularly implicated in <strong>cancer cell death, ischemia-reperfusion injury, and neurodegenerative disorders</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Necrosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Necrosis is <strong>unregulated cell death</strong> often due to ischemia or trauma.</span></li><li><span style=\"font-size:14.0pt;\">Unlike ferroptosis, <strong>necrosis shows random cellular swelling and membrane rupture</strong>, without mitochondrial-specific damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Necroptosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Programmed necrosis</strong>, distinct from ferroptosis.</span></li><li><span style=\"font-size:14.0pt;\">Mediated by <strong>RIPK1 and RIPK3 signaling</strong>, not iron accumulation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>No specific mitochondrial damage</strong> as seen in ferroptosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pyroptosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Caspase-1 and caspase-11 dependent cell death</strong>, often triggered by infections.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Involves inflammasome activation</strong> and release of IL-1\u03b2 and IL-18.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Membrane rupture occurs</strong>, but mitochondrial loss of cristae is not a feature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ferroptosis is an iron-dependent form of regulated cell death characterized by mitochondrial cristae loss and lipid peroxidation.</span></li><li><span style=\"font-size:14.0pt;\">It is distinct from apoptosis, necrosis, and necroptosis.</span></li><li><span style=\"font-size:14.0pt;\">Key regulators include iron metabolism and glutathione peroxidase (GPX4).</span></li></ul>",
    "correct_choice_id": 106612,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35933,
    "choices": [
      {
        "id": 143527,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiological antagonism&nbsp;</span></span></span></p>"
      },
      {
        "id": 143528,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemical antagonism</span></span></span></p>"
      },
      {
        "id": 143529,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reversible antagonism</span></span></span></p>"
      },
      {
        "id": 143530,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Competitive antagonism</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What type of antagonism is demonstrated when adrenaline causes bronchodilation through beta-2 receptors while histamine causes bronchoconstriction through H1 receptors?</span></span></span></p>",
    "unique_key": "Q3579537",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633801,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Physiological antagonism</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiological antagonism occurs when two drugs act on different receptors, resulting in opposite responses in the body. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In this case, adrenaline acts on beta 2 receptors, leading to bronchodilation, while histamine acts on H1 receptors, causing bronchoconstriction.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other types of Antagonism:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physical</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Substances directly bind to and neutralize the effects of toxins or drugs &ndash; E.g., Charcoal given in cases of poisoning.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemical</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Substances react to neutralize each other&rsquo;s effects &ndash; e.g., Heparin and protamine sulphate, antacids reducing the acidity of stomach</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pharmacological</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; A drug blocks the effects of the another drug by interfering with its target or mechanism of action &ndash; e.g., Aspirin inhibiting COX enzyme.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 143527,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29311,
    "choices": [
      {
        "id": 117150,
        "text": "<p><span style=\"font-size:14.0pt;\">RBC 20-22\u00b0C, FFP -30\u00b0C, Platelet 2-6\u00b0C&nbsp;</span></p>"
      },
      {
        "id": 117151,
        "text": "<p><span style=\"font-size:14.0pt;\">RBC -30\u00b0C, FFP 2-6\u00b0C, Platelet 20-22\u00b0C</span></p>"
      },
      {
        "id": 117152,
        "text": "<p><span style=\"font-size:14.0pt;\">RBC 20-22\u00b0C, Platelet 22-26\u00b0C, FFP 30\u00b0C</span></p>"
      },
      {
        "id": 117153,
        "text": "<p><span style=\"font-size:14.0pt;\">RBC 2-6\u00b0C, Platelet 20-22\u00b0C, FFP -30\u00b0C&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Storage temperature of RBC, Platelet, and Fresh Frozen Plasma (FFP) are:&nbsp;</span></p>",
    "unique_key": "Q4333811",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634544,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) RBC 2-6 \u00b0C, Platelet 20-22 \u00b0C, FFP-30 \u00b0C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The storage temperatures for various blood components are critical for maintaining their efficacy and preventing deterioration:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>RBCs (Red Blood Cells)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Storage temperature: <strong>2-6\u00b0C</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Shelf life: <strong>42 days</strong> when stored in an additive solution under sterile conditions.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Platelets</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Storage temperature: <strong>20-22\u00b0C (room temperature)</strong> with continuous gentle agitation.</span></li><li><span style=\"font-size:14.0pt;\">Shelf life: <strong>5 days</strong>. Platelets are stored at room temperature to preserve their functionality for clotting but are at a higher risk of bacterial contamination.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Fresh Frozen Plasma (FFP)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Storage temperature: <strong>-18\u00b0C to -30\u00b0C</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Shelf life: <strong>at least 1 year</strong> when stored frozen. FFP contains clotting factors and must be thawed prior to use.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>RBCs:</strong> Stored at <strong>2-6\u00b0C</strong>, shelf life <strong>42 days</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Platelets:</strong> Stored at <strong>20-22\u00b0C</strong>, shelf life <strong>5 days</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FFP:</strong> Stored at <strong>-18\u00b0C to -30\u00b0C</strong>, shelf life <strong>1 year</strong>.</span></li></ul>",
    "correct_choice_id": 117153,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26621,
    "choices": [
      {
        "id": 106426,
        "text": "<p><span style=\"font-size:14.0pt;\">Anti\u2013glomerular basement membrane antibody</span></p>"
      },
      {
        "id": 106427,
        "text": "<p><span style=\"font-size:14.0pt;\">Anti\u2013streptolysin O antibody</span></p>"
      },
      {
        "id": 106428,
        "text": "<p><span style=\"font-size:14.0pt;\">C3 nephritic factor</span></p>"
      },
      {
        "id": 106429,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Hepatitis B surface antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old previously healthy man has noticed blood in his urine for the past 2 days Laboratory findings show a serum urea nitrogen level of 39 mg/dL and creatinine level of 4.1 mg/dL. A renal biopsy specimen is obtained; the immunofluorescence pattern of staining with antibody against human IgG is shown in the figure. Which of the following serologic findings is most likely to be present in this patient?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/13/picture11.jpg\" alt=\"\" width=\"300\" height=\"192\"></span></p>",
    "unique_key": "Q6219883",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634571,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Anti\u2013glomerular basement membrane antibody</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>immunofluorescence image</strong> demonstrates a <strong>linear pattern of IgG deposition along the glomerular basement membrane (GBM)</strong>. This finding is characteristic of <strong>Goodpasture Syndrome</strong>, which is caused by <strong>anti-glomerular basement membrane (anti-GBM) antibodies</strong> targeting <strong>type IV collagen (\u03b13 chain)</strong> in the <strong>kidney</strong> and <strong>lungs</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Features of Goodpasture Syndrome:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Linear IgG deposits on immunofluorescence.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Glomerulonephritis with rapidly progressive renal failure.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Pulmonary hemorrhage leading to hemoptysis (Goodpasture Syndrome).</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Serum anti-GBM antibodies targeting type IV collagen (\u03b13 chain).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Goodpasture syndrome is classified under <strong>Rapidly Progressive Glomerulonephritis (RPGN Type 1)</strong> and can lead to <strong>crescent formation</strong> on light microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anti\u2013streptolysin O antibody:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Seen in post-streptococcal glomerulonephritis (PSGN), which shows a granular \u201clumpy-bumpy\u201d pattern on immunofluorescence</strong> due to immune complex deposition.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Not associated with linear IgG deposits.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. C3 nephritic factor:</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Found in Membranoproliferative Glomerulonephritis (MPGN Type II or Dense Deposit Disease)</strong> due to <strong>alternative complement pathway activation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Immunofluorescence in MPGN II shows C3 deposition in an \"ribbon-like\" pattern, not linear IgG deposits.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hepatitis B surface antibody:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Associated with membranous nephropathy, which shows granular IgG and C3 deposits in a \"spike and dome\" pattern on silver stain.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Not linked to Goodpasture Syndrome.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Goodpasture Syndrome is an autoimmune disorder caused by anti-GBM antibodies targeting type IV collagen (\u03b13 chain), leading to glomerulonephritis and pulmonary hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">The hallmark of Goodpasture Syndrome is a linear IgG deposition pattern on immunofluorescence microscopy.</span></li><li><span style=\"font-size:14.0pt;\">Post-streptococcal glomerulonephritis (PSGN) shows a granular immune complex deposition, while MPGN and membranous nephropathy have distinct patterns on immunofluorescence.</span></li></ul>",
    "correct_choice_id": 106426,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73407,
    "choices": [
      {
        "id": 292577,
        "text": "<p><span style=\"font-size:14.0pt;\">NS1 Ag ELISA</span></p>"
      },
      {
        "id": 292578,
        "text": "<p><span style=\"font-size:14.0pt;\">Dengue RNA by PCR</span></p>"
      },
      {
        "id": 292579,
        "text": "<p><span style=\"font-size:14.0pt;\">Antibody detection by ELISA</span></p>"
      },
      {
        "id": 292580,
        "text": "<p><span style=\"font-size:14.0pt;\">Viral culture</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient presented with retro-orbital pain and rash since the 5 days. Most appropriate test to be done now is:</span></p>",
    "unique_key": "Q2028857",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634391,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Antibody detection by ELISA</strong></span></p>",
    "correct_choice_id": 292579,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 54504,
    "choices": [
      {
        "id": 217485,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-a, 3-d, 4-b</span></span></span></p>"
      },
      {
        "id": 217486,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-b, 2-c, 3-d,4-a</span></span></span></p>"
      },
      {
        "id": 217487,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-c, 2-b, 3-d, 4-a</span></span></span></p>"
      },
      {
        "id": 217488,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1-a,&nbsp; 2-b, 3-c, 4-d</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Match the following blood components with their shelf life:&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/screenshot-2024-08-23-123037.png\" style=\"height:278px; width:1000px\" /></span></span></span></p>",
    "unique_key": "Q8717299",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634527,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A)</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> 1-c, 2-a, 3-d, 4-b</span></strong></span></span></p>\r\n\r\n<p style=\"margin-left:96px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shelf life of blood components varies depending on their storage conditions and preservation methods. Here&#39;s a detailed explanation of the correct matches:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelets</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 5 days when stored with continuous agitation to prevent clumping. This is essential to maintain the efficacy and viability of the platelets.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Packed RBC</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 42 days when stored in a preservative solution containing saline, adenine, glucose, and mannitol (SAGM). This extends the shelf life while maintaining the quality of the red blood cells.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cryoprecipitate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 1 year when stored at temperatures below -18&deg;C. Cryoprecipitate is used for patients with clotting factor deficiencies, such as hemophilia A and von Willebrand disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Granulocytes concentrate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Shelf life is 24 hours. This component contains white blood cells and is used for patients with severe neutropenia, such as those with febrile neutropenia or aplastic anemia.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Single donor platelets have a shelf life of 5 days, packed RBCs 42 days, cryoprecipitate 1 year, and granulocytes concentrate 24 hours.</span></span></span></p>",
    "correct_choice_id": 217485,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73317,
    "choices": [
      {
        "id": 292221,
        "text": "<p><span style=\"font-size:14.0pt;\">Coccidioides</span></p>"
      },
      {
        "id": 292222,
        "text": "<p><span style=\"font-size:14.0pt;\">Paracoccidioides&nbsp;</span></p>"
      },
      {
        "id": 292223,
        "text": "<p><span style=\"font-size:14.0pt;\">Histoplasma&nbsp;</span></p>"
      },
      {
        "id": 292224,
        "text": "<p><span style=\"font-size:14.0pt;\">Blastomyces&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with painful lesions in the oral mucosa and enlarged lymph nodes. The microscopy of the patient's lymph node exudate shows the following appearance. What is the most likely causative agent?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XT6wjgu.png\" width=\"514\" height=\"478\"></span></p>",
    "unique_key": "Q9505562",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634467,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Paracoccidioides</strong></span></p>",
    "correct_choice_id": 292222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 44828,
    "choices": [
      {
        "id": 178959,
        "text": "<p><span style=\"font-size:12pt;\">Sevoflurane</span></p>"
      },
      {
        "id": 178960,
        "text": "<p><span style=\"font-size:12pt;\">Desflurane</span></p>"
      },
      {
        "id": 178961,
        "text": "<p><span style=\"font-size:12pt;\">Nitrous oxide</span></p>"
      },
      {
        "id": 178962,
        "text": "<p><span style=\"font-size:12pt;\">Isoflurane</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Inhalational anaesthetic agent of choice in children is</span>(INICET MAY 2024)</p>",
    "unique_key": "Q4227132",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633391,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Sevoflurane</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Sevoflurane is the inhalational anesthetic agent of choice in children. It has a rapid onset and offset, a pleasant smell, and causes minimal airway irritation, making it ideal for inhalational induction in pediatric patients. It also has a relatively low blood-gas partition coefficient, leading to quick recovery times.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>B.</strong>&nbsp;<strong>Desflurane</strong>: Desflurane is another potent inhalational anesthetic with a very low blood-gas partition coefficient, resulting in rapid induction and emergence from anesthesia. However, it can cause airway irritation and coughing, making it less suitable for children, particularly for inhalational induction.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Nitrous oxide</strong>: Nitrous oxide is commonly used as an adjunct to other anesthetic agents due to its analgesic properties and rapid onset. However, it is not used as the sole agent for induction of anesthesia because it is not potent enough to achieve surgical anesthesia on its own.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Isoflurane</strong>: Isoflurane is a potent inhalational anesthetic but has a pungent odor and can cause airway irritation. It is less commonly used for inhalational induction in children due to these properties.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, sevoflurane is preferred for pediatric anesthesia due to its favorable profile, including rapid onset and recovery, minimal airway irritation, and a pleasant smell, making it well-tolerated by children.</span></p>",
    "correct_choice_id": 178959,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 52120,
    "choices": [
      {
        "id": 207981,
        "text": "<p><span style=\"font-size:12.0pt;\">Trichuris trichura</span></p>"
      },
      {
        "id": 207982,
        "text": "<p><span style=\"font-size:12.0pt;\">Strongyloides stercoralis</span></p>"
      },
      {
        "id": 207983,
        "text": "<p><span style=\"font-size:12.0pt;\">Ancylostoma duodenale</span></p>"
      },
      {
        "id": 207984,
        "text": "<p><span style=\"font-size:12.0pt;\">Enterobius vermicularis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Parthenogenesis is seen in which of the following worm?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q7602546",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633818,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Strongyloides stercoralis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parthenogenesis is a form of asexual reproduction where the female organism is capable of producing offspring without the need for fertilization by a male. In the case of parasitic worms, this phenomenon is specifically seen in <strong>Strongyloides stercoralis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference Paragraph Explanation:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Strongyloides stercoralis:</strong> Strongyloides stercoralis is unique among the nematodes because it can reproduce through parthenogenesis. This means that the female worms can produce fertile eggs without mating with a male. In the human host, only female Strongyloides worms are found in the intestine, and they are capable of producing eggs or larvae without male fertilization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oviparous, Viviparous, and Oviviparous Nematodes:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Oviparous:</strong> These worms lay eggs which then develop outside the female\u2019s body. Examples include Ascaris and Trichuris.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Viviparous:</strong> These worms give birth to live larvae. Examples include some species of Dracunculus and Wuchereria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oviviparous:</strong> These worms lay eggs that hatch immediately as they are laid, producing larvae. Strongyloides stercoralis is an example, as the eggs hatch into larvae almost immediately after being laid.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Trichuris trichura:</strong> This worm is oviparous, meaning it lays eggs that develop and hatch outside the female\u2019s body. It does not reproduce via parthenogenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ancylostoma duodenale:</strong> This is also an oviparous worm. It lays eggs that develop in the external environment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Enterobius vermicularis:</strong> Commonly known as pinworm, it is also oviparous, laying eggs that hatch outside the body. It does not reproduce via parthenogenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Parthenogenesis, where a female worm can produce offspring without male fertilization, is a unique reproductive strategy seen in Strongyloides stercoralis. This worm is also oviviparous, laying eggs that hatch almost immediately.</span></p>",
    "correct_choice_id": 207982,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 74158,
    "choices": [
      {
        "id": 295561,
        "text": "<p><span style=\"font-size:14.0pt;\">Competitive</span></p>"
      },
      {
        "id": 295562,
        "text": "<p><span style=\"font-size:14.0pt;\">Non-competitive</span></p>"
      },
      {
        "id": 295563,
        "text": "<p><span style=\"font-size:14.0pt;\">Un-competitive</span></p>"
      },
      {
        "id": 295564,
        "text": "<p><span style=\"font-size:14.0pt;\">Mixed</span> <span style=\"font-size:14.0pt;\">Inhibition</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the type of inhibition from the given graph:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_oq1Tr8V.png\" width=\"653\" height=\"399\"></span></p>",
    "unique_key": "Q7468870",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633405,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Mixed Inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the given Lineweaver-Burk plot:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Both the slope and Y-intercept are different</strong>, indicating that&nbsp;<strong>Vmax is decreased</strong>&nbsp;(since Y-intercept = 1/Vmax).</span></li><li><span style=\"font-size:14.0pt;\"><strong>The X-intercept is also altered</strong>, indicating that&nbsp;<strong>Km may increase or decrease</strong>&nbsp;depending on whether the inhibitor favors binding to the free enzyme or the enzyme-substrate complex.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These findings are characteristic of&nbsp;<strong>mixed inhibition</strong>, where the inhibitor can bind to both the free enzyme and the enzyme-substrate complex, but with different affinities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, the correct answer is&nbsp;<strong>(D) Mixed Inhibition.</strong></span></p>",
    "correct_choice_id": 295564,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 31806,
    "choices": [
      {
        "id": 127094,
        "text": "<p><span style=\"font-size:12pt;\">Aprepitant</span></p>"
      },
      {
        "id": 127095,
        "text": "<p><span style=\"font-size:12pt;\">Dexrazoxane</span></p>"
      },
      {
        "id": 127096,
        "text": "<p><span style=\"font-size:12pt;\">Amifostine</span></p>"
      },
      {
        "id": 127097,
        "text": "<p><span style=\"font-size:12pt;\">Dexamethasone</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which drug is used to prevent cardiotoxicity induced by daunorubicin? (INICET NOV 2023)</span></p>",
    "unique_key": "Q9019875",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633377,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Dexrazoxane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dexrazoxane is an iron-chelating agent used specifically to prevent cardiotoxicity associated with anthracycline chemotherapy agents like daunorubicin. It protects the heart by reducing the formation of free radicals that can damage cardiac tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aprepitant:</strong> Aprepitant is utilized to prevent nausea and vomiting caused by chemotherapy. It works as a neurokinin-1 receptor antagonist but does not have a role in preventing cardiotoxicity from chemotherapeutic drugs.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Amifostine:</strong> Amifostine is a cytoprotective agent that offers protection against the toxic effects of chemotherapy and radiation therapy on normal tissues, particularly for kidneys and salivary glands, but it is not indicated for the prevention of cardiotoxicity from daunorubicin.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dexamethasone:</strong> Dexamethasone is a corticosteroid used for its anti-inflammatory and immunosuppressive effects. In oncology, it is often used to prevent chemotherapy-induced nausea and vomiting and to treat certain cancer-related conditions, but it is not used to prevent daunorubicin-induced cardiotoxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Dexrazoxane is specifically used to prevent cardiotoxicity induced by anthracycline chemotherapy agents such as daunorubicin by reducing free radical formation and oxidative stress on the heart.</span></p>",
    "correct_choice_id": 127095,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 31811,
    "choices": [
      {
        "id": 127114,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oprelvekin </span></span></p>"
      },
      {
        "id": 127115,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fostamatinib </span></span></p>"
      },
      {
        "id": 127116,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Eltrombopag </span></span></p>"
      },
      {
        "id": 127117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Bosutinib</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old patient presents with widespread purpura and easy bruising. Laboratory tests reveal a significantly low platelet count with normal hemoglobin and white blood cell count, indicating a diagnosis of isolated thrombocytopenia. The patient has no prior history of autoimmune disorders or recent viral infections. Considering these symptoms and diagnosis, which tyrosine kinase inhibitor would be appropriate for this patient? (INICET NOV 2023)</span></span></p>",
    "unique_key": "Q8292950",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633379,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans B) Fostamatinib.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fostamatinib is the suitable choice in this case. It is a tyrosine kinase inhibitor used specifically for the treatment of chronic immune thrombocytopenia (ITP), a condition characterized by isolated thrombocytopenia, which manifests as low platelet counts leading to symptoms like purpura and easy bruising. It operates by inhibiting spleen tyrosine kinase (Syk), thereby reducing the destruction of platelets and helping to increase the platelet count.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Oprelvekin:</strong> Oprelvekin is not a tyrosine kinase inhibitor; it is a thrombopoietic growth factor used to increase platelet production, particularly in cases of chemotherapy-induced thrombocytopenia, rather than isolated thrombocytopenia without a clear underlying cause.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Eltrombopag:</strong> Eltrombopag is a thrombopoietin receptor agonist, not a tyrosine kinase inhibitor. It is used to treat thrombocytopenia, including ITP, but through a different mechanism - stimulating platelet production in the bone marrow.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Bosutinib:</strong> Bosutinib is a tyrosine kinase inhibitor; however, its primary use is in treating chronic myelogenous leukemia (CML), not isolated thrombocytopenia or ITP. It targets the BCR-ABL tyrosine kinase, which is not involved in the pathology of ITP.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fostamatinib is a tyrosine kinase inhibitor specifically used for treating chronic immune thrombocytopenia (ITP) by inhibiting spleen tyrosine kinase (Syk) to reduce platelet destruction and increase platelet count.</span></span></p>",
    "correct_choice_id": 127115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 52130,
    "choices": [
      {
        "id": 208021,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Opisthorchis </span></span></span></p>"
      },
      {
        "id": 208022,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary sclerosing cholangitis </span></span></span></p>"
      },
      {
        "id": 208023,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Caroli&#39;s disease </span></span></span></p>"
      },
      {
        "id": 208024,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis B</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholangiocarcinoma is not a complication of?&nbsp;</span></span>&nbsp;(INICET MAY 2024)</p>",
    "unique_key": "Q1168113",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633823,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Hepatitis B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cholangiocarcinoma is a cancer that forms in the bile ducts. It is associated with various risk factors and conditions, but Hepatitis B is not directly linked to its development. Hepatitis B virus (HBV) is primarily associated with hepatocellular carcinoma, which is a different type of liver cancer. The other options listed are known risk factors for cholangiocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Opisthorchis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This parasitic infection is a known risk factor for cholangiocarcinoma.&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Primary sclerosing cholangitis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This chronic liver disease involving inflammation and scarring of the bile ducts is a significant risk factor for developing cholangiocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Caroli&#39;s disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This congenital disorder characterized by cystic dilatation of intrahepatic bile ducts increases the risk of cholangiocarcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatitis B virus primarily causes hepatocellular carcinoma, not cholangiocarcinoma, unlike other liver conditions such as parasitic infections, primary sclerosing cholangitis, and Caroli&#39;s disease.</span></span></span></p>",
    "correct_choice_id": 208024,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 29339,
    "choices": [
      {
        "id": 117262,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium oxalate</span></p>"
      },
      {
        "id": 117263,
        "text": "<p><span style=\"font-size:14.0pt;\">Calcium phosphate</span></p>"
      },
      {
        "id": 117264,
        "text": "<p><span style=\"font-size:14.0pt;\">Magnesium ammonium phosphate&nbsp;</span></p>"
      },
      {
        "id": 117265,
        "text": "<p><span style=\"font-size:14.0pt;\">Cystine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A 35-year-old male presents with severe flank pain that radiates to the groin. He describes the pain as sudden and excruciating. Laboratory tests reveal hematuria, and imaging shows a 5mm stone located at the ureteropelvic junction of the right kidney. The patient's urine pH is 7.5. What type of kidney stone is most likely causing his symptoms?</span></p>",
    "unique_key": "Q7195125",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634558,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Magnesium ammonium phosphate&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The key clues in this case are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Urine pH of 7.5</strong>: Alkaline urine is highly suggestive of <strong>Magnesium ammonium phosphate (struvite) stones</strong>, as these stones form in the presence of alkaline pH.</span></li><li><span style=\"font-size:14.0pt;\"><strong>5mm stone at the ureteropelvic junction</strong>: Typical presentation of a kidney stone causing <strong>renal colic</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hematuria</strong>: A common finding in urinary stones.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Struvite stones</strong> are associated with urinary tract infections caused by <strong>urease-producing bacteria</strong> (e.g., <i>Proteus</i>, <i>Klebsiella</i>), which alkalinize the urine by splitting urea into ammonia. This environment promotes the precipitation of magnesium ammonium phosphate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Calcium oxalate:&nbsp;</strong>Calcium oxalate stones are the most common type of kidney stones and can form in a wide range of urine pH levels. However, they are not specifically associated with alkaline urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Calcium phosphate:&nbsp;</strong>Calcium phosphate stones can form in alkaline urine, but they are less common than struvite stones in this clinical context, especially with the history of infection-related stone formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cystine:&nbsp;</strong>Cystine stones are rare and occur in patients with <strong>cystinuria</strong>, a genetic disorder. They are associated with acidic urine, not alkaline urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Magnesium ammonium phosphate (struvite) stones</strong> form in <strong>alkaline urine</strong> due to <strong>urease-producing bacterial infections</strong>.</span></li></ul>",
    "correct_choice_id": 117264,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 52118,
    "choices": [
      {
        "id": 207973,
        "text": "<p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae</span></p>"
      },
      {
        "id": 207974,
        "text": "<p><span style=\"font-size:12.0pt;\">Chlamydia</span></p>"
      },
      {
        "id": 207975,
        "text": "<p><span style=\"font-size:12.0pt;\">Chancroid</span></p>"
      },
      {
        "id": 207976,
        "text": "<p><span style=\"font-size:12.0pt;\">Syphilis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents with swollen Bartholin glands. Discharging pus showed Gram-negative intracellular diplococci. Which is the organism?</span>(INICET MAY 2024)</p>",
    "unique_key": "Q4434298",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633817,
    "difficulty_level": "beginner",
    "subjects_id": [
      6
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Neisseria gonorrhoeae</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae is a Gram-negative diplococcus that is often found intracellularly within neutrophils. It is a common cause of sexually transmitted infections, including infections of the Bartholin glands. The typical presentation includes swelling and pus discharge, which is consistent with the given clinical scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae is characterized by its kidney or bean shape and lack of a capsule, unlike Neisseria meningitidis, which is capsulated. It is known for causing sexually transmitted infections, including those affecting the genital tract, such as Bartholin gland abscesses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Chlamydia:</strong> Although Chlamydia can cause genital infections, it is not a Gram-negative diplococcus. Instead, it is an obligate intracellular bacterium with a unique developmental cycle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chancroid:</strong> Caused by Haemophilus ducreyi, chancroid is a Gram-negative bacillus and not a diplococcus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Syphilis:</strong> Caused by Treponema pallidum, a spirochete, which is not a Gram-negative diplococcus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neisseria gonorrhoeae, a Gram-negative intracellular diplococcus, is the causative agent of gonorrhea and can infect the Bartholin glands, leading to swelling and pus discharge.</span></p>",
    "correct_choice_id": 207973,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 31817,
    "choices": [
      {
        "id": 127138,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A</span></span></p>"
      },
      {
        "id": 127139,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B</span></span></p>"
      },
      {
        "id": 127140,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C</span></span></p>"
      },
      {
        "id": 127141,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the figure shown below, mechanism of action of valproate is best represented by:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/1.jpg\" style=\"height:302px; width:400px\" /></span></span></p>",
    "unique_key": "Q7047263",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633380,
    "difficulty_level": "difficult",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) A</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mechanisms of Action of Sodium Valproate</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Enhancement of GABA Activity:</strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases the levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This is achieved primarily by stimulating the enzyme glutamic acid decarboxylase that helps in formation of GABA from glutamic acid. Valproate also acts by inhibiting GABA transaminase, the enzyme responsible for GABA breakdown, leading to increased GABA availability.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of Voltage-Gated Sodium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate modulates voltage-gated sodium channels in the neurons. By prolonging the recovery of these channels from inactivation, valproate reduces the high-frequency repetitive firing of action potentials.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of T-Type Calcium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate also affects T-type calcium channels, particularly in thalamic neurons. By inhibiting these channels, it reduces the rhythmic cortical discharges that are often seen in absence seizures.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> B represents the mechanism of action of drugs like gabapentin and pregabalin. These act by increasing the release of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> C represents the mechanism of action of tiagabine. It acts by inhibiting the reuptake of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> D is site of action of benzodiazepines like diazepam and lorazepam.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases GABA levels by stimulating the enzyme GAD (glutamic acid decarboxylase) to convert glutamate into GABA and by inhibiting GABA transaminase, preventing the breakdown of GABA.</span></span></p>",
    "correct_choice_id": 127138,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "INICET"
    ]
  },
  {
    "id": 54507,
    "choices": [
      {
        "id": 217497,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 217498,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2 and 3</span></p>"
      },
      {
        "id": 217499,
        "text": "<p><span style=\"font-size:12.0pt;\">1,3 and 4</span></p>"
      },
      {
        "id": 217500,
        "text": "<p><span style=\"font-size:12.0pt;\">1,2,3,4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a feature of delayed blood transfusion reaction?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><ol><li><span style=\"font-size:12.0pt;\">Increased unconjugated bilirubin</span></li><li><span style=\"font-size:12.0pt;\">Cola colored urine after 2 hours</span></li><li><span style=\"font-size:12.0pt;\">Increased LDH</span></li><li><span style=\"font-size:12.0pt;\">Failure of rise of hemoglobin after transfusion</span></li></ol>",
    "unique_key": "Q6089513",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634528,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delayed blood transfusion reactions typically occur more than 24 hours after the initiation of a blood transfusion. These reactions can result from various immune-mediated processes, often involving the destruction of transfused red blood cells. The features of delayed blood transfusion reactions include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased unconjugated bilirubin</strong>: This occurs due to hemolysis, where the breakdown of red blood cells releases hemoglobin that is converted into unconjugated bilirubin.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Increased LDH (Lactate Dehydrogenase)</strong>: LDH is an enzyme found in many tissues, including red blood cells. When red blood cells are destroyed, LDH levels in the blood increase.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Failure of rise of hemoglobin after transfusion</strong>: Despite the transfusion, the hemoglobin level does not increase as expected because the transfused red blood cells are being destroyed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Incorrect Statement&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2 Cola colored urine after 2 hours</strong>: Cola-colored urine shortly after transfusion is indicative of an acute hemolytic transfusion reaction, not a delayed reaction. Delayed hemolytic reactions typically present with cola-colored urine after several days, not within 2 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Delayed blood transfusion reactions occur more than 24 hours after transfusion and are characterized by increased unconjugated bilirubin, increased LDH, and failure of hemoglobin levels to rise. Immediate cola-colored urine indicates an acute reaction, not a delayed one.</span></p>",
    "correct_choice_id": 217499,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 33863,
    "choices": [
      {
        "id": 135290,
        "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
      },
      {
        "id": 135291,
        "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
      },
      {
        "id": 135292,
        "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin</span></p>"
      },
      {
        "id": 135293,
        "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 53-year-old male presented with type 2 diabetes mellitus. Which of the following anti-diabetic drug acts by causing glucosuria?</span> <span style=\"font-size:12.0pt;\">(Fmge Jan 2024)</span></p>",
    "unique_key": "Q8481318",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633425,
    "difficulty_level": "beginner",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Empagliflozin</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Empagliflozin, as an SGLT2 inhibitor, is the drug among the options provided that acts specifically by causing glucosuria. This mechanism is unique to SGLT2 inhibitors and is a direct way of lowering blood glucose levels in type 2 diabetes mellitus. The other drugs listed work through different mechanisms that do not involve the induction of glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>Acarbose:</strong> This drug is an alpha-glucosidase inhibitor. It works by slowing down the digestion of carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Glipizide:</strong> Glipizide is a sulfonylurea. It works by stimulating insulin release from the pancreatic beta cells. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Sitagliptin:</strong> Sitagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones, which increase insulin release and decrease glucagon release in a glucose-dependent manner. It does not cause glucosuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Empagliflozin is an SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitor, works by blocking glucose reabsorption in the kidney, leading to increased glucose excretion in the urine, i.e., glucosuria.</span></p>",
    "correct_choice_id": 135292,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "FMGE",
      "TreatmentBased"
    ]
  },
  {
    "id": 29315,
    "choices": [
      {
        "id": 117166,
        "text": "<p><span style=\"font-size:14.0pt;\">Hyperuricemia</span></p>"
      },
      {
        "id": 117167,
        "text": "<p><span style=\"font-size:14.0pt;\">Hyperkalemia</span></p>"
      },
      {
        "id": 117168,
        "text": "<p><span style=\"font-size:14.0pt;\">Hyperphosphatemia</span></p>"
      },
      {
        "id": 117169,
        "text": "<p><span style=\"font-size:14.0pt;\">Hypercalcemia</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">A known patient of Burkitt lymphoma undergoes chemotherapy following which he develops tumor lysis syndrome. All of the following may be seen with tumor lysis syndrome except:</span></p>",
    "unique_key": "Q1005939",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634546,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Hypercalcemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tumor Lysis Syndrome (TLS)</strong> occurs when a large number of tumor cells are destroyed in a short span of time, typically following chemotherapy or radiation therapy in rapidly growing cancers like <strong>Burkitt lymphoma</strong>.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>D.</strong> <strong>Hypocalcemia (not hypercalcemia)</strong>: Phosphate binds to calcium, forming calcium-phosphate complexes and lowering the serum calcium level. Therefore, <strong>hypercalcemia is not a feature</strong> of tumor lysis syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyperuricemia:&nbsp;</strong>True. Uric acid levels increase due to the breakdown of nucleic acids released from dying tumor cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hyperkalemia:&nbsp;</strong>True. Potassium released from lysed cells causes hyperkalemia, which may lead to cardiac arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hyperphosphatemia:&nbsp;</strong>True. Phosphate released from tumor cells contributes to hyperphosphatemia, which can also result in calcium-phosphate precipitation and renal damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Tumor Lysis Syndrome</strong> is characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperuricemia</strong>, <strong>hyperkalemia</strong>, <strong>hyperphosphatemia</strong>, and <strong>hypocalcemia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with rapidly growing tumors like <strong>Burkitt lymphoma</strong> and can cause renal failure, cardiac arrhythmias, and seizures.</span></li><li><span style=\"font-size:14.0pt;\">Prevention includes <strong>adequate IV hydration</strong> and administration of <strong>rasburicase</strong> (recombinant uricase) or <strong>allopurinol</strong> to reduce uric acid levels.</span></li><li><span style=\"font-size:14.0pt;\">Tumor lysis syndrome is associated with Burkitt lymphoma, acute lymphoblastic leukemia (ALL), chronic tumors (CLL) and uncommonly solid tumors.</span></li><li><span style=\"font-size:14.0pt;\">It is associated with hypocalcemia and not hypercalcemia.&nbsp;</span></li></ul>",
    "correct_choice_id": 117169,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73418,
    "choices": [
      {
        "id": 292621,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxidase and catalase negative, does not ferment inulin</span></p>"
      },
      {
        "id": 292622,
        "text": "<p><span style=\"font-size:14.0pt;\">Ferments glucose and maltose but not inulin</span></p>"
      },
      {
        "id": 292623,
        "text": "<p><span style=\"font-size:14.0pt;\">Oxidase and catalase positive and does not ferment maltose or glucose</span></p>"
      },
      {
        "id": 292624,
        "text": "<p><span style=\"font-size:14.0pt;\">Catalase negative, optochin sensitive</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient presented with meningitis, and the CSF sample was subjected to gram staining and microscopy and appears as shown in the microscopic image given below. Which of the following features will be characteristic of the organism?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20174730.jpg\" width=\"500\" height=\"344\"></span></p>",
    "unique_key": "Q3702928",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634394,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Catalase negative, optochin sensitive</strong></span></p>",
    "correct_choice_id": 292624,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73396,
    "choices": [
      {
        "id": 292533,
        "text": "<p><span style=\"font-size:14.0pt;\">3 days of antibiotic therapy&nbsp;</span></p>"
      },
      {
        "id": 292534,
        "text": "<p><span style=\"font-size:14.0pt;\">7 days of antibiotic therapy&nbsp;</span></p>"
      },
      {
        "id": 292535,
        "text": "<p><span style=\"font-size:14.0pt;\">12 days of antibiotic therapy</span></p>"
      },
      {
        "id": 292536,
        "text": "<p><span style=\"font-size:14.0pt;\">Clinical symptoms resolution&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">You would recommend isolation of the patient of cholera until:</span></p>",
    "unique_key": "Q9134448",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634388,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 3 days of antibiotic therapy&nbsp;</strong></span></p>",
    "correct_choice_id": 292533,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74182,
    "choices": [
      {
        "id": 295657,
        "text": "<p><span style=\"font-size:14.0pt;\">Reassure the patient that it will settle in a few days</span></p>"
      },
      {
        "id": 295658,
        "text": "<p><span style=\"font-size:14.0pt;\">Increase the dose of antipsychotic</span></p>"
      },
      {
        "id": 295659,
        "text": "<p><span style=\"font-size:14.0pt;\">Propranolol</span></p>"
      },
      {
        "id": 295660,
        "text": "<p><span style=\"font-size:14.0pt;\">Benzhexol (Trihexyphenidyl)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old male with a history of&nbsp;bronchial asthma&nbsp;was recently started on an&nbsp;antipsychotic&nbsp;for schizophrenia. After a few days, he complains of&nbsp;severe restlessness, inability to sit still, and a strong urge to move his legs constantly, making it difficult for him to focus on daily activities. Which of the following is the most appropriate management for this patient?</span></p>",
    "unique_key": "Q3794591",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633418,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Benzhexol (Trihexyphenidyl)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Drug-induced akathisia</strong>&nbsp;is an extrapyramidal side effect (EPS) caused by&nbsp;<strong>antipsychotics</strong>, characterized by:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inner restlessness</span></li><li><span style=\"font-size:14.0pt;\">Inability to sit still</span></li><li><span style=\"font-size:14.0pt;\">Constant leg movement, pacing</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of Akathisia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>First-line:</strong>&nbsp;<strong>Beta-blockers (e.g., Propranolol)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Alternative:</strong>&nbsp;<strong>Anticholinergics (e.g., Benzhexol/Trihexyphenidyl)</strong>&nbsp;\u2013 especially preferred&nbsp;<strong>in asthma patients</strong>where beta-blockers are contraindicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong>&nbsp;<strong>Reassure the patient:</strong> Akathisia does not improve on its own and requires active treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong>&nbsp;<strong>Increase the dose of antipsychotic:</strong>&nbsp;<strong>Worsens akathisia</strong>&nbsp;instead of treating it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong>&nbsp;<strong>Propranolol: </strong>First-line for akathisia, but contraindicated in&nbsp;<strong>asthma</strong>&nbsp;due to risk of bronchospasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Propranolol is the first-line treatment for akathisia, but in asthma patients, benzhexol (Trihexyphenidyl) is preferred.</span></p>",
    "correct_choice_id": 295660,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73404,
    "choices": [
      {
        "id": 292565,
        "text": "<p><span style=\"font-size:14.0pt;\">CRISPR-Cas9</span></p>"
      },
      {
        "id": 292566,
        "text": "<p><span style=\"font-size:14.0pt;\">S1 nuclease</span></p>"
      },
      {
        "id": 292567,
        "text": "<p><span style=\"font-size:14.0pt;\">Primase</span></p>"
      },
      {
        "id": 292568,
        "text": "<p><span style=\"font-size:14.0pt;\">Telomerase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following acts as an RNA-directed nuclease?</span></p>",
    "unique_key": "Q9667354",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634390,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) CRISPR-Cas9&nbsp;</strong></span></p>",
    "correct_choice_id": 292565,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73321,
    "choices": [
      {
        "id": 292237,
        "text": "<p><span style=\"font-size:14.0pt;\">Patient needs to wear a triple layer mask during isolation.&nbsp;</span></p>"
      },
      {
        "id": 292238,
        "text": "<p><span style=\"font-size:14.0pt;\">Contact monitoring must be done for a period of 21 days from day of contact.&nbsp;</span></p>"
      },
      {
        "id": 292239,
        "text": "<p><span style=\"font-size:14.0pt;\">Requires BSL-4 facilities for isolation&nbsp;</span></p>"
      },
      {
        "id": 292240,
        "text": "<p><span style=\"font-size:14.0pt;\">It is caused by an enveloped, double-stranded DNA virus.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding monkey pox is false?</span></p>",
    "unique_key": "Q2289426",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634375,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Requires BSL-4 facilities for isolation&nbsp;</strong></span></p>",
    "correct_choice_id": 292239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26613,
    "choices": [
      {
        "id": 106394,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased serum calcitonin</span></p>"
      },
      {
        "id": 106395,
        "text": "<p><span style=\"font-size:14.0pt;\">High anti-thyroid peroxidase antibody titre</span></p>"
      },
      {
        "id": 106396,
        "text": "<p><span style=\"font-size:14.0pt;\">Increased serum parathormone</span></p>"
      },
      {
        "id": 106397,
        "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Positive antinuclear antibody test</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 40-year-old woman has noted painless enlargement of her neck for the past month. On physical examination she has diffuse, symmetrical thyroid enlargement without tenderness on palpation. Laboratory studies show her serum TSH is elevated but serum thyroxine is lower side of normal limits. Her microscopic examination is shown here. Which of the following laboratory test findings is she most likely to have?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/13/picture3.jpg\" alt=\"\" width=\"300\" height=\"222\"></span></p>",
    "unique_key": "Q3411456",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634567,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) High anti-thyroid peroxidase antibody titre</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The patient's <strong>diffuse, painless thyroid enlargement</strong>, <strong>elevated TSH with low-normal thyroxine</strong>, and <strong>histopathological findings of lymphocytic infiltration with germinal centers</strong> are characteristic of <strong>Hashimoto\u2019s thyroiditis</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hashimoto\u2019s thyroiditis</strong> is an <strong>autoimmune disorder</strong> where <strong>autoantibodies (anti-TPO, anti-thyroglobulin) attack the thyroid gland</strong>, leading to <strong>progressive hypothyroidism</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The hallmark <strong>laboratory finding</strong> in Hashimoto\u2019s thyroiditis is <strong>high titers of anti-thyroid peroxidase (anti-TPO) antibodies</strong>, which are present in <strong>&gt;90% of cases</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Over time, the destruction of thyroid follicles results in <strong>fibrosis and atrophy</strong>, leading to <strong>permanent hypothyroidism</strong>, requiring <strong>lifelong levothyroxine replacement therapy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Increased serum calcitonin:</strong> <strong>Elevated calcitonin</strong> is seen in <strong>medullary thyroid carcinoma (MTC)</strong>, which is associated with <strong>C-cell hyperplasia and RET proto-oncogene mutations</strong>, <strong>not Hashimoto\u2019s thyroiditis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Increased serum parathormone: Parathyroid hormone (PTH) increases in primary hyperparathyroidism</strong>, which is unrelated to Hashimoto\u2019s thyroiditis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Positive antinuclear antibody test:</strong> While <strong>autoimmune thyroid disorders can be associated with ANA positivity</strong>, it is <strong>not a specific diagnostic marker for Hashimoto\u2019s thyroiditis</strong>. ANA is <strong>more commonly used for diagnosing systemic autoimmune diseases like lupus (SLE).</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hashimoto\u2019s thyroiditis is an autoimmune disorder characterized by high anti-TPO antibody titers and lymphocytic infiltration with germinal center formation.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>It leads to hypothyroidism with elevated TSH and low-normal/free T4 levels.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Levothyroxine is the treatment of choice.</strong></span></li></ul>",
    "correct_choice_id": 106395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 35225,
    "choices": [
      {
        "id": 140711,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir </span></span></span></span></p>"
      },
      {
        "id": 140712,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nevirapine</span></span></span></span></p>"
      },
      {
        "id": 140713,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saquinavir</span></span></span></span></p>"
      },
      {
        "id": 140714,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enfuvirtide</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male patient presents to the clinic with a 3-month history of fever, night sweats, and unintentional weight loss. On further investigation, he is diagnosed with HIV infection. The patient&#39;s CD4 count is 150 cells/mm&sup3;, and his viral load is high. The attending doctor explains to the patient that antiretroviral therapy (ART) is necessary to control his HIV infection and prevent the progression to AIDS. He prescribes a combination of ART drugs, including a protease inhibitor. Which of the following is a protease inhibitor?</span></span></span></span></p>",
    "unique_key": "Q5478244",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633807,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Saquinavir </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The names of all HIV protease inhibitors end with &lsquo;NAVIR&rsquo; e.g., saquinavir, atazanavir etc.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-retroviral Drugs</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-181723.jpg\" style=\"height:779px; width:543px\" /></span></span></strong></span></span></p>",
    "correct_choice_id": 140713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35941,
    "choices": [
      {
        "id": 143559,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Quick relief of symptoms</span></span></span></p>"
      },
      {
        "id": 143560,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To increase the metabolism of thyroxine</span></span></span></p>"
      },
      {
        "id": 143561,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To blockade the thyroxine receptors</span></span></span></p>"
      },
      {
        "id": 143562,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To decrease the synthesis of thyroxine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid storm is a medical emergency in which there is excessive secretion of thyroid hormones. Beta blockers like propranolol are commonly used in a patient of thyroid storm. What is the most important role of beta blockers in these patients?</span></span></p>",
    "unique_key": "Q7655203",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633803,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Quick relief of symptoms </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">THYROID STORM (THYROTOXIC CRISIS)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an emergency due to decompensated hyperthyroidism.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment includes:</span></strong></span></span>\r\n\t<ol>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Non-selective &beta;-blocker:</span></strong></span></span>\r\n\t\t<ul>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the most valuable measure in thyroid storm. </span></span></span></li>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In thyroid storm, most of the symptoms are because of adrenergic overactivity. This occurs due to increased tissue sensitivity to catecholamines (resulting from upregulation of &beta;-receptors) in hyperthyroidism. So, quick relief can be obtained by blocking &beta;-receptors. </span></span></span></li>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propranolol is a lifesaving drug in thyroid storm. It not only reverses the symptoms but also decreases the peripheral conversion of T4 to T3.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium channel blockers like diltiazem may be added if tachycardia is not controlled by propranolol alone.</span></span></span></li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propylthiouracil:</span></strong></span></span>\r\n\t\t<ul>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the anti-thyroid drug of choice for thyroid storm because it reduces hormone synthesis as well as peripheral conversion of T4 to T3.</span></span></span></li>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Note</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Propylthiouracil is the DOC amongst anti-thyroid drugs, but the DOC for thyroid storm is &beta;-blockers.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroid (Hydrocortisone):</span></strong></span></span>\r\n\t\t<ul>\r\n\t\t\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It inhibits both release of thyroid hormone from the gland and peripheral conversion of T4 to T3.</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ol>\r\n\t</li>\r\n</ul>",
    "correct_choice_id": 143559,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74170,
    "choices": [
      {
        "id": 295609,
        "text": "<p><span style=\"font-size:14.0pt;\">Strontium ranelate</span></p>"
      },
      {
        "id": 295610,
        "text": "<p><span style=\"font-size:14.0pt;\">Ibandronate</span></p>"
      },
      {
        "id": 295611,
        "text": "<p><span style=\"font-size:14.0pt;\">Teriparatide</span></p>"
      },
      {
        "id": 295612,
        "text": "<p><span style=\"font-size:14.0pt;\">Denosumab</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;65-year-old postmenopausal woman&nbsp;with&nbsp;osteoporosis and a history of multiple fractures&nbsp;is prescribed a medication that&nbsp;acts without inhibiting osteoclast function. Which of the following drugs fits this mechanism of action?</span></p>",
    "unique_key": "Q8395219",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633411,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>C) Teriparatide</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Teriparatide</strong>&nbsp;is a&nbsp;<strong>recombinant parathyroid hormone (PTH) analog</strong>&nbsp;that primarily&nbsp;<strong>activates osteoblasts</strong>&nbsp;to promote bone formation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike&nbsp;<strong>bisphosphonates, denosumab, or strontium ranelate, which inhibit osteoclasts</strong>, teriparatide&nbsp;<strong>does not inhibit osteoclast function</strong>, allowing balanced bone remodeling.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Works without inhibiting osteoclasts</strong>, instead&nbsp;<strong>promoting bone formation via osteoblast activation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Strontium ranelate:</strong>&nbsp;<strong>Inhibits osteoclasts and stimulates osteoblasts</strong>, but still has an anti-resorptive effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ibandronate:</strong> A&nbsp;<strong>bisphosphonate that inhibits osteoclast-mediated bone resorption</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Denosumab:&nbsp;</strong>A&nbsp;<strong>RANKL inhibitor</strong>&nbsp;that&nbsp;<strong>blocks osteoclast differentiation and function</strong>, leading to decreased bone resorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Teriparatide (PTH analog) is the only option that acts without directly inhibiting osteoclasts, making it suitable for osteoporosis treatment when bone formation needs to be enhanced.</span></p>",
    "correct_choice_id": 295611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 55067,
    "choices": [
      {
        "id": 219729,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD59</span></span></p>"
      },
      {
        "id": 219730,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C5 convertase</span></span></p>"
      },
      {
        "id": 219731,
        "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C1 inhibitor</span></span></p>"
      },
      {
        "id": 219732,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Decay accelerating factor</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to the emergency department with recurrent episodes of severe, non-pitting facial swelling and abdominal pain. She reports that these episodes often occur spontaneously or after minor trauma. There is no associated urticaria or pruritus. Her father and sister have experienced similar symptoms. Laboratory testing reveals low levels of C4 during an acute attack. Which of the following protein deficiencies is most likely responsible for her condition? </span></span></p>",
    "unique_key": "Q1668208",
    "question_audio": null,
    "question_video": null,
    "map_id": 34664906,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Ans. C) C1 inhibitor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling (angioedema) in various parts of the body, including the face, extremities, gastrointestinal tract, and airways. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">The condition is most commonly caused by a deficiency or dysfunction of C1 inhibitor (C1-INH), a protein that regulates the complement and contact systems.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">C1-INH deficiency leads to uncontrolled activation of the complement system, resulting in increased production of bradykinin, which causes the angioedema.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">This condition typically presents without urticaria, and C4 levels are often low during attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option A. CD59</span></strong><span style=\"font-size:14.0pt\">: CD59, also known as protectin, is a protein that inhibits the formation of the membrane attack complex (MAC) in the complement pathway. Deficiency in CD59 is associated with paroxysmal nocturnal hemoglobinuria (PNH), not hereditary angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option B. C5 convertase</span></strong><span style=\"font-size:14.0pt\">: C5 convertase is an enzyme complex in the complement cascade that cleaves C5 into C5a and C5b. Deficiency or dysfunction in this enzyme would not cause hereditary angioedema but could impair the formation of the MAC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:14.0pt\">Option D. Decay accelerating factor</span></strong><span style=\"font-size:14.0pt\">: Decay accelerating factor (DAF) is a protein that regulates the complement system by accelerating the decay of C3/C5 convertases. Deficiency in DAF is associated with PNH, not hereditary angioedema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:14.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">Hereditary angioedema is most commonly caused by a deficiency or dysfunction of C1 inhibitor (C1-INH), leading to episodes of severe swelling without urticaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:14.0pt\">&nbsp;This condition involves abnormal complement system activation, particularly affecting the regulation of bradykinin, which leads to angioedema.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 219731,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 6514,
    "choices": [
      {
        "id": 26025,
        "text": "<p><span style=\"font-size:12.0pt;\">Potassium chloride</span></p>"
      },
      {
        "id": 26026,
        "text": "<p><span style=\"font-size:12.0pt;\">Clarithromycin</span></p>"
      },
      {
        "id": 26027,
        "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
      },
      {
        "id": 26028,
        "text": "<p><span style=\"font-size:12.0pt;\">Triamterene</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male patient was diagnosed with atrial fibrillation with a controlled ventricular rate. The medication charts reveal that he was taking digoxin, potassium chloride, clarithromycin, atenolol, and triamterene. Suspecting the symptoms to be due to digoxin overdose, plasma levels of digoxin were ordered. It was found that his blood levels of digoxin have increased significantly. Which of his medications is most likely responsible for this increase in digoxin levels? (NEET PG 2021)</span></p>",
    "unique_key": "Q1153669",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633421,
    "difficulty_level": "beginner",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Clarithromycin.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Clarithromycin is known to inhibit the cytochrome P450 system, which is involved in the metabolism of many drugs, including digoxin. By inhibiting the metabolism of digoxin, clarithromycin can lead to elevated levels of digoxin in the blood, increasing the risk for digoxin toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Clarithromycin also acts as an inhibitor of the P-glycoprotein and can precipitate Digoxin toxicity. P glycoproteins are drug efflux pumps in the intestine that lead to a decrease in the bioavailability of drugs. Digoxin is one of the drugs that utilizes this mechanism for its metabolism. Therefore, the drugs which inhibit the Pgp can lead to the increased plasma concentration of Digoxin and lead to its toxicity.</span></li><li><span style=\"font-size:12.0pt;\">Other drugs that inhibit the Pgp include&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\">Amiodarone</span></li><li><span style=\"font-size:12.0pt;\">Verapamil</span></li><li><span style=\"font-size:12.0pt;\">Diltiazem</span></li><li><span style=\"font-size:12.0pt;\">Itraconazole</span></li><li><span style=\"font-size:12.0pt;\">Propafenone</span></li><li><span style=\"font-size:12.0pt;\">Flecainide&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Quinidine.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Potassium chloride:</strong> This medication primarily affects potassium levels and has no significant interaction with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol, a beta-blocker, is not known to significantly interact with digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Triamterene</strong>: This diuretic medication primarily affects sodium and potassium levels and is not known to have a significant impact on digoxin metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clarithromycin can significantly increase plasma levels of digoxin by inhibiting its metabolism through the cytochrome P450 system and by inhibiting P-glycoprotein, leading to an increased risk of digoxin toxicity.</span></p>",
    "correct_choice_id": 26026,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 73256,
    "choices": [
      {
        "id": 291981,
        "text": "<p><span style=\"font-size:14.0pt;\">Also known as five day fever</span></p>"
      },
      {
        "id": 291982,
        "text": "<p><span style=\"font-size:14.0pt;\">Associated with body louse&nbsp;</span></p>"
      },
      {
        "id": 291983,
        "text": "<p><span style=\"font-size:14.0pt;\">Cat is the animal reservoir&nbsp;</span></p>"
      },
      {
        "id": 291984,
        "text": "<p><span style=\"font-size:14.0pt;\">Causative organism is associated with culture negative endocarditis&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not true regarding Trench fever?</span></p>",
    "unique_key": "Q7573820",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634404,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cat is the animal reservoir</strong></span></p>",
    "correct_choice_id": 291983,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 29327,
    "choices": [
      {
        "id": 117214,
        "text": "<p><span style=\"font-size:14.0pt;\">Gonadal mosaicism</span></p>"
      },
      {
        "id": 117215,
        "text": "<p><span style=\"font-size:14.0pt;\">Genomic imprinting</span></p>"
      },
      {
        "id": 117216,
        "text": "<p><span style=\"font-size:14.0pt;\">Anticipation</span></p>"
      },
      {
        "id": 117217,
        "text": "<p><span style=\"font-size:14.0pt;\">Incomplete penetrance</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Which of the following is the phenomenon of a differential effect of the same gene from different parents?</span></p>",
    "unique_key": "Q7469758",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634552,
    "difficulty_level": "intermediate",
    "subjects_id": [],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Genomic imprinting&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Genomic imprinting</strong> refers to the phenomenon where the expression of a gene depends on whether it is inherited from the mother or the father. This occurs due to <strong>epigenetic modifications</strong> such as DNA methylation, which silence specific alleles based on their parental origin. Key examples include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Prader-Willi syndrome</strong>: Results from deletion or dysfunction of the paternal allele on chromosome 15.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Angelman syndrome</strong>: Results from deletion or dysfunction of the maternal allele on chromosome 15.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Gonadal mosaicism:&nbsp;</strong>Gonadal mosaicism refers to the presence of two or more genetically different cell lines in the gonads. It is often seen in conditions like Turner syndrome and can result in the transmission of a genetic disorder even if the parent does not have clinical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anticipation:&nbsp;</strong>Anticipation refers to the phenomenon where a genetic disorder worsens or appears at an earlier age with each successive generation. It is commonly seen in <strong>trinucleotide repeat disorders</strong> such as Huntington\u2019s disease or myotonic dystrophy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Incomplete penetrance:</strong> Incomplete penetrance occurs when an individual carries a pathogenic gene mutation but does not exhibit the clinical features of the associated disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Genomic imprinting</strong> involves the differential expression of the same gene based on parental origin. It is critical in understanding conditions such as <strong>Prader-Willi syndrome</strong> and <strong>Angelman syndrome</strong>, where the parent of origin determines the phenotype.</span></p>",
    "correct_choice_id": 117215,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35221,
    "choices": [
      {
        "id": 140695,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reslizumab </span></span></span></span></p>"
      },
      {
        "id": 140696,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mepolizumab </span></span></span></span></p>"
      },
      {
        "id": 140697,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benralizumab </span></span></span></span></p>"
      },
      {
        "id": 140698,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lebrikizumab</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old female patient with a long history of severe eosinophilic asthma presents to the clinic. Despite being treated with high-dose inhaled corticosteroids and long-acting beta-agonists, she continues to have frequent asthma exacerbations requiring systemic corticosteroids. After further evaluation, the physician decides to initiate a monoclonal antibody therapy that targets IL-5R. Which of the following medications targets IL-5R and works by antibody-dependent cell-mediated cytotoxicity (ADCC)?</span></span></p>",
    "unique_key": "Q9853836",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633805,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Benralizumab</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation for each option:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. Benralizumab</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benralizumab is a monoclonal antibody targeting IL-5R (IL-5 receptor) and exerts its effects through <strong>antibody-dependent cell-mediated cytotoxicity (ADCC)</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. Reslizumab</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reslizumab is a monoclonal antibody that targets IL-5 but does not work through <strong>antibody-dependent cell-mediated cytotoxicity (ADCC)</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. Mepolizumab</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mepolizumab is another monoclonal antibody targeting IL-5, but it does not primarily work through <strong>ADCC</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Lebrikizumab</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lebrikizumab is another monoclonal antibody that targets IL-13 and does not primarily work through <strong>ADCC</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benralizumab is a novel therapy for severe eosinophilic asthma. It binds to the IL-5 receptor (IL-5R) on the surface of eosinophils, leading to their destruction through ADCC. This reduces eosinophilic inflammation and helps prevent asthma exacerbations in patients with severe eosinophilic asthma.</span></span></span></span></p>",
    "correct_choice_id": 140697,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26694,
    "choices": [
      {
        "id": 106718,
        "text": "<p><span style=\"font-size:14.0pt;\">Irradiation&nbsp;</span></p>"
      },
      {
        "id": 106719,
        "text": "<p><span style=\"font-size:14.0pt;\">Antibiotics</span></p>"
      },
      {
        "id": 106720,
        "text": "<p><span style=\"font-size:14.0pt;\">Leuko-reduced RBCs</span></p>"
      },
      {
        "id": 106721,
        "text": "<p><span style=\"font-size:14.0pt;\">Washed RBCs</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">In a patient receiving recurrent transfusions for thalassemia, the development of fever and chills is observed during this period, without any evidence of hemolysis. Which of the following measures can help reduce the rate of transfusion reactions?</span></p>",
    "unique_key": "Q2044057",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634579,
    "difficulty_level": "beginner",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Leuko-reduced RBCs</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient is experiencing a <strong>febrile non-hemolytic transfusion reaction (FNHTR)</strong>, a common complication of <strong>recurrent transfusions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">FNHTR is <strong>caused by cytokines released from donor white blood cells (WBCs)</strong> that accumulate during blood storage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Leukocyte reduction (Leuko-reduced RBCs)</strong> helps by <strong>removing most WBCs from the transfused blood</strong>, thereby <strong>preventing cytokine accumulation</strong> and reducing the risk of FNHTR.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key Features of FNHTR:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Fever and chills</strong> <strong>during or shortly after transfusion</strong></span></li><li><span style=\"font-size:14.0pt;\">No hemolysis (i.e., no hemoglobinuria, jaundice, or significant drop in hemoglobin)</span></li><li><span style=\"font-size:14.0pt;\">More common in <strong>patients requiring multiple transfusions</strong> (e.g., thalassemia, sickle cell disease)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prevention:</strong> Use of <strong>leuko-reduced RBCs</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Irradiation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Irradiation of RBCs is done to <strong>prevent transfusion-associated graft-versus-host disease (TA-GVHD)</strong> in immunocompromised patients.</span></li><li><span style=\"font-size:14.0pt;\">It does not prevent febrile non-hemolytic transfusion reactions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Antibiotics:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">FNHTR is <strong>not an infection</strong>, so antibiotics are unnecessary.</span></li><li><span style=\"font-size:14.0pt;\">If the fever persists beyond the transfusion or is associated with hypotension, <strong>septic transfusion reaction</strong> should be considered instead.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Washed RBCs:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Washing RBCs removes <strong>plasma proteins</strong>, which is helpful in <strong>IgA-deficient patients at risk of anaphylaxis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It does not prevent FNHTR, which is cytokine-mediated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Febrile non-hemolytic transfusion reaction (FNHTR) is due to cytokines released from donor WBCs.</span></li><li><span style=\"font-size:14.0pt;\">Leuko-reduced RBC transfusions significantly decrease FNHTR risk.</span></li><li><span style=\"font-size:14.0pt;\">Irradiation prevents TA-GVHD, while washed RBCs are used for IgA-deficient patients with anaphylactic reactions.</span></li><li><span style=\"font-size:14.0pt;\">FNHTR is managed with supportive care (antipyretics) and does not require antibiotics.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Prevention \u2013</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pre-storage leukoreduction</span></li><li><span style=\"font-size:14.0pt;\">NSAIDs, if persistent fever&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Use of platelet additive solution</span></li><li><span style=\"font-size:14.0pt;\">Plasma reduced or washed products if severe reactions</span></li><li><span style=\"font-size:14.0pt;\">Restrictive transfusion approach in high-risk patients</span></li></ol>",
    "correct_choice_id": 106720,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 74191,
    "choices": [
      {
        "id": 295693,
        "text": "<p><span style=\"font-size:14.0pt;\">Octreotide, a somatostatin analog that inhibits GH secretion</span></p>"
      },
      {
        "id": 295694,
        "text": "<p><span style=\"font-size:14.0pt;\">Pegvisomant, a GH receptor antagonist that blocks GH action</span></p>"
      },
      {
        "id": 295695,
        "text": "<p><span style=\"font-size:14.0pt;\">Cabergoline, a dopamine agonist that suppresses GH secretion</span></p>"
      },
      {
        "id": 295696,
        "text": "<p><span style=\"font-size:14.0pt;\">Lanreotide, a long-acting somatostatin analog</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old male presents with&nbsp;enlarged hands and feet, coarse facial features, excessive sweating, and glucose intolerance. MRI reveals a&nbsp;pituitary adenoma. The patient prefers an&nbsp;oral medication&nbsp;for treatment. Which of the following drugs is an oral agent used to treat acromegaly?</span></p>",
    "unique_key": "Q2003084",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633423,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Cabergoline, a dopamine agonist that suppresses GH secretion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cabergoline is a dopamine agonist that inhibits GH secretion, especially in acromegaly patients with coexisting elevated prolactin levels.</span></li><li><span style=\"font-size:14.0pt;\">It is the only effective oral drug for acromegaly, although it is less potent than somatostatin analogs (Octreotide, Lanreotide).</span></li><li><span style=\"font-size:14.0pt;\">Octreotide and Lanreotide are injectable somatostatin analogs, not oral drugs.</span></li><li><span style=\"font-size:14.0pt;\">Pegvisomant is a GH receptor antagonist, but it is administered subcutaneously, not orally.</span></li></ul>",
    "correct_choice_id": 295695,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 35945,
    "choices": [
      {
        "id": 143575,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alosetron </span></span></span></p>"
      },
      {
        "id": 143576,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Clozapine </span></span></span></p>"
      },
      {
        "id": 143577,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tegaserod</span></span></span></p>"
      },
      {
        "id": 143578,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mosapride</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient present with chronic diarrhea and is prescribed an anti-diarrheal medication. Which of the following drugs acts by inhibiting 5-HT and is used specifically for irritable bowel syndrome with diarrhea (IBS-D)? </span></span></span></p>",
    "unique_key": "Q1955351",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633804,
    "difficulty_level": "difficult",
    "subjects_id": [],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Alosetron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Alosetron is a 5-HT3 receptor antagonist that reduces the symptoms of IBS-D by slowing down the colonic transit time and reducing visceral hypersensitivity. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alosetron</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It is approved for the treatment of diarrhea predominant lBS in women.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It is more potent antagonist of the 5-HT3 receptor than ondansetron.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It shows significant improvements in abdominal pain as well as stool frequency, consistency and urgency in lBS patients.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;It also diminishes visceral sensitivity and slow colonic transit.</span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Its major adverse effect is high incidence of development of ischemic colitis.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Clozapine</span></strong><span style=\"font-size:12.0pt\"> is an atypical antipsychotic used for the treatment of schizophrenia. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tegaserod</span></strong><span style=\"font-size:12.0pt\"> is a 5-HT4 receptor partial agonist used for the treatment of constipation-predominant IBS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mosapride</span></strong><span style=\"font-size:12.0pt\"> is a 5-HT4 receptor agonist used for the treatment of gastrointestinal disorders such as GERD and functional dyspepsia.</span></span></span></p>",
    "correct_choice_id": 143575,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73413,
    "choices": [
      {
        "id": 292601,
        "text": "<p><span style=\"font-size:14.0pt;\">Single-stranded negative-sense RNA&nbsp;</span></p>"
      },
      {
        "id": 292602,
        "text": "<p><span style=\"font-size:14.0pt;\">May be transmitted by mosquito</span></p>"
      },
      {
        "id": 292603,
        "text": "<p><span style=\"font-size:14.0pt;\">Fruit bats acts as reservoir</span></p>"
      },
      {
        "id": 292604,
        "text": "<p><span style=\"font-size:14.0pt;\">Nosocomial transmission seen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">False about the Ebola virus is:&nbsp;</span></p>",
    "unique_key": "Q2822292",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634392,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) May be transmitted by mosquito</strong></span></p>",
    "correct_choice_id": 292602,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 94365,
    "choices": [
      {
        "id": 375676,
        "text": "<p><span style=\"font-size:14.0pt;\">Cowden disease- Hamartomatous polyps</span></p>"
      },
      {
        "id": 375677,
        "text": "<p><span style=\"font-size:14.0pt;\">Hereditary nonpolyposis colorectal carcinoma (HNPCC) - Multiple adenomatous polyps</span></p>"
      },
      {
        "id": 375678,
        "text": "<p><span style=\"font-size:14.0pt;\">Peutz-Jeghers syndrome-associated with colon carcinoma</span></p>"
      },
      {
        "id": 375679,
        "text": "<p><span style=\"font-size:14.0pt;\">Colonic hyperplastic polyp has malignant potential</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">All are true about intestinal polyp syndrome except:</span></p>",
    "unique_key": "Q8871010",
    "question_audio": null,
    "question_video": null,
    "map_id": 34662223,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Colonic hyperplastic polyp has malignant potential</strong></span></p>",
    "correct_choice_id": 375679,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73296,
    "choices": [
      {
        "id": 292137,
        "text": "<p><span style=\"font-size:14.0pt;\">Incorrect antigen&nbsp;</span></p>"
      },
      {
        "id": 292138,
        "text": "<p><span style=\"font-size:14.0pt;\">Incorrect antibody</span></p>"
      },
      {
        "id": 292139,
        "text": "<p><span style=\"font-size:14.0pt;\">Antibody excess&nbsp;</span></p>"
      },
      {
        "id": 292140,
        "text": "<p><span style=\"font-size:14.0pt;\">Antigen excess</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A patient presented with a prolonged fever of unknown origin (PUO), raising suspicion of brucellosis. To confirm the diagnosis, various dilutions of the patient's serum sample are prepared for a standard agglutination test. The outcome is as follows: Agglutination is observed at serum dilutions of 1:20 and 1:40, while no agglutination occurs at dilutions of 1:80 and 1:160. What factor is accountable for the lack of agglutination in the last two dilutions?&nbsp;</span></p>",
    "unique_key": "Q4223143",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634412,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Antigen excess</strong></span></p>",
    "correct_choice_id": 292140,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73340,
    "choices": [
      {
        "id": 292313,
        "text": "<p><span style=\"font-size:14.0pt;\">ICAM-1&nbsp;</span></p>"
      },
      {
        "id": 292314,
        "text": "<p><span style=\"font-size:14.0pt;\">Nicotinic acetylcholine receptor&nbsp;</span></p>"
      },
      {
        "id": 292315,
        "text": "<p><span style=\"font-size:14.0pt;\">CD4&nbsp;</span></p>"
      },
      {
        "id": 292316,
        "text": "<p><span style=\"font-size:14.0pt;\">ACE2 receptor&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is the cellular receptor for the virus shown in the image below?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_46t8Whl.png\" width=\"482\" height=\"320\"></span></p>",
    "unique_key": "Q7712425",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634468,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) ACE2 receptor</strong></span></p>",
    "correct_choice_id": 292316,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 73334,
    "choices": [
      {
        "id": 292289,
        "text": "<p><span style=\"font-size:14.0pt;\">Sporothrix schenckii</span></p>"
      },
      {
        "id": 292290,
        "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcus aureus</span></p>"
      },
      {
        "id": 292291,
        "text": "<p><span style=\"font-size:14.0pt;\">Nocardia asteroides</span></p>"
      },
      {
        "id": 292292,
        "text": "<p><span style=\"font-size:14.0pt;\">Mycobacterium marinum</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">A young man presents with skin lesions as shown in the image below. All of the following organisms can spread through dermal and subcutaneous lymphatics, except?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-03-04%20144955.jpg\" width=\"502\" height=\"287\"></span></p>",
    "unique_key": "Q6225060",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634381,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;B) Staphylococcus aureus</strong></span></p>",
    "correct_choice_id": 292290,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ImageBased"
    ]
  },
  {
    "id": 44805,
    "choices": [
      {
        "id": 178867,
        "text": "<p><span style=\"font-size:12.0pt;\">Aztreonam</span></p>"
      },
      {
        "id": 178868,
        "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
      },
      {
        "id": 178869,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
      },
      {
        "id": 178870,
        "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 45-year-old patient with a known allergy to penicillin presents with a enterococcal endocarditis. The physician needs to prescribe an antibiotic but wants to ensure it is safe for a patient with a penicillin allergy. The patient has had previous allergic reactions to penicillin, including rash and swelling. Which of the following drugs can be used safely in a patient allergic to penicillin?</span></p>",
    "unique_key": "Q2506207",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633388,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Vancomycin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical scenario involves a 45-year-old patient with enterococcal endocarditis and a known allergy to penicillin, presenting with previous allergic reactions including rash and swelling.&nbsp;</span></li><li><span style=\"font-size:12pt;\">The physician needs to choose an antibiotic that is safe for a patient with a penicillin allergy as well as effective for enterococcal endocarditis. Let's review the options:</span></li><li><span style=\"font-size:12pt;\">Vancomycin is a glycopeptide antibiotic that is not related to penicillin.&nbsp;</span></li><li><span style=\"font-size:12pt;\">It is safe for patients with penicillin allergies and is commonly used to treat gram-positive infections, including those caused by enterococci.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Aztreonam: </strong>Aztreonam is a monobactam antibiotic that is generally considered safe for patients with penicillin allergies because it does not share the beta-lactam ring structure of penicillins, which is typically responsible for allergic reactions. However, aztreonam is effective only against gram negative bacteria and is not suitable for enterococcal infections which is a gram positive bacteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ceftriaxone: </strong>Ceftriaxone is a third-generation cephalosporin. Although cephalosporins have a beta-lactam ring similar to penicillins, the rate of cross-reactivity is relatively low, especially with third-generation cephalosporins. However, caution is advised in patients with a history of severe penicillin allergy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Piperacillin: </strong>Piperacillin is a penicillin derivative and should be avoided in patients with penicillin allergies due to the high risk of cross-reactivity and potential for severe allergic reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Conclusion</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The safest options for a patient with a penicillin allergy are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Aztreonam (Option a)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Vancomycin (Option b)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the specific need to avoid penicillin and its derivatives and to treat gram positive (enterococcal) infections, Vancomycin is a safe and effective choice for treating enterococcal endocarditis in this patient. Therefore, the correct answer is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">b. Vancomycin</span></p>",
    "correct_choice_id": 178868,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ]
  },
  {
    "id": 31801,
    "choices": [
      {
        "id": 127074,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methadone </span></span></p>"
      },
      {
        "id": 127075,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Piperidine </span></span></p>"
      },
      {
        "id": 127076,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Morphine </span></span></p>"
      },
      {
        "id": 127077,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tramadol</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 46-year-old male with a history of depression has been treated with fluoxetine for the past six months. He presented to the emergency department with altered consciousness and an ECG showing QT prolongation, with a QTc of 447 ms. Recently, he was prescribed an additional medication for chronic pain management. Which of the following drugs was most likely added to his regimen that could have contributed to his current condition?&nbsp;</span></span>(INICET MAY 2023)</p>",
    "unique_key": "Q4140971",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633375,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Methadone</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Methadone</strong> is known to cause QT prolongation and can interact with fluoxetine, which is an SSRI and inhibits CYP450 enzymes, particularly CYP2D6, that metabolize many drugs including methadone. The inhibition can increase methadone levels, thus increasing the risk of QT prolongation and potential torsades de pointes.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Piperidine</strong> is not a drug but rather a chemical class that includes various analgesics, such as fentanyl and its analogs. These medications do not typically cause QT prolongation; therefore, this would not be the likely cause of the patient&#39;s altered consciousness associated with QT prolongation.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> <strong>Morphine</strong> is an opioid analgesic but is not commonly associated with QT prolongation. It is less likely to be the cause of the EKG changes in the scenario provided.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Tramadol</strong> is a centrally acting opioid analgesic, which also inhibits the reuptake of serotonin and norepinephrine. It can potentially interact with fluoxetine, leading to increased serotonin levels and risk of serotonin syndrome. While it is less commonly associated with QT prolongation compared to methadone, it can still pose a risk, especially when combined with other drugs that affect serotonin levels or when overdosed.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Based on the clinical history and QTc value provided, methadone is the most likely cause of QT prolongation in this scenario, making option (a) the correct answer.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Methadone can cause QT prolongation, and when combined with fluoxetine, which inhibits its metabolism, the risk of QT prolongation and related cardiac issues increases significantly.</span></span></p>",
    "correct_choice_id": 127074,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ]
  },
  {
    "id": 73323,
    "choices": [
      {
        "id": 292245,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 5</span></p>"
      },
      {
        "id": 292246,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4&nbsp;</span></p>"
      },
      {
        "id": 292247,
        "text": "<p><span style=\"font-size:14.0pt;\">3, 4</span></p>"
      },
      {
        "id": 292248,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">1-3)-B-D glucan assay cannot be used in?&nbsp;</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Invasive cryptococcosis</span></li><li><span style=\"font-size:14.0pt;\">Invasive aspergillosis</span></li><li><span style=\"font-size:14.0pt;\">Pneumocystis jiroveci pneumonia</span></li><li><span style=\"font-size:14.0pt;\">Invasive candidiasis&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Mucormycosis&nbsp;</span></li></ol>",
    "unique_key": "Q9241708",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634376,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) 1, 5</strong></span></p>",
    "correct_choice_id": 292248,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 44779,
    "choices": [
      {
        "id": 178763,
        "text": "<p><span style=\"font-size:12pt;\">Acetylcholine</span></p>"
      },
      {
        "id": 178764,
        "text": "<p><span style=\"font-size:12pt;\">Dopamine</span></p>"
      },
      {
        "id": 178765,
        "text": "<p><span style=\"font-size:12pt;\">Epinephrine</span></p>"
      },
      {
        "id": 178766,
        "text": "<p><span style=\"font-size:12pt;\">Nor Epinephrine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following neurotransmitters is released from SA node in response to increase in blood pressure?</span></p>",
    "unique_key": "Q6824575",
    "question_audio": null,
    "question_video": null,
    "map_id": 34633385,
    "difficulty_level": "intermediate",
    "subjects_id": [
      4
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Acetylcholine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Acetylcholine is the primary neurotransmitter released by the parasympathetic nervous system. When blood pressure increases, baroreceptors in the carotid sinus and aortic arch detect this change and stimulate the parasympathetic nervous system. This leads to the release of acetylcholine from the vagus nerve at the SA node, resulting in a decrease in heart rate (bradycardia) and a reduction in cardiac output, which helps to lower blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Dopamine</strong>: Dopamine is a neurotransmitter involved in several central nervous system functions, including movement and reward. It is not directly involved in the regulation of heart rate or blood pressure in the context of the SA node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Epinephrine</strong>: Epinephrine (adrenaline) is released by the adrenal medulla and acts on both alpha and beta adrenergic receptors. It generally increases heart rate and blood pressure. It is not released from the SA node in response to increased blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Norepinephrine</strong>: Norepinephrine is a neurotransmitter released by the sympathetic nervous system. It acts on alpha and beta adrenergic receptors to increase heart rate and blood pressure. However, in response to increased blood pressure, the sympathetic activity is typically reduced, and norepinephrine release is decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, the correct neurotransmitter released from the SA node in response to an increase in blood pressure is acetylcholine, as it is part of the parasympathetic response to decrease heart rate and lower blood pressure.</span></p>",
    "correct_choice_id": 178763,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ]
  },
  {
    "id": 73416,
    "choices": [
      {
        "id": 292613,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3</span></p>"
      },
      {
        "id": 292614,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      },
      {
        "id": 292615,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 4</span></p>"
      },
      {
        "id": 292616,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Identify the correct statements:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Miyagawa corpuscles are found in K.granulomatosis</span></li><li><span style=\"font-size:14.0pt;\">S. sonnei shows late lactose fermentation</span></li><li><span style=\"font-size:14.0pt;\">B. Cepacia complex strains are intrinsically resistant to &nbsp;Aminoglycosides and cephalosporins</span></li><li><span style=\"font-size:14.0pt;\">Cytomegalovirus is the leading cause of infection in renal transplant recipients during the first four months post-transplantation.</span></li></ol>",
    "unique_key": "Q3051795",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634393,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong></span><strong>&nbsp;</strong><span style=\"font-size:14.0pt;\"><strong>D) 2, 3, 4</strong></span></p>",
    "correct_choice_id": 292616,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 73356,
    "choices": [
      {
        "id": 292373,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 292374,
        "text": "<p><span style=\"font-size:14.0pt;\">1, 3</span></p>"
      },
      {
        "id": 292375,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 4</span></p>"
      },
      {
        "id": 292376,
        "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is wrong regarding primary and secondary immune response?</span></p><p>&nbsp;</p><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\">Lag phase is shorter in primary immune response.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Higher amount of antibody produced in secondary immune response</span></li><li><span style=\"font-size:14.0pt;\">Primary response appears mainly in the lymph nodes and spleen</span></li><li><span style=\"font-size:14.0pt;\">Mainly IgG antibody is produced in secondary immune response</span></li></ol>",
    "unique_key": "Q5474768",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634384,
    "difficulty_level": "intermediate",
    "subjects_id": [
      43
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong>&nbsp;<strong>D) 2, 3, 4</strong></span></p>",
    "correct_choice_id": 292376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  },
  {
    "id": 26609,
    "choices": [
      {
        "id": 106378,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-c, 3-a, 4-b&nbsp;</span></p>"
      },
      {
        "id": 106379,
        "text": "<p><span style=\"font-size:14.0pt;\">1-b, 2-d, 3-a, 4-c&nbsp;</span></p>"
      },
      {
        "id": 106380,
        "text": "<p><span style=\"font-size:14.0pt;\">1-c, 2-d, 3-b, 4-a&nbsp;</span></p>"
      },
      {
        "id": 106381,
        "text": "<p><span style=\"font-size:14.0pt;\">1-d, 2-a, 3-b, 4-c&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:14.0pt;\">Match the following complement deficiencies with the disorders given:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_V8CoFN3.png\" width=\"1082\" height=\"352\"></p><p style=\"text-align:justify;\">&nbsp;</p>",
    "unique_key": "Q1263871",
    "question_audio": null,
    "question_video": null,
    "map_id": 34634565,
    "difficulty_level": "intermediate",
    "subjects_id": [
      5
    ],
    "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-b, 2-d, 3-a, 4-c&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Complement deficiencies <strong>impair the immune response</strong>, increasing susceptibility to <strong>specific infections and disorders</strong>.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>C1 esterase inhibitor deficiency \u2192 Hereditary angioneurotic edema (b)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>C1 inhibitor</strong> regulates the complement and kallikrein-kinin system.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency leads to <strong>uncontrolled bradykinin production</strong>, causing <strong>episodic swelling (angioedema)</strong> without urticaria.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>C3 deficiency \u2192 Pyogenic infections (d)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>C3 is central to the complement cascade</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency results in <strong>impaired opsonization</strong>, leading to <strong>recurrent bacterial infections, particularly with encapsulated organisms (e.g., Streptococcus pneumoniae, Haemophilus influenzae).</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Factor H deficiency \u2192 Hemolytic uremic syndrome (a)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Factor H regulates alternative complement pathway</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency leads to <strong>uncontrolled complement activation</strong>, which damages <strong>endothelial cells</strong>, causing <strong>hemolytic uremic syndrome (HUS)</strong> characterized by <strong>hemolysis, thrombocytopenia, and acute kidney injury</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>C5 to C8 deficiency \u2192 Recurrent Neisseria infections (c)</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">These <strong>late complement components</strong> are essential for <strong>membrane attack complex (MAC) formation</strong>, crucial for killing <strong>gram-negative bacteria like Neisseria gonorrhoeae and Neisseria meningitidis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Deficiency leads to <strong>increased susceptibility to Neisseria infections</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>C1 esterase inhibitor deficiency causes hereditary angioedema</strong> due to <strong>unregulated bradykinin production</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>C3 deficiency leads to recurrent pyogenic infections</strong> due to <strong>defective opsonization</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Factor H deficiency is linked to hemolytic uremic syndrome (HUS)</strong> due to <strong>uncontrolled complement activation</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>C5-C8 deficiencies impair the formation of the membrane attack complex (MAC)</strong>, increasing the risk of <strong>recurrent Neisseria infections</strong>.</span></li></ul>",
    "correct_choice_id": 106379,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": []
  }
];
        let quizName = '(The Champion Batch Hyderabad) - 30-09-2025';
        const quizFilename = 'the-champion-batch-hyderabad-30-09-2025-571c2d88.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Champions Batch"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>